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Abstract
During lens development, epithelial cells located at the equatorial region of the 
lens undergo terminal differentiation to form fibre cells; resulting in cell 
elongation and degradation of all intracellular organelles. Failure to complete this 
process successfully can result in cataract. This process is thought to be an 
attenuated form of classical apoptosis. This study was completed to give a 
comprehensive analysis of apoptosis genes in the developing mouse lens.
Macroarrays containing 243 immobilised cDNAs with a known role in apoptosis 
were utilised to examine the gene expression at different developmental stages. 
The stages examined were postnatal day 7 and postnatal day 14. Over 100 
apoptosis genes were shown to be expressed above background with 20 genes 
demonstrating significantly differential expression (2-fold or greater change in 
expression, p -value < 0.05), with highest expression at P I4. PCR confirmed 
expression of all the genes identified from the array results, and differential 
expression was confirmed for 52% of the genes. Protein expression of two 
selected genes, axl and mcl-1, was demonstrated using western blotting.
Lens morphology was examined in transgenic mice generated to contain an 
extended CAG repeat in the huntingtin gene (one of the genes identified from the 
arrays). Morphology was compared between homozygote, heterozygote and 
wild-type mice. The presence of the mutated gene did not affect denucleation 
during lens differentiation and no statistically significant difference was seen in 
the dimensions of the organelle free zone (OFZ) of the wild-type and 
homozygote mice.
A cross-species comparison was completed. Gene expression of the genes shown 
to be highly expressed and differentially expressed from the array results was 
examined in embryonic chick lenses. From the results of this part of the study 
expression was seen for 83% of genes. These results add to the argument that the 
process of differentiation is similar in both mouse and chick lenses.
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Chapter 1: Introduction
Introduction
1.1. General Introduction
The lens is located in the eye between the iris and the vitreous body, where its 
function is to focus light onto the retina. The lens is made up of two different 
types of cells; a single layer of epithelial cells at the anterior and fibre cells 
which make up the remainder of the lens. The lens epithelial cells differentiate 
into fibre cells at the equatorial region of the lens. During this process, which has 
been likened to classical apoptosis (a type of programmed cell death), the 
intracellular organelles are degraded. This process of organelle degradation 
ensures that any potential light-scattering structures are removed from the visual 
axis.
Differentiation of lens epithelial cells into fibre cells continues throughout life, 
constantly covering underlying fibre cells with new ones. This leads to an 
increase in lens size throughout life. The cells contained within the lens persist 
throughout the lifetime of the organism and so protein turnover is limited to the 
outer epithelial cells. This means that the proteins of the lens have to be very 
stable to avoid denaturation. Any disruption to either the structure of the proteins 
within the lens, or the process of organelle removal during differentiation can 
result in cataract e.g. in Rubella syndrome (McAlister Gregg 2001).
The purpose of this introductory chapter is to give the reader background 
information about the lens including its development, differentiation and ageing. 
It will also provide details of the process of classical apoptosis to allow 
comparisons to be made between this process and that of organelle degradation 
in the lens.
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1.2. Apoptosis
Apoptosis (programmed cell death) is essential in both development and tissue 
homeostasis, selectively deleting a cell. It is now known that apoptosis occurs at 
a low rate in most healthy mammalian tissues where it complements the role of 
mitosis, thus ensuring the maintenance of cell number. Apoptosis was first 
described in 1972 when a form of cell death that was morphologically distinct 
from necrotic death was observed (Kerr et al. 1972). It has since been shown that 
apoptosis pathways are evolutionarily conserved between species (Ameisen 
2002).
Apoptosis is characterised by a series of distinct morphological changes. The cell 
and its nucleus are seen to shrink; chromatin condensation and marginalisation 
are seen to accompany this. Ultimately, the cell surface protuberances separate to 
produce membrane-enclosed apoptotic bodies in which the cytoplasmic 
organelles remain well preserved. The formation of these apoptotic bodies is 
completed in several minutes. They are then phagocytosed by macrophages or 
taken up by neighbouring cells and digested within lysosomes in vivo. The 
apoptotic bodies are recognised by the presence of phosphatidylserine on the 
outer surface which acts as a target signal for phagocytes (Kerr et al. 1972).
In 1980, it was shown that the morphological changes occurring during apoptosis 
are associated with a distinctive double-strand cleavage of nuclear DNA at the 
linker regions between nucleosomes (Wyllie et al. 1980). This results in 
multiples of 180-200 base pair oligonucleosomal fragments which when viewed 
on an agarose gel results in a distinctive DNA ladder. This DNA ladder is widely 
recognised as the major molecular criterion of apoptosis.
Three phases of apoptosis have been identified; firstly there is the initiation 
phase, followed by the effector phase and then finally the degradation phase 
(Kroemer et al. 1995). Apoptosis can be triggered by both extracellular signals, 
such as a withdrawal of growth factors or intracellular signals, such as DNA 
damage (Evan and Littlewood 1998; Green and Reed 1998; Nagata 1997).
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The initiation phase is dependent on death-inducing primary stimuli, which are 
integrated by members of the Bcl-2 family of proteins. The signalling pathways 
generated during the initiation phase then converge on the mitochondria where 
they are amplified and then focused onto the caspase cascade. This then activates 
the degradation phase where mitochondrial proteins are released leading to the 
cleavage of key cellular proteins and DNA fragmentation.
1.2.1. Bcl-2 Family Members
Bcl-2 was the first mammalian regulator of apoptosis identified. Many more 
structurally similar proteins were recognised later, forming the Bcl-2 related 
family of proteins. There are at least 15 members of the Bcl-2 family found in 
mammalian cells (Adams and Cory 1998). The Bcl-2 family of proteins contains 
a number of apoptosis-regulatory proteins, which act upstream of the caspase 
cascade.
Bcl-2 family members can be organised into two groups, one group which 
inhibits apoptosis (e.g. Bcl-2, B c1-Xl, M cM l) and one which promotes it (e.g. 
Bax, Bak, Bcl-Xs, and M cl-ls ) . The structures of these proteins vary with both 
their location and function. All family members have been shown to have at least 
one of four conserved Bcl-2 homology (BH) regions (Adams and Cory 1998). 
The proteins with the most structural similarity to Bcl-2 have been shown to 
inhibit apoptosis (as demonstrated in Figure 1.1); anti-apoptotic members of the 
Bcl-2 family typically contain all 4 BH domains, e.g. B c1-Xl and Bcl-W 
(Antonsson 2001). In contrast, the pro-apoptotic proteins have few common 
domains with Bcl-2. This pro-apoptotic set of proteins can be further divided into 
two groups: the multidomain proteins including Bax and Bak, and the BH3 only 
proteins e.g. Bad and Bid (Burlacu 2003). One of the BH domains, the BH3 
group, has been shown to be required for death-inducing activity (Chittenden et 
al. 1995; Hunter and Parslow 1996).
4
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Antiapoptotic Bh 3 BH1 TM ] .r.
Bcl-2, Bcl-XL, Mel-1, A l, Bel w
Proapoptotic N .l BH3 BH1 BH2 TM I -C
Bax, Bak, B ok
N -1 BH3 TM | -C
Bik, BNIP
W-i BH3 I.C
Bad, Bid, Bim, EGL-1
Figure 1.1: Diagram showing the structure o f the different Bcl-2 family members. BH1-4 
represent the Bcl-2 homology domains; TM represents the transmembrane domain. Figure was 
adapted from Burlacu 2003
Both pro- and anti-apoptotic members of this family have been shown to be 
localised to distinct compartments within the cell. Anti-apoptotic proteins, e.g. 
Bcl-2, are initially integral membrane proteins found in the mitochondria, 
endoplasmic reticulum and nuclear envelope (Akao et al. 1994). In contrast, the 
pro-apoptotic proteins, e.g. Bax, tend to be cytosolic proteins which, following 
the induction of apoptosis, undergo a conformational change following a death 
signal allowing them to integrate into the mitochondrial outer membrane (Wolter 
et al. 1997).
The fate of a cell (as to whether or not it will undergo apoptosis) is determined 
by posttranslational modifications (proteolysis and phosphorylation) to these 
proteins and the ratio of both pro- and anti-apoptotic proteins (Oltvai et al. 1993). 
The BH regions within the proteins affect their ability to interact with one 
another. Bcl-2 family members are capable of either hetero- or 
homodimerisation; by forming dimers, these proteins can seemingly control their 
function. It has been observed that Bcl-2 can form heterodimers with Bax 
suppressing its death-inducing activity (Oltvai et al. 1993). Bcl-2 has also been 
noted to form homodimers which have been shown to promote cell survival, 
whereas when Bax homodimerises it inserts into the mitochondrial membrane 
causing mitochondrial permeabilisation, leading to apoptosis.
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Anti-apoptotic family members seem to promote cell survival by inhibiting 
adapters required for activation of the downstream caspases (Adams and Cory 
1998). Pro-apoptotic proteins dismantle the adapters from the pro-survival 
proteins, thereby allowing the activation of caspases, ultimately resulting in cell 
death.
Anti-apoptotic protein Bcl-2 acts on the mitochondria preventing the release of 
cytochrome c (Yang et al. 1997a). Cytochrome c is required for the formation of 
the apoptosome, a protein complex composed of Apafl, procaspase-9, dATP and 
cytochrome c (Li et al. 1997). This formation of the apoptosome leads to the 
activation of caspase-9 which subsequently cleaves and activates caspase-3. 
Following the activation of caspase-3, the recognised caspase substrates are 
cleaved and the morphological changes of apoptosis observed.
In contrast to the mechanism described above, Bax (a pro-apoptotic protein) has 
been suggested to cause cell death by damaging organelles, forming channels in 
the mitochondrial membrane (Antonsson et al. 1997). Even in the presence of 
caspase inhibitors, Bax and Bax-like proteins were shown to cause DNA 
condensation and membrane alterations, resulting in cell death (Gross et al.
1998).
1.2.2. The Role of Mitochondria in Apoptosis
The mitochondrial phase of apoptosis is characterised by an irreversible loss of 
mitochondrial membrane barrier function. The outer membrane becomes 
permeabilised leading to the release of intermembrane proteins into the cytosol. 
During the permeabilisation of the mitochondria membrane, the inner 
mitochondrial membrane potential (A\j/m) is lost (Newmeyer and Ferguson-Miller 
2003).
Permeabilisation of the membrane leads to the release of intermembrane proteins 
including cytochrome c, apoptosis inducing factor (AIF), endonuclease G, and 
Smac/DIABLO (van Gurp et al. 2003). Cytochrome c forms the apoptosome, 
leading to the activation of caspase-9 as previously described above. AIF is 
usually localised in the mitochondria; although, following an apoptosis signal it
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is translocated to the nucleus. Overexpression of AIF induces DNA 
fragmentation, chromatin condensation, exposure of phosphatidlyserine on the 
plasma membrane and dissipation of the mitochondrial potential (van Gurp et al 
2003). Endonuclease G is also translocated to the nucleus in the presence of an 
apoptotic signal, where it cleaves DNA independently of caspase activation (van 
Gurp et al 2003). Smac/DIABLO has been shown to regulate apoptosis 
indirectly by interacting with inhibitors of apoptosis proteins (IAPs) (Verhagen et 
al 2000). IAPs bind to activated caspases thereby inhibiting their enzymatic 
activity (Deveraux and Reed 1999). Smac/DIABLO dislodges caspases from 
IAPs upon reaching the cytosol, triggering caspase activity (Degli Esposti 2003).
1.2.3. The Caspase Family
Apoptotic cell death is accompanied by highly selective and specific proteolytic 
events. Members of the caspase (cysteine-containing aspartate-specific proteases) 
family play a significant role in this process by mediating the majority of 
proteolytic events. The caspases are involved in amplifying the initial death 
signal from initiator to effector caspases in a proteolytic cascade (Wilson 1999).
Caspases -8 and -9 are initiator caspases. Once activated, these initiator caspases 
trigger downstream effector caspases, such as caspases -3, -6 and -7. These 
downstream caspases can then in turn cleave key structural components such as 
DFF45, ICAD, poly (ADP-ribose) polymerase (PARP) and nuclear lamins (Vaux 
and Strasser 1996; Wilson 1999). Cleavage of these molecules results in the 
change in structural morphology characteristic of apoptosis.
DNA fragmentation factor (DFF) is a heterodimer made up of two subunits, DFF 
40 (40kDa) and DFF 45 (45kDa). During apoptosis caspase-3 cleaves DFF 45 to 
release the active 40kDa subunit triggering DNA fragmentation and chromatin 
condensation (Liu et al 1998; Liu et a l 1997). Following cleavage of DFF, 
caspase-3 plays no further role in DNA fragmentation although it still cleaves 
PARP and lamin B which may help the degradation of the nuclear envelope.
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PARP is a nuclear enzyme which binds to DNA breaks. Following exposure to 
genotoxic agents PARP triggers the base excision repair pathway (Ding et al 
1992; Ding and Smulson 1994). Cleavage of PARP by caspase-3 during 
apoptosis incapacitates the DNA damage surveillance network, thereby 
preventing attempts at repairing the fragmented DNA. Cleavage of lamins, the 
major structural proteins of the nuclear envelope, has also been shown to 
accompany the apoptotic process (Lazebnik et al. 1995).
1.3. Vertebrate Eye Structure and Development
As a result of gastrulation, the embryo contains three germ layers; the ectoderm, 
the mesoderm and the endoderm. The ectoderm, the outer layer of cells, will give 
rise to the major parts of the eye (Gilbert 2003). The development of the lens 
begins once the optic vesicle and surface ectoderm are in close proximity. The 
opposing tissues thicken forming the lens placode. During this period of 
induction, the optic vesicle and the lens placode are held tightly together through 
a network of collagenous fibrils and cytoplasmic processes (Chow and Lang 
2001).
Due to the close proximity of the lens ectoderm to the optic vesicle, it was 
believed that the optic vesicle was the lens inducer. Indeed, early experiments 
carried out by Spemann in 1901 seemed to show just that (Spemann 1901). The 
optic vesicle was removed from an amphibian, resulting in an absence of lens 
formation. Later experiments in other species showed contradictory results, 
suggesting that the optic vesicle was not the only tissue involved in lens 
induction.
This period of induction is the stage during development where the primitive lens 
structure first begins to appear. The primitive lens is composed of a spherical 
layer of epithelial cells surrounding a hollow interior (shown in Figure 1.2.). 
This cavity is filled by the elongation of epithelial cells located at the posterior of 
the lens vesicle. These cells are the primary fibre cells. The cells located at the 
anterior pole of the lens vesicle remain as epithelial cells, thus providing the lens 
with its characteristic polarity. Mitotically active cells are found around the
Introduction
epithelial region just above the lens equator. These cells make up the germinative 
zone. Lens structure is shown in Figure 1.3.
A B
Cornea
Presumptive Retina
IVnunpiw Primary
Figure 1.2: Overview of lens induction. Induction o f the lens is dependent on the close contact o f  
the optic vesicle and surface ectoderm. The surface ectoderm thickens to form the lens placode 
which then invaginates forming the lens vesicle (A). This presumptive lens is composed o f a 
spherical layer o f cells surrounding a hollow lumen (B). Cells from the posterior o f the lens 
vesicle elongate to fill the lumen forming the primary lens fibres (represented by the red arrows 
in the diagram). Figure adaptedfrom Piatogorsky 1981.
Daughter cells from this germinative zone migrate into the equatorial region of 
the lens where they elongate and differentiate into secondary lens fibres. New 
secondary lens fibres are continuously added to the fibre mass throughout life. 
Therefore, the lens continues to grow throughout the lifetime of the organism 
with new fibres successively added and retained for the entire life of the 
organism.
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Figure 1.3: Lens structure. The lens is contained within a basement membrane, the lens capsule 
(shown here in green). The lens is made up o f two types o f cells: epithelial cells (LEC) (shown in 
yellow) and fibre cells (LFC). As the epithelial cells reach the equatorial region (EQ) they begin 
to differentiate into secondary fibre cells. The primary fibre cells, formed during embryonic 
development, are shown here in red.
Experiments carried out by Coulombre and Coulombre (1963) demonstrated that 
differentiation of lens epithelial cells is dependent on their location within the 
eye. They studied changes in the embryonic chicken lens after surgical reversal, 
so the lens epithelium faced the vitreous body. Just two days after the operation, 
all the epithelial cells were shown to be elongated. The fibres, which had 
differentiated previously were now located anteriorly and ceased to elongate as 
soon as the lens was reversed. A narrow ring of epithelium was left at the equator 
of the lens. The cells produced from this epithelial ring, which moved towards 
the neural retina, became fibre cells, whereas those that migrated towards the 
cornea became simple cuboidal epithelial cells. Eventually the lens reversed its 
organisation: producing new fibre cells posteriorly and rebuilding an epithelium 
anteriorly (Coulombre and Coulombre 1963). Later studies showed that the 
vitreous, but not the aqueous, induced the morphological changes characteristic 
of lens cell differentiation (Lovicu et al. 1995). Further details about the growth 
factors involved in lens differentiation are given in Section 1.3.2.
During differentiation, both primary and secondary fibre cells lose their nuclei 
and organelles. The way in which these cells differentiate leads to the formation 
of a concentric gradient of age and stage of differentiation. The cells at the
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centremost region of the lens will be the oldest and the most highly 
differentiated, while those at the periphery are the youngest. These combined 
characteristics make the lens a good model for research into development, ageing 
(as the exact age and differentiation stage of the cells used can be identified) and 
apoptosis (Piatigorsky 1981; Wride 1996).
1.3.1. Crystallin Expression in the Lens
Terminal differentiation from epithelial cells to fibre cells is characterised by 
changes in protein expression. The level of crystallins is increased dramatically 
during this process, the synthesis of which is initiated by contact between the 
lens placode and the optic cup during induction. Crystallins are members of the 
small heat shock family of proteins and have been shown to be required for both 
generating and maintaining lens clarity (Harding 1991). Four distinct families of 
crystallins have been identified, a-, (3-, y- and 8-crystallin, (8-crystallin is not 
found in mammalian lenses) which make up approximately 90% of the soluble 
proteins in the lens (Piatigorsky 1981).
The principle protein found in the lens is a-crystallin. Alpha-crystallin is a 
hetero-oligomeric complex composed of two different subunits aA- and aB- 
crystallin which has a known role as a molecular chaperone, preventing 
aggregation of proteins in the lens (Horwitz 1992). The expression of crystallins 
in the lens has been shown to alter during differentiation; firstly a-crystallin 
expression increases followed by observed increases in both (3- and y-crystallins 
(Peek etal. 1992).
Following the introduction of a-crystallins to bovine lens cultures the cells 
underwent morphological changes reminiscent of the changes observed during 
lens epithelial differentiation (Boyle and Takemoto 2000). Previously a- 
crystallin had been shown to bind to actin (Del Vecchio et al. 1984), type III 
intermediate filament proteins and the beaded filament proteins CP49 and CPI 15 
(Carter et al 1995). These findings along with the results of Boyle and 
Takemoto’s study lead to the suggestion that the increase in expression of a- 
crystallin could play a role in the membrane cytoskeleton remodelling observed 
during lens epithelial cell differentiation.
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A number of a-crystallin knockout mice have been generated to elucidate the 
physiological function of these proteins. The aA knockout mice presented with 
early-onset cataract (Brady et al. 1997) and increased cell death in lens epithelial 
cells (Xi et al. 2003). In contrast, the aB knockout lenses demonstrated 
hyperproliferation of the epithelial cells and an increase in genomic instability 
(Andley et al. 2001). In the lenses of the aA/aB double knockout mice lens fibre 
cells were observed to disintegrate following the degradation of all intracellular 
organelles. This disintegration of fibre cells was thought to be attributable to an 
increase in caspase activity; higher levels of both caspase-6 and caspase-3 were 
noted. An interaction between aA-crystallin and caspase-6 was observed leading 
to the suggestion that the a-crystallins could be suppressing caspase activity in 
the lens (Morozov and Wawrousek 2006). Members of the crystallin family of 
proteins have also been shown to interact with members of the Bcl-2 family of 
proteins, inhibiting their function (Mao et al. 2004). An anti-apoptotic role for 
the a-crystallins has previously been recognised; a-crystallins have been shown 
to protect cells from apoptosis induced by a variety of apoptotic agents (Andley 
et al. 1998; Andley et al. 2000).
1.3.2. Signals Involved in Lens Development
Contact between the optic vesicle and surface ectoderm is a critical period during 
eye development, during which inductive signals are exchanged between these 
two tissues. Many factors which influence lens development have now been 
identified (reviewed in Lang 1999). Proliferation has been shown to be restricted 
to the epithelial cells in the lens. However, there are areas of the epithelium in 
which the proliferative index varies. The epithelial cells with the highest level of 
proliferation are located near the ciliary body. The lowest level of proliferation is 
found in the centre of the epithelium (Zhou et al. 2006). This suggests that the 
factors regulating proliferation may be found in the ciliary body and the 
availability of these factors may be modulated by the surrounding tissues. This 
also suggests that regulation of these factors would be essential to maintain the 
rate and location of proliferation of these cells.
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1.3.2.1. The Role of Pax6 in Lens Development
Pax6 is a transcription factor proven to be essential for lens formation (Grindley 
et al. 1995). It has been shown to be highly conserved across species suggesting 
its importance in this process (Graw 1996). Pax6 has been shown to be expressed 
in the lens during morphogenesis and is continually expressed in the lens 
epithelium. Pax6 expression was shown to be missing from lens fibre cells and 
overexpression of Pax6 in these cells was shown to inhibit fibre cell 
differentiation and maturation (Duncan et al. 2004). A number of other 
transcription factors have been observed in the lens during development, 
including Eya, Sox and Msx and it has been proposed that these transcription 
factors form a complex with Pax6, regulating eye development in both 
vertebrates and invertebrates (McAvoy et al. 1999).
1.3.2.2. FGFs in Lens Development
Fibroblast growth factors (FGFs) have been identified as potent inducers of fibre 
differentiation. Rat lens epithelial cells in explants containing FGF showed 
increased proliferation, cell migration and fibre differentiation. The inhibition of 
these processes by a bFGF antibody provides support for this molecule initiating 
all three processes (McAvoy and Chamberlain 1989). It has been observed that 
the response of epithelial cells to FGF is dependent on the concentration of the 
growth factor. As the concentration of FGF increases, the cells begin to 
proliferate. The concentration must then be increased further before they begin to 
migrate. Finally, fibre differentiation requires the highest concentration of FGF 
(McAvoy and Chamberlain 1989). This observation fits in with the spatial 
patterns of cellular behaviour observed in the lens. A concentration gradient of 
FGF is present in the eye; from negligible concentrations in the aqueous of the 
anterior chamber to concentrations in the vitreous high enough to induce fibre 
differentiation.
Epithelial cells in the central region of the epithelium do not undergo 
differentiation and are found to be non-proliferative. These cells are bathed by 
the aqueous. Epithelial cells at the equator and in the germinative zone still show 
no signs of differentiation, though they are highly proliferative. These cells are
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exposed to the aqueous in the anterior chamber, so are still exposed to relatively 
low levels of FGF. Migration of the cells at the equator is achieved by exposure 
of the cells to a higher level of FGF as they are located at the junction between 
the aqueous and vitreous. Cells below the equator are bathed by the vitreous; 
therefore, they are exposed to a high enough concentration of FGF to allow them 
to differentiate, thereby becoming fibre cells. It has been suggested that the 
retina, due to its close proximity to the vitreous, may be the major source of FGF 
in the eye (McAvoy and Chamberlain 1989). However, the high inducing 
property of the vitreous may not only be due to the presence of FGF, other 
factors may also be present such as insulin-like growth factor (IGF-1) (Lang
1999). This observation of the vitreous inducing lens differentiation correlates 
with the findings from the Coulombres’ experiment described previously 
(Coulombre and Coulombre 1963).
1.3.2.3. IGF
IGF was first implicated in lens differentiation when a factor in the chick 
vitreous was identified that could stimulate cell differentiation in culture (Beebe 
et al. 1980). Since then IGF-1 has been shown to have a potent differentiation 
effect on chick lens epithelial cells, but a minimal effect on proliferation (Hyatt 
and Beebe 1993). In contrast, explants of epithelial cells from the rat lens showed 
increased DNA synthesis but poor differentiation when exposed to IGF-1 alone 
(Liu et al. 1996). However, when the lens cells were exposed to IGF in addition 
to FGF, the differentiation effect of FGF was seen to be amplified (Liu et al. 
1996) This has lead to the proposal that IGF-1 and FGF act together to regulate 
differentiation and proliferation in rodents, whereas IGF-1 alone stimulates cell 
division (Lang 1999).
1.3.2.4. BMP4
Bone morphogenetic protein 4 (BMP4) is another signalling molecule that has 
been implicated in embryonic tissue interactions (Trousse et al. 2001). It has 
been shown to be strongly expressed in the optic vesicle and weakly expressed in 
the surrounding mesenchymal tissue. It has been shown to have a crucial role in 
lens induction and in BMP4 homozygous null mice no lens induction occurs 
(Furuta and Hogan 1998). Another member of the BMP family, BMP7 has also
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been shown to be essential for embryonic eye development (Furuta and Hogan 
1998).
I.3.2.5. Other Factors Involved in Lens Differentiation
Other factors with a known role in lens development include members of the 
Wnt and TGFp families. Several members of the Wnt family have been shown to 
be expressed in the lens epithelium of both rats and chicks, with expression 
extending into the germinative zone, their localisation suggests a role for this 
family in lens differentiation (Fokina and Frolova 2006; Stump et al. 2003).
When TGFp receptor signalling was disrupted in lens fibre cells by the 
overexpression of a mutant truncated form impaired fibre maturation was 
observed, suggesting a role for this family in differentiation (de Iongh et al 
2001). However, despite the observations that these families have some influence 
over the differentiation of lens cells FGF still seems to be the main initiation 
factor of the differentiation process (Lovicu and McAvoy 2005).
1.3.3. Apoptosis in Lens Development
Mohamed and Amemiya (2003) investigated the development of the lens vesicle 
in rats. They suggested that the process of programmed cell death plays a 
fundamental role in the development of the lens vesicle. Results showed that by 
day 11 of gestation, apoptotic cells were present in the mesenchymal cells 
between the surface ectoderm and the optic vesicle, before the start of lens 
invagination, suggesting that these cells needed to be eliminated to provide space 
to enable contact between these two tissues. Apoptotic cells were also found at 
the junction of the surface ectoderm and lens placode as well as in the outer layer 
of the optic vesicle. These observations have shown that apoptosis plays a major 
role in lens vesicle development, from eliminating the cells between the surface 
ectoderm to aiding invagination of the lens and facilitating separation from the 
surface ectoderm (Mohamed and Amemiya 2003). In addition to these roles in 
development, an apoptosis-like process is thought to be responsible for the 
degradation of organelles in differentiating lens fibre cells.
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1.4. Lens Organelle Degradation
During the terminal differentiation of lens epithelial cells to lens fibre cells a 
number of characteristic morphological changes are observed. The cell increases 
50- to 100- times in length during differentiation. This elongation is accompanied 
by an increase in fibre-specific proteins including the intermediate filament 
proteins CP49 and CP95 (Ireland et al. 2000) and the crystallins (reviewed in 
Cvekl and Piatigorsky 1996). The process of terminal differentiation also results 
in the elimination of all the intracellular organelles. It has been suggested that the 
process of organelle elimination in lens fibre cells is analogous to programmed 
cell death (Bassnett 2002; Dahm 1999; Wride 2000). This process has been 
shown to have many similarities to apoptosis: known members of the apoptotic 
cascade have been shown to be active and all cytoplasmic organelles are 
removed as in apoptosis. However, unlike conventional apoptosis, the cells from 
which the organelles have been removed persist throughout life, rather than being 
destroyed. Other structural differences have also been observed. For example, the 
cytoskeleton persists in fibre cells that have completed organelle degradation 
whereas it is completely degraded during apoptosis (Bassnett and Beebe 1992; 
Dahm et al. 1998). Also, there is no flipping of phosphatidylserine to the outer 
membrane of the lens fibre cells as observed in apoptosis (Bassnett and Mataic 
1997; Wride and Sanders 1998). This could suggest an underlying difference in 
these pathways or different regulation of the same pathway.
There are two types of lens fibre differentiation; primary and secondary. Primary 
fibre differentiation occurs early on during embryonic development when the 
cells at the posterior of the lens vesicle elongate to fill the vesicle. Secondary 
fibre differentiation occurs later when the epithelial cells at the lens equator 
differentiate and elongate. These two processes are thought to occur in different 
ways. In primary fibre differentiation condensation of the nucleoplasm and 
accumulation of dense bodies in the cytoplasm (most likely formed from 
chromatin) of the fibre cells has been observed (Vrensen et al. 1991). This is in 
contrast to the process of secondary fibre differentiation where the nucleoplasm 
is gradually degraded resulting in a density similar to that of the cytoplasm 
(Kuwabara and Imaizumi 1974).
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Lens organelle degradation results in the formation of an organelle free zone 
(OFZ) in the centre of the lens. The OFZ begins to form between 17.5dpc and 
birth in mice (Kuwabara and Imaizumi 1974) and at around embryonic day 12 
(E l2) in chicks (Modak and Perdue 1970). In chick embryos, it has been 
observed that by E21 (hatching) the diameter of the OFZ is large enough to fill 
the pupil of the eye (Bassnett and Beebe 1992). This means that any existing 
organelles in the superficial cells are in the shadow of the iris and so are not 
disrupting the optical path. The degradation of cytoplasmic organelles in the lens 
eliminates potentially light scattering structures and is essential to the formation 
of an optically clear cytoplasm. Disturbances in this process have been shown to 
lead to congenital cataract, e.g. in Rubella syndrome (Gregg and Banatvala 2001) 
and disorganisation in the lens fibres (Bassnett and Mataic 1997).
Cells at the boundary of the OFZ have been studied extensively. It has been 
shown that, as in the case of apoptosis, mitochondrial permeability transition is 
an early event in lens organelle degradation. Mitochondria in cells bordering the 
OFZ suddenly fragment and lose their ability to retain rhodamine-123 (cationic 
A\|/m-sensitive dye) (Bassnett 1992; Bassnett and Beebe 1992). This indicates that 
the mitochondrial potential (A\j/m) is lost. There is no evidence to suggest whether 
the loss of mitochondrial potential occurs in all mitochondria throughout the lens 
or whether it occurs in a wave-like progression.
Previous studies using the chick lens have shown that the mitochondria and 
nucleus disappear coincidentally and abruptly (Bassnett and Beebe 1992). 
Experiments were also carried out to observe the fate of the Golgi apparatus and 
the endoplasmic reticulum. Towards the lens equator the Golgi apparatus was 
shown to fragment. The Golgi apparatus was only found in the superficial lens 
fibre cells. The endoplasmic reticulum was more abundant, extending to the edge 
of the OFZ where it was degraded along with the nucleus and mitochondria 
(Bassnett 1995). These observations suggest a wave of organelle degradation 
extending out from the centre of the lens. However, the actin cytoskeleton still 
remains after fibre cell differentiation, suggesting that this is a selective process 
rather than a global breakdown of the cell (Bassnett and Beebe 1992).
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1.4.1. Denucleation of the Lens Fibre Cells
Lens denucleation occurs during the differentiation process of lens epithelial 
cells to fibre cells at the equatorial region of the lens. A similar situation has been 
observed in the terminal differentiation of both keratinocytes and erythrocytes 
(Lockshin and Zakeri 2004). Differentiation of epithelial cells to fibre cells 
includes a change in the morphology of the nucleus. The nuclear breakdown 
observed during this process has been noted to be morphologically similar to that 
seen in classical apoptosis (Dahm and Prescott 2002). Epithelial cells contain 
slightly round nuclei then, as they mature, they elongate and shrink to a more 
globular and highly condensed shape (Counis et al. 1998). A wave of nuclear 
degeneration spreads outwards from the centre of the lens, to the outermost 
fibres, which still contain intact nuclei (shown in Figure 1.4). This results in an 
increase in the size of the OFZ as development proceeds. Final DNA degradation 
and complete loss of the nuclei have been shown to be relatively late events in 
fibre cell differentiation occurring after the loss of the mitochondria, 
endoplasmic reticulum and the breakdown of the nuclear membrane (Bassnett 
and Mataic 1997). Morphological studies of lens fibre denucleation have 
documented the disintegration of the nuclear envelope into a chain of membrane 
vesicles with the nuclear contents eventually becoming indistinguishable from 
the cytoplasm (Kuwabara and Imaizumi 1974). Experiments have shown that 
DNA degradation is a gradual process with cells up to 100-200pm into the OFZ 
of an embryonic chick lens still containing collapsed nuclei. Small remnants of 
nuclear material have been observed in the centre of the chick lens (Bassnett and 
Mataic 1997) along with lamin B and histone proteins (Bassnett 1995).
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Figure 1.4: Nuclear degeneration o f the lens. A wave o f denucleation in the lens is observed 
from the intact nuclei in the outermost fibre cells (A) to the OFZ in the centre o f the lens (D). The 
intermediate stage o f nuclear degeneration, pycknotic nuclei, are represented by B and C. Figure 
was adapted from the figure in Wride 2000.
Non-random DNA degradation occurs during organelle degradation. The DNA 
degradation products resulting from lens fibre denucleation produce the same 
distinctive DNA ladder as apoptosis (Modak and Perdue 1970). It has been 
suggested that the cleavage of the DNA could be controlled by the protein 
environment. Counis et al (1998) proposed that the DNA is deprived of 
protective proteins during lens fibre differentiation, which would favour the 
action of endonucleases.
As described previously, DNA fragmentation factor (DFF) is a heterodimer made 
up of two subunits, DFF 40 (40kDa) and DFF 45 (45kDa). During apoptosis 
caspase-3 cleaves DFF 45 to release the active 40kDa subunit. In the chicken 
embryo lens, the active cleavage product of DFF45 is observed around E l2 
(Wride et al 1999). This is also the stage at which organelle degradation is 
initiated (Modak and Perdue 1970). However, following the generation of a DFF 
knockout mouse with no reported ocular phenotype an absolute requirement for 
DFF in organelle degradation is unlikely (Zhang et al 1998). Therefore, another 
endonuclease must be responsible for the degradation of the nucleus.
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DNase II-like acid DNase (DLAD) has been shown to be uniquely expressed in 
the lens of both humans and mice (Nishimoto et al. 2003). DLAD deficient mice 
were shown to be incapable of degrading DNA during lens fibre differentiation; 
the undigested DNA accumulated in the fibre cells causing cataracts. The results 
from this experiment showed that DLAD was responsible for degrading DNA 
during lens fibre differentiation and that if DNA is not degraded then cataracts 
form (Nishimoto et al. 2003). A later study has shown that the expression of 
DLAD was confined to the lysosomes within the layer of cortical fibre cells 
immediately surrounding the OFZ; no expression was observed in the epithelial 
cells (Nakahara et al. 2007). In this study, DLAD was transiently activated 
during the later stages of organelle degradation with expression localised to the 
degenerating nuclei. The results from this study could suggest a role for DLAD 
and the lysosomes in this process of denucleation. To support this hypothesis 
microarray studies comparing gene expression of lens epithelial and fibre cells 
demonstrated increased expression of some lysosomal enzymes (cathepsins and 
lipases) in the fibre cells (Nakahara et al. 2007).
1.4.2. The Role of Apoptotic Proteins in the Lens
Despite the observations that complete apoptosis does not occur during terminal 
differentiation members of both the caspase family and the family of Bcl-2 
related proteins have been shown to be present in lens fibre cells (Sanders and 
Parker 2002; Wride et al. 1999) and at least three classical caspase substrates 
have been shown to be cleaved at the border of the OFZ; poly (ADP-ribose) 
polymerase (PARP), lamin B and DFF (Bassnett and Mataic 1997; Ishizaki et al. 
1998; Wride et al. 1999).
It has been noted that overexpression of Bcl-2 in both mouse and chick lenses 
resulted in abnormal lens fibre differentiation; the resulting lens fibre cells 
displaying incomplete elongation (Fromm and Overbeek 1997; Sanders and 
Parker 2003). Chick lenses overexpressing Bcl-2 were found to be 
morphologically different from the untreated controls (Sanders and Parker 2003). 
Fibre cells within the lenses appeared more disorganised and the lenses more 
spherical in shape when compared to controls. A greater number of nuclei was 
observed in the core region of the lenses overexpressing Bcl-2 in addition to a
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reduction in the activation of caspase-9 and a failure of nuclear chromatin to 
condense within the lens core (Sanders and Parker 2003). Transgenic mice have 
also been generated which overexpress Bcl-2 in their lenses (Fromm and 
Overbeek 1997). In this study, the central lens fibres were shown to contain 
intact or fragmented nuclei. These results suggest that the overexpression of Bcl- 
2 interferes with the denucleation of secondary lens fibres.
The cleavage of the three known caspase substrates during lens fibre 
differentiation suggests a potential role for the caspases in this process. PARP, an 
116kDa protein, is a known substrate for caspase-3 which, during apoptosis, 
cleaves PARP producing an 85kDa product (Lazebnik et al. 1994; Nicholson et 
al. 1995). During lens fibre differentiation, the PARP cleavage product was 
observed in outer lens fibre cells, but was not found in the anterior epithelium 
(Ishizaki et al. 1998). Following the addition of peptide caspase inhibitors to lens 
cell cultures PARP cleavage was prevented (Ishizaki et al. 1998; Wride et al. 
1999). These results suggest a potential role for caspase-3, or a closely related 
protease, during lens fibre differentiation.
The nuclear lamina has been demonstrated to disintegrate during organelle 
elimination (Bassnett and Mataic 1997). Lamin B, a prominent component of the 
nuclear lamina, is ultimately degraded. During apoptosis, lamin B has been 
shown to be cleaved by caspase-3 (Slee et al. 2001). It has been suggested that 
this caspase is also active during organelle degradation causing the breakdown of 
lamin B. The presence of the cleavage product of DFF has also been noted 
during lens fibre differentiation. The role of DFF in apoptosis has been 
previously discussed in Section 1.2.3.
Further studies provided additional evidence that caspases are involved in this 
process. The general caspase inhibitor (Z-VAD-FMK) has been shown to abolish 
denucleation in rats (Ishizaki et al. 1998) and following the addition of peptide 
inhibitors of caspases-1, -2, -4, -6 and -9 to differentiating chick lens epithelial 
cells a 50-70% reduction in denucleation was observed (Wride et al. 1999). From 
the same study it was shown that inhibitors of caspases -3 and -8 did not have 
the same effect on denucleation.
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However, recently the role of caspases in this process has come under 
scrutiny. The role of executioner caspases (caspase-3, -6 and -7) has been 
examined during lens differentiation (Zandy et al 2005). In this study transcripts 
were identified for each of the executioner caspases in the fibre cells, although 
western blotting results detected no active forms of these caspases in the lens. 
Examination of lenses extracted from the mice deficient in each of the 
executioner caspases showed no significant difference in the size and shape of 
the OFZ between the knockout and the age-matched wild-type lenses, suggesting 
that the executioner caspases are not essential for lens organelle degradation.
TNFa has also been implicated in the process of denucleation (Wride and 
Sanders 1998). Wride and Sanders showed that the addition of TNFa to chick 
lens epithelial cell cultures increased the number of nuclei positively staining 
with TUNEL i.e. degenerating nuclei. TNFa was identified at embryonic day 8 
(E8), the day at which nuclear degeneration in the embryonic chick lens begins 
(Modak and Perdue 1970), suggesting a role for this molecule in the denucleation 
process.
A recent study was completed to examine the role of the actin cytoskeleton in 
lens differentiation. The results of this study showed that the predominant actin 
filament structure of undifferentiated lens epithelial cells was stress fibres which, 
during differentiation, were disassembled and replaced with cortical filaments. 
Disassembly of actin stress fibres by cytochalasin D was shown to be sufficient 
to induce lens cell differentiation (Weber and Menko 2006). This disassembly of 
actin stress fibres was demonstrated to have an effect on members of the 
apoptotic pathway; disassembly of stress fibres was observed coincidently with 
the activation of caspase-3 and this depolymerisation of actin filaments was 
shown to inhibit Bcl-2 expression.
A suggested alternative to the classical apoptosis pathway in this terminal 
differentiation process is the ubiquitin/proteasome pathway (UPP). The UPP is 
used to selectively degrade proteins. It is a two-step process; the attachment of 
ubiquitin to the protein to signal degradation and the subsequent degradation of 
protein by the 26S proteasome (reviewed in Varshavsky 2005). Both lens
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epithelial cells and fibre cells have been shown to contain a fully functioning 
ubiquitin pathway (Pereira et al. 2003; Shang et al. 1997) and components of the 
UPP have been shown to be upregulated during fibre differentiation (Shang et al. 
1999; reviewed in Wride et al. 2006). Immunohistochemical studies examining 
the expression of UPP components in the lens demonstrated that the staining 
became progressively weaker moving towards the centre of the lens, where 
differentiation is already complete (Girao et al. 2005). The results of this study 
showed redistribution of UPP components during differentiation; demonstrated 
localisation of the UPP components in both the nuclei and cytoplasm in epithelial 
cells, whereas staining was only observed in the nuclei of fibre cells. This 
redistribution of the UPP proteins during lens differentiation supports the 
hypothesis that this pathway is involved in this process. Additional evidence that 
this pathway is involved in the process of lens differentiation comes from a later 
study which demonstrated that following the treatment of lens epithelial explants 
with a proteasome inhibitor FGF-induced proliferation and differentiation was 
delayed (Guo et al. 2006).
The onset of organelle degradation has been shown to correlate with a 6-fold 
increase in VEIDase activity (Foley et al. 2004). This increase in VEIDase 
activity is the only known proteolytic activity shown to increase with the onset of 
organelle degradation. VEID is an abbreviation for the amino acid sequence 
representing valine, glutamic acid, isoleucine and aspartic acid. The ability to 
cleave a VEID substrate is normally attributable to endogenous caspase-6 
activity (Thomberry et al. 1997). However, following the results of the study 
completed by Zandy and Bassnett, the executioner caspases were shown not to 
be required for this process, with no observed morphological changes in the 
lenses of the knockout mice (Zandy et al. 2005). A later study was completed to 
identify the protease(s) responsible for this VEIDase activity. The resulting data 
showed that the VEIDase had a molecular weight of approximately 700kDa and 
following the addition of proteasome inhibition the degradation of succinate- 
ubiquione oxidoreductase (an integral mitochondrial membrane protein) was 
prevented. It was suggested, following these results, that the observed proteolytic 
activity was due to the proteasome (Zandy and Bassnett 2007).
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Other alternatives to the apoptosis pathway in the process of organelle 
degradation include 15-lipoxygenase (15-LOX). This protein has previously been 
shown to be expressed in reticulocytes, a precursor of erythrocytes, with 
expression peaking immediately before organelle degradation. Lipoxygenase 
expression has been demonstrated in the lens and was shown to be limited to the 
area in which organelle degradation occurs (van Leyen et al 1998). A decrease 
in endoplasmic reticulum staining was co-localised with an increase in 
lipoxygenase staining suggesting that 15-LOX initiates pore formation in 
organelle membranes allowing subsequent degradation by another pathway 
possibly the ubiquitin/proteasome pathway. A subsequent study showed that the 
inhibition of 15-LOX leads to the retardation of mitochondrial degradation 
during terminal differentiation of reticulocytes but does not prevent degradation 
entirely (Grullich et al. 2001).
1.4.3. Triggers of Organelle Degradation
In chicken embryos, the OFZ forms at around E l2. At first, only the primary lens 
fibres are included within the OFZ, but it gradually increases in size such that it 
includes an increasing number of secondary fibre cells (reviewed in Bassnett
2002). Suggestions for triggers of organelle degradation include a drop in the 
cytoplasmic pH, a gradient of diffusion of a metabolic substance or an 
accumulation of waste products in the centre of the lens (Wride 2000). The 
concentration of oxygen has also been proposed as a trigger for this process 
(Bassnett and McNulty 2003). The oxygen concentration would be at the lowest 
level in the lens core. If the concentration in the lens core reaches a sufficiently 
low level, mitochondrial integrity would be compromised leading to the release 
of Ca+ which could result in the activation of an apoptotic cascade. Hypoxia is 
known to trigger apoptosis and it has been hypothesised that it could also trigger 
organelle degradation in the lens. It has been suggested that as fibre cells become 
buried by newer fibre cells they are subjected to increasing hypoxia. Recently, 
experiments have been carried out on chicken eggs under hyperoxic (50% O2) 
and normoxic (21% O2) conditions to test this hypothesis (Bassnett and McNulty
2003). The lens fibres in hyperoxic conditions should be exposed to higher 
oxygen concentrations and therefore organelle loss should be prevented to a 
degree. Results showed that in hyperoxic lenses, organelle loss was triggered at a
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greater depth in the lens than in those lenses under normoxic conditions, (100pm 
deeper than normoxic lenses). This suggests that the critical level of oxygen 
concentration for organelle degradation is found deeper in hyperoxic lenses than 
in normoxic lenses (Bassnett and McNulty 2003).
1.4.4. RNA Stability in Differentiating Lens Fibre Cells
Transcription has been observed in fibre cells until the onset of nuclear 
condensation and their inclusion into the OFZ (Shestopalov and Bassnett 1999). 
However, in principle, translation could still occur in anucleated cells if the 
appropriate translational proteins and mRNA were present. Many studies have 
been carried out to try to identify when translation ceases.
1.4.4.1. Transcription in Anucleated Fibre Cells
Faulkner-Jones et al have identified a RNA-depleted zone (RDZ) in the lenses of 
chick embryos. Acridine orange was used to label the RNA. Intense fluorescence 
was observed in the lens epithelium and the outer fibres, but decreased towards 
the centre of the lens, an area the authors termed the RDZ. The RDZ was first 
visible at E l3 and expanded in size after that time (Faulkner-Jones et al. 2003). 
By E l9, central fibre cells were seen to lack nuclei and the RDZ was well 
defined. RNA concentration was seen to decrease sharply at the border of the 
RDZ suggesting the RNA is quickly degraded in this area of the lens.
1.4.4.2. Translation in Anucleated Fibre Cells
Experiments have been carried out to elucidate the ability of fibre cells to 
transcribe and translate microinjected templates (Shestopalov and Bassnett 
1999). An absence of protein synthesis in the core of the lens was identified, 
suggesting that the cessation of translation also occurs at the time of organelle 
loss. This leads to the hypothesis that the protein contained within the centre of 
the lens had been present since foetal development (Ozaki et a l 1985; 
Shestopalov and Bassnett 1999). It is likely, therefore, that protein synthesis does 
not persist in the lens core for an extended period after denucleation and that the 
processes of both transcription and translation cease at the time of organelle 
degradation.
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7.5. The Ageing Lens and Cataract
As described previously, the lens is constantly growing and changing shape due 
to the continuous addition of fibre cells, covering the underlying fibre cells. 
There is no protein turnover in the lens, leaving the lens susceptible to age- 
related changes. Cataract occurs when opacities form in the normally transparent 
lens. These opacities can be congenital or can form after exposure to toxic insults 
e.g. UV radiation. Cataract is a major ocular condition and is the commonest 
cause of blindness worldwide (Congdon 2001; Francis et al 2000; Francis et al
1999). There are a number of different types of cataract; nuclear, where the 
cataract forms in the lens nucleus, cortical where the cataract forms in the cortex 
of the lens and subcapsular where the opacities form under the lens capsule. 
Apart from opacification of the lens (cataract) other diseases of the lens are 
relatively uncommon (Graw 1999).
1.5.1. Congenital Cataracts
Congenital cataracts are rare in developed countries with an observed frequency 
of 30 cases among 100,000 births (Graw 2004). Many of the genetic causes of 
cataract are due to mutations affecting the structure and/or transparency of the 
lens. Mutations of genes required early in development can affect the formation 
of the lens vesicle. For example a mutation in the promoter for Pitx3, a 
transcription factor downstream of Pax6, leads to a decrease of Pitx3 expression 
resulting in the formation of small eyes which lack a lens (Semina et al 2000). 
The role of Pax6 has already been described in Section 1.3.2.1, and mutations in 
this gene have been shown to lead to the lack of lens induction (Grindley et al 
1995). Mutations in the other transcription factors important for lens 
development, Maf, Sox, Fox and Eya, have also been shown to result in cataract 
(reviewed in Graw 2004).
Following the formation of the lens vesicle, cataracts can also be caused by 
mutations in proteins affecting the lens cell membranes; these include mutations 
in aquaporinO, important in forming the specialised junctions between fibre cells, 
and the connexins (reviewed in Graw and Loster 2003). The connexins are a 
well-characterised family of proteins shown to play a structural role in the lens as
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functional building blocks of the gap junction channels. In the eye three 
connexins been shown to play major role in development C X 4 3 , C X 4 6  and C X 5 0  
(Gong et al 2007). Knockouts of both CX46 and CX50 have been shown to result 
in nuclear cataracts (Gong et a l 1997; White et al 1998).
Observed mutations in the crystallin genes have been shown to result in the 
formation of cataracts. The aA-crystallin and aB-crystallin knockouts have 
already been described in Section 1.3.1. From the knockout mouse studies, it has 
been demonstrated that the knockout of aA-crystallin, and not that of aB- 
crystallin, resulted in the formation of cataract. However, point mutations in both 
the Cryaa and Cryab genes have been shown to cause dominant congenital 
cataract (reviewed in Graw and Loster 2003). Mutations in p- and y-crystallin 
genes have also been shown to result in the formation of cataracts (Billingsley et 
al 2006; Cohen et al 2007; Pauli et a l 2007; Talla et al 2006; Wang et al 
2007).
External factors can also lead to congenital cataract. Cases of maternal rubella 
have been shown to cause congential cataract. The cataract was normally present 
at birth, usually bilateral and was observed to fill the pupillary area (Gregg and 
Banatvala 2001). All of these data lead to the suggestion that dysregulation of 
any element essential for the maintenance of lens transparency could result in 
opacification.
1.5.2. Age-Related Cataract
The lens contains only a single epithelial layer on the anterior surface, which is 
essential for the maintenance of its metabolic homeostasis and transparency. The 
epithelial cells have a relatively long life span under normal conditions, although 
their viability is threatened when exposed to oxidative stress, UV radiation or 
other toxic agents (Robman and Taylor 2005).
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Exposure to UV radiation has been shown to cause cataractogenesis. A study was 
completed by Li and Spector (1996) who tried to understand the progression of 
cataract after exposure to UVB radiation. Cultured rat lens epithelial cells were 
exposed to UVB radiation for 60 minutes and the extent of apoptosis was 
monitored by TUNEL labelling and DNA fragmentation assays. As shown in 
previous studies with hydrogen peroxide, (Li et al. 1995), opacification of the 
lens appeared to follow death of the epithelial cells suggesting that apoptotic 
death induced by UVB initiates cataract development (Li and Spector 1996).
A study by Pendergrass et a l showed that in cataractous old mouse lenses DNA 
and mitochondria were not degraded properly; fibre cells were noted to contain 
accumulations of DNA, nuclear fragments and aggregated mitochondria 
(Pendergrass et al. 2005). These inclusions were shown to colocalise with the 
subcapsular and cortical cataracts and resulted from the failure of the fibre cells 
in the bow region to undergo terminal differentiation.
1.5.3. Treatment for Cataract
Insights into the pathways that lead to the formation of cataract could lead to the 
development of novel treatments e.g. to delay the onset/ progression of cataract. 
At present the only available treatment for cataracts is surgery (Francis et al.
2000). During surgery, an opening is created in a portion of the anterior capsule, 
through which the cataractous lens is removed. An artificial intraocular lens 
(IOL) is then inserted into the remaining capsular bag.
1.5.4. Posterior Capsule Opacification
Although cataract surgery is usually very successful, a number of patients suffer 
from posterior capsule opacification (PCO). PCO is the commonest complication 
following cataract surgery and requires further treatment if it affects the visual 
axis (Marcantonio and Vrensen 1999; Spalton 1999). This condition is caused by 
the continued growth and differentiation of the residual LECs remaining in the 
capsular bag following surgery. These cells proliferate soon after surgery to form 
monolayers on the capsular surfaces. These monolayers can remain throughout 
life without any visual consequences. However, if the cells continue to 
differentiate, undertaking an epithelial-mesenchymal transition, larger structures
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appear which are capable of scattering light, therefore reducing lens transparency 
(Marcantonio and Vrensen 1999). The epithelial-mesenchymal transition is 
driven by cytokines and leads to the expression of extracellular matrix proteins 
not normally found in the lens. PCO can be treated by Neodynium:Yttrium 
Aluminium Garnet (Nd:YAG) laser treatment.
Alternative treatments for PCO are being sought as treatment using the Nd:YAG 
laser is not completely risk free and a number of problems can result including 
retinal detachment and damage to the lens capsule (Pandey et al 2004). Recently 
a study was completed using an adenovirus-mediated gene transfer to introduce 
the expression of proapoptotic molecules (P53, procaspase-3, Bax and TRAIL) 
into cultured lens cells in an attempt to induce programmed cell death. Injection 
of Bax or procaspase-3, but not P53 or TRAIL, into lens capsular bag following 
phacoemulisification prevented PCO in rabbits (Malecaze et al. 2005).
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1.6. Aims of this Study
Although this process of organelle degradation may not be a direct form of 
conventional apoptosis, a number of apoptosis-related genes have been shown to 
be present in the lens (Wride et al. 2003; Wride et al. 1999) and further 
investigation is required to clarify the role of these apoptotic pathways in the 
process of denucleation and organelle degradation.
The studies described in this thesis have been designed to test the hypothesis 
that an apoptosis gene-specific macroarray is a useful tool for identifying 
apoptosis genes in the lens during development, therefore implicating them 
in the process of lens differentiation and identifying pathways of apoptosis 
gene expression involved in this process.
The aims of this study are:
• To examine the global apoptosis gene expression during mouse lens 
development using macroarrays. Once this has been completed the 
protein expression will be studied for selected proteins across the same 
developmental stages.
• To investigate the morphological changes of the lens in a transgenic 
mouse generated to contain a mutant copy of one of the genes identified 
from the array results.
• Finally, to complete a cross-species comparison identifying whether the 
genes identified in the mouse lens are also shown to be expressed in the 
embryonic chick lens.
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General Methods
2. Materials and Equipment
The composition of all chemicals and solutions prepared for this study is listed in 
Appendix 1. All other chemicals bought from the manufacturers are included in 
the text along with the supplier.
All protocols using RNA were carried out using RNase free filter tips and double 
autoclaved distilled water to prevent contamination of the samples. Solutions 
used for RNA work were made in autoclaved bottles and double autoclaved.
Due to the nature of the chemicals used, during the formaldehyde denaturing 
gels, the gels were set and run in the fume hood (Bigneat, Chemcap™ Laboratory 
Safety Cabinet).
The radioactive parts of these methods were carried out in a designated lab. 
Constant monitoring was carried out using a Geiger-Muller counter. Personal 
monitoring was also in place. Disposal of radioactive materials was carried out in 
accordance with the university guidelines.
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2.1. Tissue Collection
2.1.1. Collection of Mouse Tissue
The mice used in this study were from the strain 129Sv/Ev. Lenses were 
extracted from mice at different stages of maturation. The stages used were new 
bom (NB), postnatal day 7 (P7), postnatal day 14 (PI4) and 4 weeks (4wk). The 
mice were sacrificed by a schedule 1 method (cervical dislocation) and 
enucleated. The lenses were then removed from a posterior incision in the 
eyeballs under a research stereo microscope (Nikon SMZ800) using No. 5 
forceps (Sigma, UK).
Lenses were extracted from a litter of mice (average number = 7, range = 5-10) at 
each time point and then pooled to generate each sample of RNA. A different 
litter was used for each pooled lens RNA sample collected, this accounted for 
biological variation.
2.1.2. Collection of Chick Tissue
Lenses were also collected from White Leghorn chick embryos (Henry Stewart 
and Co, Lincolnshire, UK). Eggs were placed in an incubator at 37.5°C (40-50% 
humidity, turning every 45 minutes) until they reached the required time points 
(Brinsea Octagon 100, Jencons, UK). The embryos were placed in a fridge to 
cool down, then decapitated using a fresh scalpel blade before the lenses were 
removed using tungsten needles under a dissecting microscope (Nikon SMZ800). 
Lenses were collected from both eyes of embryos at embryonic days (E) 6, 8, 10, 
12, 14 and 16. Lenses were pooled from a number of embryos to generate each 
RNA sample (ranging from 24 for an E6 sample to 16 for an E l6 sample).
2.1.3. Obtaining RNA
Once collected, the lenses were immediately homogenised in TRIzol® reagent 
(Invitrogen, UK) using a tissue grinder (Wheaton). RNA was then isolated from 
these lenses using the protocol provided by Invitrogen, briefly described here. 
Chloroform (0.2ml per 1ml of TRIzol® originally used) was added to the sample 
before centrifugation (12,000 x g for 15 minutes at 4°C) in an eppendorf bench-
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top centrifuge (Sorvall® fresco). After centrifugation, the mixture was separated 
into three phases; a lower pink phenol-chloroform phase, an interphase, and a 
colourless upper aqueous phase. RNA from the sample remained in the 
colourless aqueous phase. The aqueous phase was removed and placed in a new 
eppendorf tube before isopropyl alcohol (0.5ml per 1ml of TRIzol® originally 
used) was added. The samples were placed into isopropyl alcohol in the freezer 
at -20°C overnight to precipitate the RNA from the sample collected. The sample 
was then removed from the freezer and centrifuged again (12,000 x g for 10 
minutes at 4°C). The RNA precipitate formed a white pellet on the bottom of the 
tube. This pellet was then washed by the addition of 75% RNase free ethanol 
(lml per 1ml of TRIzol® originally used). After addition of ethanol, the sample 
was then mixed and centrifuged, (7,500 x g for 5 minutes at 4°C). The pellet that 
formed on the bottom of the tube was then allowed to air dry for 5-10 minutes. 
Finally, the pellet was resuspended in RNase free water (Sigma, UK) (10-60pl) 
by pipetting it up and down before being incubated at 60°C for 10 minutes.
2.1.4. Quantification of RNA Samples
The RNA samples collected were quantified using a spectrophotometer 
(GeneQuant II, Pharmacia Biotech). Nuclease-free water (Sigma, UK) was used 
as a reference sample. RNA (2pl) was added to water (98pl) before the 
absorbance was read at 260nm. An absorbance value was also taken at 280nm 
and a ratio calculated. The RNA concentration was then calculated by 
multiplying the absorbance at 260nm by the dilution factor and then by 40 (the 
RNA constant).
2.1.5. Checking Integrity of RNA
Following isolation from the lenses, the RNA was run out on a formaldehyde 
denaturing gel to check its integrity. Intact RNA should show two distinct bands 
corresponding to the 28S and 18S ribosomal species. If there was any smearing 
on the gel, it would suggest that the RNA had been degraded.
One hundred millilitres of gel solution was made (composition of the gel is given 
in Appendix 1), poured into the gel mould and left to set for 1-2 hours in the 
fume cupboard. The denaturation reaction for each sample of RNA was then set
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up in an eppendorf tube (components for one reaction are given overleaf in 
Table 2.1).
Component Volume
RNA 4.0pl
lOx MOPS electrophoresis buffer 2.0pl
Formaldehyde 3.5 pi
Formamide lO.Opl
Ethidium bromide 0.5pl
Table 2.1: Components o f  RNA denaturation reaction
Once all the components of the denaturation reaction had been added, the 
eppendorf tubes were incubated for 15 minutes at 55°C in a water bath (Grant, 
JB Series). The samples were then chilled on ice for a minute. Sufficient running 
buffer (composition given in Appendix 1) was then added to the gel dock tray to 
cover the gel to a depth of approximately 1mm. Loading buffer (composition 
given in Appendix 1) was then added (5 pi) to each sample prior to loading onto 
the gel. To begin with, the gel was run at 40V (Consort E l22 Power Pack). This 
was increased to 80V when the samples or loading dye could be visualised on the 
gel.
The RNA bands were visualised by placing the gel on a UV transilluminator and 
photographed under UV illumination using a Gel Doc system and digital camera 
(UVP BioDoc-It™ System).
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2.2. Apoptosis Arrays
2.2.1. Generating Labelled cDNA
After the integrity of the RNA had been confirmed, the RNA could then be used 
to generate radiolabelled cDNA, incorporating P-dCTP (Amersham 
Biosciences, UK). The labelling reactions are performed in two steps. The first 
step, the annealing reaction, shown in Table 2.2, involves the annealing of 
mouse apoptosis cDNA primers (Sigma-Genosys, UK) to the RNA template. The 
mouse apoptosis primers used contained 250 apoptosis-gene-specific primers 
optimised for generating cDNA from total RNA extracted from mice. During the 
second step, radiolabelled nucleotides and reverse transcriptase (Sigma-Genosys, 
UK) were added to initiate the cDNA synthesis reaction.
Final Concentration Volume for One Reaction
2pg total RNA 2-1 lpl
Mouse Apoptosis cDNA 4pl
Labelling Primers
Sterile distilled water to 15pl
Table 2.2: Composition o f the Annealing Reaction. Table taken from Panorama™ Mouse 
Apoptosis Gene Arrays Protocol provided by Sigma-Genosys.
For the annealing step, the components from the table above were added to an 
eppendorf tube. The primers were annealed to the RNA template by heating at 
90°C for 2 minutes and then transferring to a heating block set at 42°C for 20 
minutes.
The components of the annealing reaction were added to the components of the 
reverse transcriptase reaction, (shown in Table 2.3), mixed and then incubated at 
42°C for 2-3 hours on a heating block (Grant, QBT2).
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Final Concentration Stock Reagent Volume for One Reaction |
1 Components from table 2.1 15 pi
lx Reverse Transcriptase Buffer 5x 6 pi 1
333 pM dATP 10 mM 1 pi
333pM dGTP 10 mM
1 ^
333pM dTTP 10 mM Ipl
1.67pM dCTP 100 pM 0.5 pi
20pCi [a-33P] dCTP 10 pCi/pl 3 pl
20 U Ribonuclease Inhibitor 40 U/pl 0.5 pi
50 U AMY Reverse Transcriptase 25 u/pl ^ Pi I
Sterile distilled water to a final volume of 30 pi
Table 2.3: Composition o f the Reverse Transcriptase Reaction. Table adapted from 
Panorama™ Mouse Apoptosis Gene Arrays Protocol provided by Sigma-Genosys.
2.2.2. Pre-Hybridisation of the Arrays
Panorama™ mouse apoptosis arrays (Sigma-Genosys, UK) were used for this set 
of experiments. These arrays are nylon membranes containing 243 known 
apoptosis related genes. The complete list of genes present on the array is given 
in Appendix 2. Before the arrays were hybridised with the radiolabelled cDNA 
they were first pre-hybridised to prevent non-specific binding of DNA to the 
arrays. The arrays were washed in 50ml 2x SSPE (containing NaCl and EDTA, 
pH 7.4, Sigma, UK) at room temperature for 5 minutes. The arrays were then 
pre-hybridised in hybridisation solution (Sigma, UK) containing salmon testes 
DNA (lOOjul Salmon testes DNA in 10ml hybridisation solution) at 65°C for at 
least an hour before the addition of the radiolabelled cDNA.
2.2.3. Removal of Unincorporated Radiolabelled Nucleotides
The unincorporated radiolabelled nucleotides had to be removed from the 
reaction mix before it was added to the arrays. This should result in a reduction 
in the background signal during the hybridisation reaction. To remove the 
unincorporated radiolabelled nucleotides a spin column containing sephadex 
beads (Sigma-Genosys, UK) was used. The spin column was centrifuged to 
remove any excess buffer before the sample was added. Once the sample had 
been added to the centre of the spin column, the column was centrifuged at 1100
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x g for 4 minutes. The eluate from the column contained the purified cDNA 
sample; this sample could then be added to the arrays.
2.2.4. Hybridisation of the Arrays
The purified labelled cDNA was then added to 2-3mls hybridisation solution 
(containing lOOpl salmon testes DNA per 10ml hybridisation solution). The 
DNA was then denatured by heating at 95°C for 10 minutes. The hybridisation 
solution containing the labelled cDNA was then added to the arrays, which were 
hybridised overnight for 18 hours in the hybridisation oven at 65°C (UVP, HC- 
3000 Hybricycler).
2.2.5. Washing the Arrays
After the hybridisation reaction was complete, the arrays were then washed to 
remove any unbound DNA with increasing concentrations of salt solution. The 
hybridisation solution was decanted and discarded and 40-50ml of wash solution 
I (composition in Appendix 1) was added to the roller bottles. The arrays were 
washed by gently inverting the bottles by hand at room temperature for 2-3 
minutes. This process was repeated twice more, with a new aliquot of wash 
solution I each time. 80-100ml of wash solution I (pre-warmed to 65°C) was then 
added to the roller bottles and the arrays were washed in the hybridisation oven 
at 65 °C for 20 minutes, before the wash solution was discarded. This process was 
repeated once more. Wash solution II (pre-warmed to 65°C: composition given in 
Appendix 1) was then added to the roller bottles (80-100ml) and washed for a 
further 20 minutes in the hybridisation oven. The wash solution was then 
discarded and the arrays were wrapped in clingfilm before placing them into a 
storage phosphor screen (Amersham Biosciences, UK). The arrays were exposed 
to the phosphor screen for 5-7days.
2.2.6. Scanning the Arrays
The phosphor screen was then scanned using the Typhoon scanner (Amersham 
Biosciences, Typhoon 9410 Variable Mode Imager) which extracted the energy 
from the screen and converted it into a computer image which could later be 
analysed by use of image analysis software.
38
General Methods
2.2.7. Stripping the Arrays
Once the phosphor screen had been scanned, the arrays were stripped removing 
any residual bound DNA. This ensured that each array could be reused. The 
arrays were added to 200ml of stripping solution (composition given in 
Appendix 1), which had been brought to the boil. The arrays were then added to 
the stripping solution, which was then allowed to cool. The arrays were then 
removed from the solution, the excess drained and the arrays wrapped in 
clingfilm. Once stripped, the arrays were stored at -20°C. Some stripped arrays 
were exposed to the phosphor screen to check that the residual radiolabelled 
cDNA had been removed.
2.2.8. Analysing the Results
The results were analysed using an image analysis program, ImaGene 5 
(Biodiscovery). Using ImaGene, a virtual grid was placed over the image of the 
arrays assigning each spot a know grid reference; this allowed for the intensity of 
each spot to be calculated and also allowed the correct gene ID to be allocated to 
each spot (see Figure 3.2.). Once ImaGene had calculated the spot intensities, 
the data were then exported to Microsoft® Excel for further analysis. The data 
obtained from ImaGene produces a spot intensity and a background signal value 
for each individual spot. The background value for each spot was calculated as a 
mean of the intensity of a set number of pixels surrounding the spot (as shown in 
Figure 2.1.).
Figure 2.1: Diagram demonstrating how spot intensity was measured. Diagram shows the area 
used to measure the spot intensity. An excluded area was included around the original spot to 
prevent false background values due to contamination from the original spot (approximately 10 
pixels wide).
Area for background 
calculation
Area to exclude
Original spot
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The data produced were normalised using the mean expression of the 
housekeeping genes from the arrays; housekeeping genes are genes continuously 
expressed throughout development. The normalisation process allowed 
comparisons of gene expression to be made between the completed arrays; 
accounting for variations of the signal between arrays.
2.2.8.I. Normalisation with Housekeeping Genes
The mean and standard deviation were calculated using the individual 
background values for each spot; these values were subsequently used to filter 
the data later on in the analysis process. The spots whose original signal (signal 
value generated from the analysis completed using ImaGene) was lower than the 
mean plus two standard deviations of the background values were removed from 
the rest of the results following normalisation.
The individual background values were then subtracted from the corresponding 
spot intensity, to give a corrected intensity. Each corrected spot value was 
normalised before being filtered. The spots were normalised using the 
housekeeping genes printed on the apoptosis arrays. A mean value was 
calculated from the corrected spot intensities from each of these housekeeping 
genes as well as GAPDH (a standard housekeeping gene), which was also 
printed on the array. The array data were then normalised using the ratios of 
these mean values.
One of the arrays was designated as standard. A ratio was calculated for each 
array by dividing the mean housekeeping value from the standard array by the 
mean housekeeping value from that array. The corrected spot intensities were all 
multiplied by this ratio.
After normalisation, a mean value for each spot across the set of arrays was 
calculated using the corrected intensities. The mean values for each spot were 
then compared for P7 and P I4 using an unpaired t-test. Spots with a 2-fold 
difference between these two time points and a /7-value <0.05 were considered to 
have a significant change in gene expression.
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2.2.8.2. Global Normalisation
The mean corrected gene intensity (corrected intensity = original spot intensity 
minus background value) was calculated for each spot on each array; 
housekeeping genes, negative controls and positive controls were excluded from 
the data set. One of the arrays was designated as the standard. For the other 
arrays a normalisation ratio was calculated by dividing the mean spot intensity 
for the standard array by the mean intensity calculated for each array. All the 
corrected spot intensities were then multiplied by the ratio for each array. This 
allowed the spot intensities to be compared across arrays.
Following normalisation, a mean value was calculated for each gene across the 
arrays at each time point. The mean values were compared between P7 and P14 
using an unpaired t-test. Genes were considered to be significantly differentially 
regulated if they showed a 2-fold or greater difference between values and a p- 
value of less than 0.05.
41
General Methods
2.3. PCR Confirmations
2.3.1. DNase Digestions
Before cDNA synthesis, the RNA samples were first treated with the addition of 
a DNase to remove any contaminating genomic DNA. DNase digestion was 
completed using Ambion’s TURBO DNase protocol, briefly described here. 10 x 
DNase I buffer ( V i o  of the volume of the original sample) and lpl of DNase I 
(Ambion, UK) was added to each RNA sample. This mixture was then gently 
mixed and incubated at 37°C for 30 minutes. DNase inactivating reagent 
(typically 2pl or '/jo volume of the sample, whichever was greatest) was then 
added to the samples and the samples left at room temperature for 2 minutes, 
mixing occasionally. The samples were then centrifuged at 10,000 x g for 1 
minute. The supernatant (containing the DNase digested RNA sample) was then 
removed from the pellet of the DNase inactivation reagent and transferred to a 
new eppendorf tube. Samples with a concentration of 200pg/ml or above had to 
be diluted (to approximately 10pg/50pl) before addition of the DNase.
2.3.2. Reverse Transcriptase Reaction
This DNase digested RNA was then used to generate cDNA. Synthesis of cDNA 
was completed in accordance with the protocol provided by Invitrogen in the 
Superscript™ First-Strand Synthesis System for RT-PCR kit. The sample (5pi) 
was added to lpl of oligo(dt) primers (Invitrogen, UK) and lpl of lOmM dNTP 
mix (Invitrogen, UK). Double autoclaved water was then added to bring the 
volume of the sample up to 12pl. These reactions were set up in duplicate; one 
was used to synthesise the cDNA, the other was used as a control to which no 
reverse transcriptase would be added. The mixtures were then heated to 65°C for 
5 minutes before being chilled on ice. The tubes containing these mixtures were 
then briefly centrifuged before 2pl of 10 x RT buffer, 4pl of 25mM MgCk, 2pl 
of 0.1 M DTT and lpl of RNaseOUT™ were added, before incubation at 42°C 
for 2 minutes. Following this incubation, lpl Superscript™ II RT (Invitrogen, 
UK) was added (except to the no RT controls). The tubes were then incubated for 
50 minutes at 42°C. The reaction was inactivated by heating the tubes at 70°C for 
15 minutes. RNase H (lpl) was added to each tube and the samples were
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incubated at 37°C for 20 minutes. Finally, samples were diluted by the addition 
of 30pl nuclease free water.
2.3.3. Primer Design
Mouse primers were designed for the genes shown to be differentially expressed 
from the array results using the primer design programme Primer3 
(http://ffodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) using the FASTA 
sequence of the gene. The sequence for the gene in question was looked up on 
Gene (provided by NCBI). The first primer pair suggested by Primer3 was used. 
Primers for the housekeeping genes were taken from published work; mouse 
housekeeping gene (GAPDH) used for the PCR confirmations was taken from 
Mansergh et al. (2004). Primers were ordered from Operon and were 
resuspended in nuclease free water (Sigma, UK) in the amounts specified.
Chick primers were designed for the genes shown to be highly expressed and 
differentially expressed. The sequence for most of the genes was available on 
Gene; the FASTA sequence was used to design primers using Primer3 (as 
described above). However, some of the sequences were not available on Gene 
and so BLAST searches had to be completed to try to identify the chick 
homologue of the gene. The accession number for the mouse sequence was 
compared to the chick genome. Sequences with an identity of 70% or greater 
were used to design primers. The primer sequences for the housekeeping gene 
used, GAPDH, was taken from Faulkner-Jones et al. 2003. Both the mouse and 
chick primer sequences used are shown in Appendix 4.
2.3.4. PCR Reactions
Primers were run out on a gel prior to the PCR reactions to ensure that they were 
all at similar concentrations. Promega’s GoTaq® protocol was used to complete 
the PCR reactions. The components of the PCR reaction (shown in Table 2.4) 
were added to a sterile microcentrifuge tube on ice. The PCR reaction mix was 
overlaid by 50pl mineral oil (Sigma, UK) to prevent evaporation before the 
microcentrifuge tubes were placed into the PCR machine (Techne Flexigene). 
PCR was completed using the parameters shown in Table 2.5. Equal loading of 
cDNA was monitored using the products of the GAPDH PCR reaction and
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subsequent image analysis. Adjustments were made to the amount of cDNA used 
in the PCR reactions until the resulting bands from the GAPDH PCR reaction 
were shown to be the same intensity.
1 Component Final Volume Final Concentration
5x Green GoTaq Flexi Buffer lOpl
lxMgCl2 Solution, 25mM 3 pi 1.5mM 1
PCR Nucleotide Mix, lOmM lpl 0.2mM each dNTP
1 Forward Primer Xpl O.l-l.OpM
Reverse Primer Ypl O.l-l.OpM
I GoTaq DNA polymerase (5u/pl) 0.25pl 1.25u
Template DNA Zpl <0.5pg/50pl
Nuclease-Free water to 50pl -
Table 2.4: Components o f PCR Reaction
The PCR products were then loaded onto a 2% agarose gel alongside a 1Kb 
DNA ladder (Invitrogen, UK). The products were visualised due to the addition 
of ethidium bromide (Sigma, UK) to the agarose gel. The resulting gels were 
visualised by placing the gel on a UV transilluminator and photographed under 
UV illumination using a Gel Doc system and digital camera (UVP BioDoc-It™ 
System). Three PCR reactions for each gene were completed; using a different 
pooled RNA sample for each repetition.
1 Step Temperature Time Number of Cycles
1 Initial Denaturation 95°C 2 minutes 1
Denaturation 95°C 1 minute 25-35
1 Annealing 42-65°C 1 minute
Extension 72°C 1 minute 20 seconds
Final Extension 72°C 5 minutes 1
Soak 4°C Indefinate 1
Table 2.5: PCR Parameters
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2.3.5. PCR Image Analysis
The images of the gels were imported into Scion Image for analysis. This 
programme allowed for the band intensities to be calculated (measured as mean 
pixel intensity). A background reading was measured, which was later subtracted 
from the band intensities measured for the bands of the gel. These measurements 
from Scion Image were then imported into Microsoft® Excel. Data were 
collected from all the repetitions of PCR reactions in Excel and normalised using 
the band intensities from the GAPDH bands from the first set of reactions. A 
mean normalised value of band intensity along with the standard error of the 
mean (SEM) was calculated for each gene at each time point.
The mean normalised band intensity value was compared across the time points 
to identify any statistically significant changes in expression using a one-way 
ANOVA with Tukey’s post-hoc test. Statistical significance was only observed if 
the resulting p -value was less than 0.05.
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2.4. Western Blotting
2.4.1. Isolation of Protein
Protein was isolated from postnatal mouse lenses using 
RadioImmunoPrecipitation Assay (RIPA) buffer (0.5M Tris-HCl pH 7.4, 1.5M 
NaCl, 2.5% deoxycholic acid, 10% NP-40, lOmM EDTA, Upstate, USA). 
Lenses were collected from a litter of mice at each of the time points to generate 
each protein sample. Prior to the addition of RIPA buffer to the lenses, the buffer 
first had to be diluted 10-fold. Immediately before the addition of RIPA buffer to 
the lenses, protease inhibitor cocktail (Sigma, UK) was added to the buffer 
(lOOpl of protease inhibitor cocktail per 10ml diluted RIPA buffer). RIPA buffer 
(500pl) was added to the lenses before homogenisation. The sample was then 
transferred to an eppendorf tube before incubation at 4°C on a rotator for 30 
minutes. The sample was then centrifuged at 13,000 x g for 30 minutes at 4°C. 
The supernatant was removed and aliquoted into new eppendorf tubes before 
storage at -20°C.
2.4.2. Quantification of Protein
The protein samples collected were quantified using a BCA assay (Pierce, UK). 
The assay was completed using the protocol provided by the manufacturer; 
briefly described here. A number of bovine serum albumin (BSA) standards of 
varying concentrations (2,000pg/ml-0pg/ml) were made by diluting the BSA 
stock solution provided. Enough working solution (50 parts of reagent A: 1 part 
reagent B) was prepared to run each unknown sample (plus BSA standards) in 
duplicate. Each sample and standard (25pi) was added to a microplate, 200pl of 
working reagent was added to each sample/standard. The microplate was then 
covered in foil and incubated at 37°C for 30 minutes. The absorbance of each of 
the samples were then measured at 570nm using a plate reader (Multiskan 
Ascent, Labsystems). The absorbance readings for the standards were used to 
produce a standard curve allowing for the concentrations of the unknown 
samples to be calculated.
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2.4.3. SDS-PAGE
The Bio-Rad Mini-Protean® 3 cell system was used to run the SDS-PAGE. Glass 
plates were cleaned with ethanol before using. A short plate was placed on top of 
a tall plate before placing into the casting frame, where it was locked into 
position. Distilled water was used to check for leaks from the apparatus. The 
resolving and stacking gels were made up as described in Tables 2.6 and 2.7. 
The percentage of the resolving gel used was altered depending on the molecular 
weight of protein; for mcl-1 and axl a 10% resolving gel was used. The resolving 
gel was allowed to set for 20 minutes before the stacking gel mixture was layered 
on top of the resolving gel. A comb was then inserted into the glass spacers. The 
gel was then allowed to set for an hour, damp tissue was placed over the casting 
frame to prevent the gel from drying out. After an hour, the glass plates, with the 
gel inside, were removed from the casting frame and placed into the electrode 
assembly (short plate facing inwards, creating the inner buffer chamber). The 
electrode assembly was then locked into the clamping frame which in turn was 
placed into the mini tank. Approximately 125ml running buffer (100ml lOx 
Tris/glycine/SDS buffer, Bio-Rad, and 900ml distilled water) was added to the 
inner buffer chamber. 200ml was added to the outer buffer chamber.
Resolving gel to a final volume of 10ml
Final %age Gel 10% 12% 15%
Range (MW) 20-100 10-70 8-50
Acrylamide (30%) 3.3ml 4ml 5ml
Water 4m 1 3.3ml 2.3ml
1.5M Tris pH 8.8 2.5ml 2.5ml 2.5ml
10% SDS lOOpl lOOpl lOOpl
10% APS lOOpl lOOpl lOOpl
TEMED 20pl 20pl 20pl
Table 2.6: Components o f the resolving gelfor SDS-PAGE
47
General Methods
Stacking gel to a final volume of 10ml
A c r y l a m i d e  ( 3 0 % ) 1 .6 7 m l
W a t e r 5 .8 3 m l
1 .5 M  T r is  p H  8 . 8 2 .5 m l
1 0 %  S D S lO O p l
1 0 %  A P S 5 0 p l
T E M E D lO p l
Table 2.7: Components o f the stacking gel for SDS-PAGE
2.4.4. Preparation of Protein Samples
The protein samples were diluted to the same concentration (~2.5pg/pl) by 
addition of the lysis buffer (RIPA buffer, Upstate). Equal amounts of the diluted 
protein sample and sample loading buffer (Bio-Rad, UK) were added to an 
eppendorf. These samples were then boiled at 100°C for 5 minutes on a heating 
block (Grant QBT2) to denature the proteins. Following boiling, the protein 
samples were added to the gel using the lane guide provided by Bio-Rad. 8 pi of 
protein/loading buffer mix was added to each well (~10pg protein). 8pi of 
molecular weight marker (Bio-Rad Precision Plus Molecular weight marker) was 
added to the outermost lanes. The lid was the placed on the mini tank and the gel 
run for 30 minutes at 200 volts, 300mA.
2.4.5. Transfer of Proteins onto the Nitrocellulose Membrane
Transfer buffer was made up (200ml methanol, 100ml Tris/glycine buffer and 
700ml distilled water). The nitrocellulose membrane (Hybond™-ECL™, 
Amersham Biosciences, UK) was cut to size using a short glass plate as a 
template. After completion of electrophoresis, the inner chamber assembly was 
removed from the mini tank. The gel was removed from the glass plates by 
gently separating the plates. The stacking gel was discarded, whilst the resolving 
gel was placed into transfer buffer. Following the completion of the SDS-PAGE 
the nitrocellulose membranes, filter paper, fibre pads and the gels were soaked in 
transfer buffer on the rocker for 15 minutes
48
General M ethods
A gel sandwich was then made up in a gel holder cassette composed of two fibre 
pads, two pieces of filter paper, the gel and the nitrocellulose membrane. This 
sandwich was then placed into the mini tank, which had been filled with transfer 
buffer (~600ml), alongside a frozen cooling unit. A magnetic stirrer was placed 
into the mini tank to keep the buffer circulating during the transfer process in 
order to prevent overheating of the system. Transfer conditions used were 100V, 
350mA for 45 minutes. Following completion of the transfer, the gel sandwich 
was unpacked in the same order as it was packed. The membrane was placed in 1 
x TB S/Tween where it was stored in the fridge for up to a week. Proteins were 
visualised on the membrane using Ponceau S (Sigma, UK), this allowed the 
success of the transfer to be visualised. Following staining with Ponceau S the 
membranes were photographed under white light (UVP BioDoc-It™ System). 
Membranes were then washed with 1 x TB S/Tween to remove the Ponceau S 
before the blocking step in the protocol.
2.4.6. Blocking the Membrane
5% milk was used to block the membrane in order to prevent non-specific 
binding. Approximately 20ml of blocking solution was added to each membrane. 
The membranes were then left on the rocker for 1 hour at room temperature. 
After an hour the blocking solution was removed from the membranes and the 
membranes were washed 6 times with 1 x TBS/Tween for 5 minutes each time.
2.4.7. Incubation with the Primary Antibody
Antibody dilutions were made up in 1% milk. A range of dilutions were used to 
try to optimise the conditions used. 20ml of antibody solution was added to the 
membrane. The membranes were then left on the rocker for an hour at room 
temperature. Following incubation with the primary antibody the membranes 
were washed in lx TBS/Tween for 30 minutes ( 6 x 5  minute washes).
2.4.8. Incubation with the Secondary Antibody
20ml of secondary antibody solution (1% milk and antibody) was added to the 
membrane. Incubation with the secondary antibody was also an hour at room 
temperature, with the membrane on the rocker. Following incubation, the
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membrane was washed for 30 minutes with lx  TBS/Tween ( 6 x 5  minute 
washes).
2.4.9. Exposing the Membrane to Film
The membranes were then placed inside a plastic wallet in the developing 
cassette (Hypercassette™, Amersham Biosciences). The cassette was then taken 
into the dark room. The ECL reagents were mixed (50 parts of reagent A: 1 part 
reagent B) (ECL Plus Western Blotting Detection Reagents, Amersham 
Biosciences, UK). Approximately 1ml of the mixed solution was added to each 
membrane. It was allowed to incubate for 5 minutes at room temperature before 
the membranes were exposed to the first film. The plastic wallet was closed and 
a film (Hyperfilm™, Amersham Biosciences, UK) was placed on top of the 
plastic wallet. The developing cassette was then closed and the exposure time 
measured. A number of different exposure times were used in an attempt to 
obtain the best picture, ranging from 1 to 10 minutes. Following exposure the 
film was then placed in developer solution (Photosol Limited, UK) for 3 minutes, 
then fixer solution (Photosol Limited, UK) for 3 minutes, before being rinsed in 
water. The film was then dried.
2.4.10. Stripping the Membranes
Following membrane exposure to the film, the membrane was stripped to remove 
the bound antibody. This allowed for the expression of a secondary protein to be 
examined; in this case, actin expression was used as a loading control. Stripping 
buffer (~20ml) was added to each membrane (composition given in Appendix 
1). The membranes were washed twice with stripping buffer at room temperature 
for 10 minutes each time. Following the removal of the stripping buffer the 
membranes were washed with lx  PBS twice for 10 minutes each time. The 
membranes were then placed into lx  TBS/Tween for 5 minutes before they were 
ready for the blocking stage. Blocking and incubating with antibodies were 
completed as described previously (Sections 2.4.6.-2.4.8.) before the membrane 
was again exposed to film.
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2.4.11. Analysis of the Western Blotting Results
The films produced from the western blotting experiments were scanned (Epson 
Expression 1680 Pro). The resulting images were imported into the Labworks™ 
software (Media Cybernetics, UK) to enable the completion of densitometry 
analysis. The optical denisity was recorded for each of the bands observed and 
these results were imported into Microsoft® Excel. Data were collected from all 
the sets of experiments and normalised to the actin results. This was completed to 
ensure that any differences observed would be true differences in expression 
rather than due to varying quantities of protein at each time point. Mean 
normalised band intensity along with the standard error of the mean was 
calculated for each protein at each time point. Statistical analysis was completed 
to identify any significant changes in expression (one-way ANOVA with 
Tukey’s post-hoc test, statistical significance is only observed if the resulting p- 
value is less than 0.05).
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2.5. Histology Examination o f Lens Morphology
2.5.1. Tissue Collection
Eyeballs were collected from mice at postnatal day 2 (P2) and fixed in 4% 
paraformaldehyde (PFA). At the same time tail-tips from each of the pups were 
collected; DNA extracted from these tail-tips allowed the genotype of each pup 
to be established. The eyeballs were left in the fixative for 24 hours. The fixative 
was then removed and the eyeballs were washed in lx PBS three times for 30 
minutes each time. The tissues were then left in PBS overnight. The following 
morning the eyes were soaked in increasing concentrations of ethanol (50% for 
30 minutes, 70% for 1 hour, 90% for 5 hours then 100% for 3 hours). The tissue 
was then submerged in 50:50 ethanolixylene for 15 minutes. The 50:50 
ethanol:xylene solution was then replaced and the tissue was left overnight in this 
solution.
The tissue was then moved to xylene, in which it was washed twice, for 1 hour 
each time. The eyeballs were then placed in hot wax and allowed to soak in the 
oven for 2 hours. The wax was then replaced and the tissues left in wax for 
another 2 hours (65°C). Following this incubation in wax the eyeballs were 
removed from the molten wax and placed onto a pre-cooled base of wax in a 
mould tray. Molten wax was then added so that it covered the tissue and then left 
to cool. Once cooled the mould trays were then transferred to the fridge for 
storage overnight. The blocks were left for 24 hours at room temperature before 
being sectioned.
2.5.2. Sectioning of Tissue
Once the wax blocks had set, they could then be sectioned. The wax blocks were 
secured to the microtome (HM 325, Microm), trimmed around the tissue and 
sections were cut at 7pm intervals. Sections were floated on water to ensure they 
were flat before placing them onto slides.
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2.5.3. Haematoxylin and Eosin Staining
Haematoxylin and eosin were used to stain the sections obtained in order to 
examine lens morphology. The slides of sections were placed in xylene twice for 
5 minutes each time. The slides were then placed in decreasing concentrations of 
IMS: 100% IMS twice for 5 minutes each time, then 90%, 70% and 50% with 2 
minutes in each concentration. Slides were then placed in haematoxylin for 2 
minutes before being washed under running water for 10 minutes. Following 
washing, the slides were placed in eosin for 2.5 minutes, before being washed for 
the last time in running water for 10 minutes.
Finally, following staining with haematoxylin and eosin, the slides were placed 
into a slide holder and dehydrated: slides were placed in 50% IMS through 
increasing concentrations of IMS, before being placed into xylene. Two drops of 
mounting medium (DPX, Raymond Lamb Laboratories, UK) was added to each 
slide. A coverslip was gently lowered onto the slide to avoid the introduction of 
air bubbles. The slides were left in the mounting hood overnight to dry, before 
being examined under a microscope (Leica DMRA2). Photographs were taken of 
the slides which were later analysed using Image-Pro Plus (MediaCybemetics), 
which allowed the dimensions of the lens to be measured.
As the samples for one of the genotypes (heterozygotes) were not of sufficient 
quality, results were only examined from two genotypes. Prior to the use of 
statistical analysis to compare the data collected an F-test was first completed to 
check for equal variation across the data sets. If the result from the F-test 
produced a value greater than 0.05 the result is not deemed significant and equal 
variation can be assumed. Following this an unpaired t-test was used. Statistical 
significance is only observed if the resulting p- value is less than or equal to 0.05.
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Examination o f  Apoptosis Gene Expression in the Postnatal M ouse Lens
3.1. Introduction
The removal of potential light-scattering organelles during differentiation of lens 
epithelial cells into fibre cells is thought to involve apoptosis signalling (Bassnett 
2002; Dahm 1999; Wride 2000) . This process has been shown to have 
similarities to apoptosis and a number of apoptosis-related genes have been 
shown to be present in the lens (Wride et a l 1999) (described in more detail in 
the introduction). However, this process does not result in the plasma membrane 
changes characteristic of apoptosis, suggesting the presence of different control 
systems.
Previously, microarrays have enabled the global gene expression of the lens to be 
identified in both development and disease. A study by Wride et al. (2003) used 
microarrays to gain insight into the gene expression of the lens. Gene expression 
of the lens tissue was compared to non-lens tissue in order to identify genes 
preferentially expressed in the lens. Lenses of different ages were also compared 
to investigate the changes in gene expression during maturation. 1,668 genes 
were expressed in one or more of the time points examined at levels significantly 
above background. A number of the genes identified were previously unknown 
to be expressed in the lens. A selection of apoptosis-related genes and various 
isoforms of haemoglobin were also shown to be present (Wride et al. 2003).
In addition to looking at genes specifically expressed in the lens, this technique 
has also been used to examine the gene expression between different cell types in 
the lens. Ivanov et a l demonstrated that there was differential gene expression 
between young elongating fibre cells and the mature non-elongating fibre cells in 
the lens (Ivanov et a l 2005). From this study 65 genes were demonstrated to 
have differential expression; 25% were shown to be activated in maturing fibre 
cells, 75% were downregulated. Included in the number of genes shown to be 
downregulated were 7 genes encoding metabolic enzymes. This result was 
expected as metabolic activity decreases in the centre of the lens as cells become 
separated from the nutritious ocular humors. From this study several classes of 
apoptosis-related genes were also shown to be activated during differentiation. 
For example, DNase II-like acid DNase (DLAD) demonstrated elevated
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expression during differentiation. This enzyme has been shown to be the DNase 
responsible for nuclear degradation during lens cell differentiation (Nishimoto et 
al. 2003). Data from this study confirms the expression of both pro- and anti- 
apoptotic genes during fibre maturation suggesting a potential role for the 
apoptotic pathway in this process.
Recently a study has been completed examining the gene expression in 
embryonic mouse lenses. Microarrays were utilised to compare the expression in 
lenses at embryonic days 10 and 12 (Xiao et al 2006). From this study 1573 
genes were confirmed as having differential expression; 965 were downregulated 
at E l2, 617 shown increased expression. Genes that promote the cell cycle were 
seen to be downregulated at E l2 as the progenitor cells from the lens pit exit the 
cell cycle and begin to differentiate into primary fibre cells. Members of both the 
IGF and Wnt families were shown to be differentially regulated between these 
two time points. Between E10 and E l2 positive regulators of Wnt signalling 
were seen to be downregulated whilst negative regulators were upregulated. This 
seems to suggest that modulation of the Wnt family is necessary for normal lens 
differentiation. Expression of crystallins, markers of fibre cell differentiation, 
was also seen to increase.
Microarrays have given researchers the ability to study the underlying global 
gene expression changes of diseases, allowing the classification of diseases and 
possibly leading to the identification of potential targets for treatments. Recently, 
studies have been carried out to elucidate the genetic causes of a number of 
ocular diseases, including cataract (Wilson et al. 2002). Mansergh et al. (2004) 
looked at the changes in gene expression in the progression of cataract in the 
SPARC knockout mouse; a mouse model known to develop age-related cataract. 
Using microarrays, 54 genes were shown to be differentially expressed after the 
formation of cataract, these included 5 of the mouse globin genes (Mansergh et 
al. 2004). The identification of the differentially expressed genes from this study 
allowed for the generation of hypothesises about the role these genes play in the 
pathogenesis of cataract. The presence of globins in the lens has lead to 
suggestions that these proteins could play a role in lens ion transport and/or 
metabolism, oxygen transport or could potentially act to promote apoptosis.
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Microarray studies have also been completed to identify the gene expression 
changes between human cataractous and normal age-matched lenses (Hawse et 
al 2003; Hawse et a l 2004; Ruotolo et al 2003; Segev et al 2004). These 
studies demonstrated differential expression between cataractous lenses and age- 
matched controls. A number of structural proteins were included in the list of 
genes shown to be down-regulated in cataract, suggesting that the structural 
changes associated with age-related cataract could be due to the decreased 
expression of structural components.
This study aims to identify which apoptosis genes are present in the mouse lens 
during postnatal maturation through the use of a macroarray containing 243 
genes with known roles in apoptosis. The presence of these genes in the lens 
could suggest a potential role in the processes of lens differentiation and 
organelle degradation. Incomplete organelle degradation has been shown to 
result in the formation of cataract. Prevention of DNA degradation in a mouse 
model, due to DLAD deficiency, was shown to lead to DNA accumulation in the 
lens causing cataract (Nishimoto et al. 2003). A study by Pendergrass et al 
demonstrated the accumulation of nuclear and mitochondrial fragments in 
cortical cataract as a result of incomplete differentiation of fibre cells at the 
equatorial region (Pendergrass et a l 2005).
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3.2. Experimental Design
The arrays used during this study are nylon macroarrays (Panorama™ Mouse 
Apoptosis Arrays) on which 243 apoptosis-related cDNAs are immobilised. The 
genes on the array included both pro- and anti-apoptotic factors including 
members of the caspase family, cell cycle regulators and signalling molecules 
amongst others. The housekeeping genes, where present, were used to normalise 
the array data so that comparisons could be made across the repetitions in each 
time point. Genes shown to be differentially expressed between the time points 
examined or shown to have high expression levels were identified from the 
arrays to try to elucidate the role of apoptosis signalling pathways in lens 
organelle degradation.
The macroarrays used in this study were hybridised with cDNA synthesised from 
RNA collected from whole lenses of newborn, postnatal day 7 and 14 mice 
(array methods given in Section 2.2). Following hybridisation and exposure to 
the phosphor imaging screen the arrays were stripped to remove any residual 
radiolabelled cDNA (see Section 2.2.7 for more details).
These postnatal stages were used as they avoided the ethical considerations 
connected with collecting tissue from embryonic time points. The three time 
points examined using the arrays are prior to eye-opening, seen to occur at P14 
(Kuwabara and Imaizumi 1974). By eye-opening the OFZ fills the pupillary area, 
therefore, a large amount of organelle degradation will have occurred before this 
time and the genes involved in this process could potentially be identified.
Semi-quantitative PCR was used to confirm array results (see Section 2.3 for 
methods) as well as to examine the expression of selected genes at other 
postnatal time points. RNA was isolated from whole lenses of newborn and 4 
week old mice in addition to that collected from lenses of mice at postnatal days 
7 and 14. This RNA was used to synthesise cDNA, which was later used in PCR 
reactions.
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Primers were designed for genes shown to be differentially expressed from the 
array results (sequences shown in Appendix 4). PCR reactions using each set of 
primers were completed three times; each time with a different cDNA sample. 
Each cDNA sample was synthesised from a litter of pooled lenses. The resulting 
gels were photographed and the band intensities quantified using Scion Image 
(see Section 2.3.5. for details).
GAPDH was used as a loading control, ensuring that the same amount of cDNA 
was used for each time point. This meant that any expression differences 
observed should be representative of the true differences of gene expression 
rather than discrepancies in the quantity of cDNA used for the reactions. The 
PCR reactions for each set of cDNAs were first normalised to GAPDH before 
being used to examine the expression of other genes identified from the arrays. 
Normalisation to GAPDH was completed by taking densitometry readings of the 
bands produced on the gel from the GAPDH products; as a result the amounts of 
cDNA were altered in the PCR reactions until the densitometry values were the 
same across all time points.
Following the completion of the three sets of PCR results for the genes shown to 
have differential expression, an average band intensity value was calculated to 
show the change in expression between the time points examined. Standard error 
of the mean was calculated for each time point/gene to give an idea of the 
variation observed from the three sets of results.
Subsequently protein expression of selected genes was examined using western 
blotting. Protein was extracted from lenses of postnatal mouse lenses at birth, 
postnatal days 7 and 14 and 4 weeks old, and quantified using a BCA assay 
(Pierce). Western blotting was used to examine the presence of mcl-1 and axl. A 
10% resolving gel was used to separate the proteins. Primary antibodies used 
were raised in rabbit: mcl-1 (Santa Cruz, sc-819), axl (Santa Cruz, sc-20741). 
The secondary antibody used was goat anti-rabbit IgG (Santa Cruz, sc-2004). 
Both the mcl-1 and axl antibodies were used at a dilution of 1:2000. The 
secondary antibody was used at a dilution of 1:5000. The films were exposed for
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three different periods of time for each of the antibodies used (1, 5 and 10 
minutes) before developing and fixing.
Following film exposure the membranes were stripped (see Chapter 2 for 
methods) and reprobed using a goat polyclonal actin antibody (Santa Cruz, sc- 
1616). The secondary antibody used was donkey-anti goat IgG (Santa Cruz, sc- 
2020). Reprobing the membranes with the actin antibody allowed for 
confirmation of equal loading. The resulting films were scanned (Epson 
Expression El 680 Pro). Three sets of protein were used to complete the western 
blots for each of the antibodies.
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3.3. Results
3.3.1. Checking the Integrity of RNA Samples
Following isolation, RNA integrity was confirmed using a denaturing gel (an 
example of which is shown in Figure 3.1). Intact RNA should produce two 
distinct bands on a denaturing gel corresponding to the 28S and 18S ribosomal 
bands. These bands should be in a ratio of 2:1, with the 28S band twice as intense 
as the 18S band. If the RNA has degraded a smear would be observed on the gel.
1 2  3  4  5  6
 <- 2 8 S
 <- 1 8 S
Figure 3.1: An example o f an RNA denaturing geL Samples run on the gel were isolated from
whole mouse lenses using TRlzot*. Lane contents as follows; lane 1: P7 RNA, lanes 2 and 3: PI 4
RNA, lanes 4-6: 4 week RNA.
3.3.2. Array Results
The arrays were completed as described previously (see Section 2.2). Results 
from the arrays hybridised with the RNA collected from newborn mice were not 
of sufficient quality for further analysis. Consequently data were only collected 
from the arrays hybridised with P7 and P I4 RNA. Four arrays were hybridised 
with the P7 RNA and 3 were hybridised with P14 RNA. The first two arrays 
from each time point were completed on fresh arrays i.e. they had never been 
used. The remainder, however, were carried out on arrays which had been 
previously stripped to remove the bound cDNA. An example of the array results 
obtained is shown in Figure 3.2.
To confirm the effectiveness of the stripping protocol the stripped arrays were 
exposed to the phosphor screen for 5-7 days before scanning. Any residual 
cDNA bound to the arrays would show up during scanning as small spots on the 
array. After the arrays were scanned, no spots were observed (data not shown); 
demonstrating that the stripping protocol was effective.
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Figure 3.2: An example o f array results obtained. Phosphoimage o f an array hybridised with P7 
RNA. The arrays used were fresh; i.e. they had not been previously stripped. Genes identified on 
the array include the genomic DNA used to align the arrays, the housekeeping genes, the 
intensity o f which was used for analysis. A few  o f the highly expressed genes, 14-3-3 eta, 
caspase-7 and SARP-2/sFRP-l are also identified. The position o f the genes o f interest used for 
further studies is also indicated. The spots for two o f these genes (axl and hd) are hard to 
visualise, but these genes were shown to have a higher expression at P14 and so would not show 
up intensly on this array.
3.3.2.I. Analysis o f Array Data
The computer image generated by the typhoon scanner was imported into 
ImaGene (Biodiscovery, USA). A virtual grid was placed over the image using 
the genomic DNA in the comers of the array as orientation points. A screenshot 
from ImaGene demonstrating the analysis process is shown in Figure 3.3. The 
results were then analysed in Microsoft® Excel as described in the methods 
section (Section 2.2.8). The raw array data have been submitted to GEO, an 
online database of results generated from array experiments 
(http://www.ncbi.nlm.nih.gov, GEO accession: GSE8731).
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Figure 3.3: Screenshots taken from ImaGene. Figure 3.3A shows the spot alignment process. A 
virtual grid is aligned over the spots to allow assignment o f grid references to each spot. Grid 
spots could be moved manually to allow correct alignment. Figure 3.3B shows the analysis 
screen generated for each array by ImaGene. In the top left corner is a representation o f the spot 
being analysed. Next to the original spot is a diagram showing the areas used to calculate both 
the mean signal intensity and the mean background value. The pixels coloured in red are used to 
calculate the mean signal intensity, those in green are used to calculate the background value. 
The area immediately around the spot was ignored for the background value; this prevents the 
generation o f an artificially high background value (see Figure 2.1). Underneath the spots is an 
example o f the data produced fo r each spot on the array, including the mean signal and mean 
background values used to analyse the results. On the right o f the picture is a histogram which 
represents the mean signal intensities fo r  all the spots on the array.
63
Examination o f  Apoptosis Gene Expression in the Postnatal M ouse Lens
The results produced from ImaGene included a mean spot intensity and a mean 
background value. Following the collection of the array results, the mean 
background value for the whole array was calculated along with the standard 
deviation. Genes which showed an original spot intensity below the mean 
background plus 2 standard deviations for at least half of their data spots were 
designated as reliably below background and were filtered out of the data set. 
After viewing previous published array articles the mean background plus 2 
standard deviations appears to be the standard value used to filter the data set. 
The number of genes that survived filtering from each gene family was 
calculated and plotted on a graph (Figure 3.4). A greater number of genes 
survived filtering at P14 than P7, suggesting differential expression between 
these two time points. The list of genes surviving the filtering process at each 
time point is included in Appendix 3.
Figure 3.4: Graph showing the number o f  genes surviving the filtering process at the two time 
points examined. The average background intensity was measured along with the standard 
deviation. The mean background value was calculated along with the standard deviation. Spots 
were considered to be below background i f  their original intensity was lower than the mean 
background intensity plus 2 standard deviations. Genes have been grouped into the gene families 
assigned by Sigma.
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Following filtering, the ten genes, which were not housekeeping genes, with the 
highest expression at each time point were identified. These are shown in Table 
3.1.
Highly Expressed Transcripts
Gene Name Accession
Number
Normalised 
Band 
Intensity P7
Normalised 
Band 
Intensity PI 4
Gene Family
Cluster in N M _ 0 1 3 4 9 2 7 5 . 3 6 6 3 . 2 5 A p o p t o s i s - R e la t e d  F a c to r s
Gpxl N M  0 0 8 1 6 0 5 5 . 0 9 4 8 . 4 6 A p o p t o s i s - R e la t e d  F a c to r s
Pin N M _ 0 1 9 6 8 2 5 0 . 6 4 4 2 . 0 9 A p o p t o s i s - R e la t e d  F a c to r s
14-3-3 eta N M _ 0 1 1 7 3 8 4 7 . 4 5 2 8 . 9 5 S ig n a l  T r a n s d u c t io n
SARP-2/sfrp-l N M  0 1 3 8 3 4 3 9 . 3 4 5 6 . 2 8 A p o p t o s i s - R e la t e d  F a c to r s
Dad-1 N M 0 1 0 0 1 5 3 2 . 6 3 2 7 . 4 9 A p o p t o s i s - R e la t e d  F a c to r s
Cyclin G1 N M  0 0 9 8 3 1 2 8 .6 1 5 1 . 2 8 C e l l  C y c le  R e g u la to r s
Mydl 18 N M  0 0 8 6 5 5 2 8 .6 1 2 0 . 3 7 S ig n a l  T r a n s d u c t io n
Mts-1 N M 0 1 1 3 1 1 2 3 . 7 4 2 8 . 2 7 A p o p t o s i s - R e la t e d  F a c to r s
Caspase-7 N M  0 0 7 6 1 1 1 8 .9 2 1 8 .7 9 C a s p a s e s  a n d  R e g u la to r s
Table 3.1: Highly expressed genes. This table lists the ten genes shown to have the highest 
expression at both P7 and P14.
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Two normalisation methods were used to analyse the array data; normalisation 
with housekeeping genes and global normalisation (see Section 2.2.8 for more 
details). Genes that demonstrated a 2-fold or greater change in expression and a 
p-value of less than 0.05 (i.e. statistically significant difference in gene 
expression) after each normalisation method were identified and are shown in 
Tables 3.2 and 3.3.
The array results were first normalised using a mean housekeeping gene value; 
this was Sigma’s recommended method of analysis for the arrays. This method 
of analysis showed 20 genes to be significantly differentially expressed between 
the two time points. An alternative method of normalisation was utilised as three 
of the housekeeping genes were not shown to be expressed on the arrays, 
possibly affecting the normalisation process. Global normalisation was the 
second method of analysis to be used. This method involved calculating a mean 
spot intensity and using that to normalise the values across the arrays (more 
detail given in Section 2.2.8.2). From this method of analysis 60 genes were 
shown to have differential expression; included in the 60 genes identified were 
the 20 previously identified by the housekeeping method of analysis. Following 
this analysis, it was decided to continue using the housekeeping method of 
normalisation as it appears to be a more stringent method. The 20 genes 
identified by this method were also identified by the global normalisation, 
suggesting that these genes were worthy of further investigation.
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Differentially Expressed Transcripts Identified by Normalisation with Housekeeping Genes
Gene Name AccessionNumber
Mean
Normalised
Expression
P7
Mean
Normalised
Expression
P14
Fold
Difference p-value
P2rxl N M  0 0 8 7 7 1 2 . 0 5 1 8 .0 5 8 .8 1 1 .6 E - 0 5
Hd N M 0 1 0 4 1 4 2 . 9 7 2 1 . 9 6 7 .3 4 4 .5 E - 0 6
Icad/Djfa N M _ 0 1 0 0 4 4 3 .9 1 1 5 .0 3 3 .8 4 0.0002
Mdm2 N M _ 0 1 0 7 8 6 4 . 7 8 1 6 .8 3 .5 1 4 . 6 E - 0 7
Mfge8 N M  0 0 8 5 9 4 2 . 5 2 7 .8 9 3 .1 3 0 . 0 0 0 4
IGFlr N M 0 1 0 5 1 3 2 . 3 3 6 . 8 4 2 .9 3 0.0001
Axl N M  0 0 9 4 6 5 2 . 8 5 8 .2 7 2 .9 0 .0 0 1 7
Galectin-3 N M _ 0 1 0 7 0 5 2 . 4 9 6 . 6 7 2.68 0.0002
A1 N M  0 0 9 7 4 2 2 . 4 6 6 .5 3 2.66 0 .0 0 1 4
Cdk4 N M  0 0 9 8 7 0 2 . 7 9 7 .2 2 .5 8 0 .0 0 0 5
Srebf2 X M _ 1 2 7 9 9 5 4 . 6 2 11.86 2 .5 7 0 .0 0 6 2
Tgffi2 N M  0 0 9 3 6 7 3 .8 3 9 . 3 2 2 .4 3 2 .5 E - 0 6
Integrin-aV N M  0 0 8 4 0 2 6 . 5 6 1 4 .6 1 2 .2 3 0.0002
Dap I N M  1 4 6 0 5 7 7 . 5 6 1 6 .8 5 2 .2 3 0 .0 0 1 3
Trp53/p53 N M _ 0 1 1 6 4 0 3 . 1 7 7 .0 1 2.21 0.0101
Srebfl N M _ 0 1 1 4 8 0 2 . 4 9 5 .4 3 2 . 1 8 0 .0 0 7
IGF-l N M 0 1 0 5 1 2 3 . 5 2 7 .6 5 2 . 1 7 0 .0 3 5
Mcl-1 N M  0 0 8 5 6 2 3 . 7 9 8 .0 4 2.12 5 .9 E - 0 6
Thrombospondin N M  0 0 1 1 5 8 0 2 . 9 9 6 . 0 4 2.02 0 .0 0 3
Daxx N M  0 0 7 8 2 9 2 . 1 4 4 . 3 2 2.01 0 .0 2 4
Table 3.2: Significant genes identified using normalisation with housekeeping genes. This 
table lists the genes shown to have a 2-fold or greater difference in expression between P7 and 
P I4 and ap-value less than 0.05.
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Differentially Expressed Transcripts Identified by Global Normalisation
Gene Name
Accession
Number
Mean
Expression
P7
Mean
Expression
P14
Fold
Difference p-value
P2rxl* N M  0 0 8 7 7 1 1 .7 8 2 2 .2 3 1 2 .5 0 4 .3 6 E - 0 6
Hd* N M  0 1 0 4 1 4 2 . 6 2 2 7 .0 8 1 0 .3 3 9 .2 8 E - 0 7
Icad/Dffa* N M  0 1 0 0 4 4 3 . 5 0 1 8 .3 8 5 .2 5 6 .1 8 E - 0 6
Axl* N M  0 0 9 4 6 5 2 . 4 4 1 0 .1 6 4 . 1 6 1 .8 5 E - 0 5
Mdm2* N M  0 1 0 7 8 6 5 . 0 5 2 0 . 6 2 4 .0 8 3 . 5 5 E - 0 8
Mfge8* N M  0 0 8 5 9 4 2 . 5 2 9 .6 4 3 .8 3 1 .6 2 E - 0 5
Ar N M  0 1 3 4 7 6 1 .1 3 4 . 1 6 3 .6 9 0 . 0 0 4 4
IGFR* N M  0 1 0 5 1 3 2 . 2 8 8 .3 8 3 .6 7 2 .5 2 E - 0 6
Al* N M  0 0 9 7 4 2 2.21 8 .0 8 3 .6 6 1 .3 4 E - 0 5
Galectin-3* N M  0 1 0 7 0 5 2 . 4 0 8.20 3 .4 1 2 .5 4 E - 0 6
Cdk4* N M  0 0 9 8 7 0 2 . 7 6 8 .8 4 3 .2 1 8 .0 1 E - 0 6
Srebf2* X M  1 2 7 9 9 5 4 . 5 5 1 4 .5 2 3 .1 9 0.0012
TR/TeRc U 3 3 8 3 1 2 .3 1 7 .0 4 3 .0 5 0.0012
TRP53/p53* N M  0 1 1 6 4 0 2 . 8 4 8 .6 2 3 .0 4 0.0001
IGF-I* N M  0 1 0 5 1 2 3 . 1 2 9 . 3 8 3 .0 0 0 .0 0 2 5
Bah N M  0 0 7 5 2 3 2.21 6 .4 3 2 .9 1 0 .0 0 1 4
Tgf-fi2* N M  0 0 9 3 6 7 3 . 9 8 1 1 .4 5 2.88 9 .9 9 E - 1 0
Daxx* N M  0 0 7 8 2 9 1 .8 9 5 .3 3 2 . 8 7 0 .0 0 0 3
Srebfl* N M  0 1 1 4 8 0 2 . 3 8 6 . 6 2 2 . 7 8 0.0002
Caspase-3 N M  0 0 9 8 1 0 2 . 1 8 5 . 9 9 2 .7 5 8 .5 8 E - 0 5
Calcyclin N M  0 1 1 3 1 3 2 . 9 9 8 .0 5 2 . 6 9 0 .0 0 0 4
RAR/32 S 5 6 6 6 0 2.20 5 .7 4 2 .6 1 0.0012
CRADD N M  0 0 9 9 5 0 1 .5 3 3 . 9 6 2 . 5 9 0 .0 0 6 2
Thrombospondin * N M  0 0 1 1 5 8 0 2 . 9 0 7 .4 2 2 . 5 6 2 .5 4 E - 0 5
Cyclin Dl M 6 4 4 0 3 2 . 7 2 6 .9 5 2 . 5 6 0 .0 0 0 4
FLIPUCash N M  0 0 9 8 0 5 1 .5 6 3 . 9 9 2 . 5 6 0 .0 1 1 7
DNAsel N M  0 1 0 0 6 1 2 .0 3 5 .1 2 2 .5 3 0 .0 0 1 9
TRAF2 N M  0 0 9 4 2 1 1 .6 7 4 . 2 0 2 . 5 2 0 .0 0 5 5
DEDD N M  0 1 1 6 1 5 3 .5 5 8 .7 7 2 . 4 7 0 . 0 0 0 6
Integrin-aV* N M  0 0 8 4 0 2 7 . 2 8 1 7 .9 7 2 . 4 7 0.0002
Bel-10 N M  0 0 9 7 4 0 2 . 0 4 5 .0 1 2 .4 5 0 .0 0 2 7
TGF-P3 N M  0 0 9 3 6 8 2 . 4 4 5 .9 7 2 .4 5 0.0012
TFAR15 A F 1 5 9 3 6 8 2.01 4 . 9 0 2 .4 3 0 . 0 0 4 0
Mcl-1* N M  0 0 8 5 6 2 4 . 1 3 9 . 8 8 2 . 3 9 1 .4 1 E - 0 6
TDAG8 N M  0 0 8 1 5 2 2 . 6 2 6 . 1 9 2 . 3 6 0.002
Spl N M  0 1 3 6 7 8 2 . 1 8 5 .0 9 2 . 3 4 0 . 0 0 6
TRAF6 N M  0 0 9 4 2 4 3 .5 3 8 .1 7 2 . 3 2 5 .1 6 E - 0 6
IFN-y R1 N M  0 1 0 5 1 1 1 .8 5 4 . 2 6 2 .3 1 0 . 0 1 0 7
RP105/Ly78 N M  0 0 8 5 3 3 1 .5 6 3 .5 4 2 .2 8 0 . 0 2 0 6
CDC2 N M  0 0 7 6 5 9 2 . 0 4 4 .6 3 2 .2 7 0 .0 0 5 3
CAS/CSE1 A I 5 4 9 6 2 5 2.01 4 . 5 7 2 . 2 7 0 . 0 1 6 6
Dapl* N M  1 4 6 0 5 7 9 .1 1 2 0 . 6 9 2 . 2 7 0 . 0 0 2 9
TWEA K/TNFSF12 A F 0 3 0 1 0 0 1 .7 7 3 .9 7 2 . 2 4 0 .0 2 1 5
PDCD2 N M  0 0 8 7 9 9 2.10 4 .6 8 2 .2 3 0 . 0 1 2 4
NF-kBP65 N M  0 0 9 0 4 5 3 .7 1 8 .2 5 2 .2 3 2 . 3 8 E - 0 5
E2F1 N M  0 0 7 8 9 1 4 . 1 2 8 .9 3 2 .1 7 2 . 6 2 E - 0 5
PARP-2 N M  0 0 9 6 3 2 2 . 0 8 4 .4 9 2 .1 6 0 . 0 0 5 8
Cytochrome p450 
oxidoreductase N M  0 0 8 8 9 8 2 . 6 2 5 .6 4 2 .1 5 0 . 0 1 7 7
Table 3.3. c o n t in u e d  o v e r l e a f
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Gene Name AccessionNumber
Mean
Expression
P7
Mean
Expression
P14
Fold
Difference p-value
TRANK N M  0 1 6 7 6 4 2 . 6 2 5 .5 8 2 .1 3 0 . 0 0 1 8
IL-2 N M  0 0 8 3 6 6 1 .9 8 4 .1 9 2.12 0 . 0 1 6
TRAF3/CRAF1 N M  0 1 1 6 3 2 2 . 3 4 4 .9 4 2.11 0 . 0 0 5 9
CD47 N M  0 1 0 5 8 1 2 . 0 8 4 .3 7 2.10 0.0102
Cox-l/Ptgsl N M  0 0 8 9 6 9 1 .7 6 3 .6 4 2 .0 6 0 . 0 4 5 3
Cyclin G1 N M  0 0 9 8 3 1 3 0 . 8 9 6 3 .7 3 2 .0 6 0.0010
IFN-y R2 N M  0 0 8 3 3 8 2 . 3 7 4 .8 9 2 .0 6 0 . 0 0 3 0
PDCD1 N M  0 0 8 7 9 8 1 .3 9 2 .8 5 2 .0 5 0 . 0 3 7 7
53BP2 U 5 8 8 8 1 1 .7 4 3 .5 6 2 .0 4 0 . 0 3 3 0
CLDN3 N M  0 0 9 9 0 2 1 .7 2 3 .4 8 2.02 0 . 0 0 3 4
CDK5 N M  0 0 7 6 6 8 2 . 8 3 5 .7 2 2.02 0.0001
Bim N M  0 0 9 7 5 4 2 . 0 4 4 . 1 0 2.01 0 .0 1 5
erbB2 U 7 1 1 2 6 2 . 0 4 4 . 1 0 2.01 0 .0 2 6 5
Table 3.3: Significant genes identified using global normalisation. This table lists the genes 
shown to have a 2-fold or greater difference in expression between P7 and P14 and a p-value 
less than 0.05. Gene names marked with an asterisk were also identified through normalisation 
with the housekeeping genes.
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3.3.2.2. Reproducibility of Array Data
To examine the reproducibility of array results obtained, normalised signal 
intensities were compared. Results observed from arrays hybridised with P7 
cDNA were compared by plotting them on an X-Y scatter plot (Figure 3.5A-C). 
Two of the arrays hybridised with P7 cDNA were fresh, i.e. they had never been 
used before. The remainder had previously been stripped (methods described in 
Section 2.2.7.). If the data are reproducible, a straight line should be generated at 
a 45° angle dissecting equal values on both the X and Y axes. When the results 
from the fresh arrays were compared (Figure 3.5A) the resulting graph 
demonstrated a general trend towards the expected 45° line (Revalue: 0.95). 
When the results from the two stripped arrays were compared (Figure 3.5B) 
again this trend towards the expected 45° line was observed (R2-value: 0.88). 
However, when the results were compared from arrays hybridised under different 
conditions (fresh versus stripped, Figure 3.5C) the trendline generated did not 
dissect equal values on both the X and Y axes, but instead demonstrated a bias 
towards the results generated from the fresh array (Revalue: 0.41). This was not 
unexpected, as the stripping process may have removed some of the original 
bound cDNA on the arrays, which could lead to a reduction in the resulting 
signal. To counteract this potential problem, all of the array results were 
normalised with respect to the mean housekeeping gene expression so the weaker 
signals observed from the stripped arrays should not affect the overall results.
Three arrays were completed using P I4 cDNA. The results from the arrays 
hybridised with P14 cDNA are shown in Figure 3.5D-E. Again, when the results 
were compared from the arrays treated identically there was a general trend 
towards the expected 45° line (R2-value: 0.94).
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Scatter Plots Demonstrating Reproducibility o f the Array Results
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Figure 3.5: Reproducibility o f  array results. These graphs were produced by plotting the 
normalised signal intensities from one array against another. Array results were compared 
between arrays which had been treated identically (i.e. fresh array compared with a fresh array, 
or a stripped array compared with a stripped array) or that had been treated differently (fresh 
versus stripped). Results from the arrays hybridised with P7 cDNA (A-C) or P14 cDNA (D-E) 
show that when arrays are compared with others that have been treated identically they have a 
high level o f reproducibility. However, when the results were compared from two different 
conditions the trendline did not dissect equal values on both the X  and Y axes (C). The R2-value is 
shown on each graph. The closer this value is to 1, the greater the correlation between the two 
sets o f data.
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3.3.3. PCR Confirmations
Semi-quantitative PCR was used to confirm differential expression of the genes 
identified from the arrays using the housekeeping gene normalisation method. 
Primers were designed for these 20 genes using the FASTA sequence provided 
by the NCBI Gene database (more details given in Section 2.3.3). Once 
resuspended in the volumes of water as specified by Operon, primers were run 
out on an agarose gel to ensure that they were all at the same concentration (since 
experience showed that not all primers resuspend to the same degree). An 
example of this is shown in Figure 3.6. Once the gel had been photographed a 
dilution factor for each of the primers could be identified, where necessary.
Figure 3.6: Example of a get produced following the running out o f resuspended primers.
Primers were run out on an agarose gel; following this a dilution factor could be identified to 
ensure that each o f the primers was at the same concentration.
3.3.3.I. Housekeeping Genes
Three of the seven housekeeping genes printed on the arrays were not shown to 
be expressed above the background level (Transferrin R, Hprt and p2- 
microglobulin). To investigate if these genes are expressed in the lens, primers 
were designed for these three genes (primer sequences shown in Appendix 4) 
and semi-quantitative PCR completed. The results from these PCR reactions are 
shown in Figure 3.7.
As shown in Figure 3.7., all three of the housekeeping genes were found to be 
expressed in the lens at both P7 and P I4. This result suggests that there could 
have been a problem with the spotting of these genes on the original arrays.
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Figure 3.7: Semi-quantitative PCR results for the housekeeping genes not shown to be 
expressed using the arrays. Three housekeeping genes were not shown to be expressed above 
background from the array results. Semi-quantitative PCR was used to examine the expression o f 
these genes. PCR results demonstrated expression o f all three o f these genes at the stages 
examined. Gels presented are representative o f  the three sets o f results produced.
3.3.3.2. Differentially Expressed Genes
A number of different cycle numbers and annealing temperatures were tried in 
order to obtain the optimum results for each PCR reaction. DNA gels 
representative of the PCR results for the differentially expressed genes are shown 
in Figure 3.8. The gels produced from the PCR reactions were analysed using 
Scion Image (USA), producing average pixel intensities for each band. The band 
intensities were then normalised with respect to GAPDH, before being compared 
to the other repetitions. The average band intensity was calculated along with the 
standard error of the mean, this is shown graphically in Figure 3.9. The original 
band intensities are included in Appendix 5.
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From the PCR results differential expression between P7 and P14 was confirmed 
for 10 of the 19 genes tested (52%). For the remaining 9 genes, although 
differential expression was not confirmed, expression of these genes was 
observed in the lens. The fold difference between the average normalised values 
was calculated (shown in Appendix 5). The ratios observed from the PCR results 
did not match those identified from the array results for any of the genes 
examined although the majority of results demonstrated a similar trend in 
expression. However, some of the results demonstrated the opposite, e.g. igf-1 
showed almost a 7 fold decrease in expression between P7 and PI4.
Statistical analysis of the PCR results was completed using a one-way ANOVA 
with Tukey’s post-hoc test. This analysis would demonstrate whether there were 
any significant changes in expression of the genes between the time points 
examined. Following the completion of this analysis, 2 genes were shown to 
have significant differences in expression; thrombospondin and igf-1. 
Thrombospondin demonstrated a statistically significant change in expression 
between the newborn and 4 week stages, and P7 and 4 weeks. A significant 
change in expression of igf-1 was noted between P7 and P I4, and P7 and 4 
weeks. Results from the statistical analysis are shown in Appendix 6.
Results for the P2rxl PCR were not obtained, despite altering both the cycle 
number and annealing temperature. PCR reactions were also completed using 
two different sets of primers for this gene, but to no avail.
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Figure 3.8: Semi-quantitative PCR results fo r differentially expressed genes. Gels presented 
are representative o f the three sets o f results produced. Results are arranged in order o f the fold  
difference observedfrom the array results.
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Figure 3.9: Graphical representation o f the PCR results obtained. The results from the three 
sets o f PCR reactions completed were combined to give the average band intensity presented 
here. Each set was completed using a different cDNA sample generated from independent RNA 
samples collectedfrom different litters o f  mice. Error bars displayed represent the standard error 
o f the mean. Asterisks demonstrate statistical significance.
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3.3.4. Western Blotting Results
Following the identification of the genes shown to have significantly differential 
expression between the time points examined from the arrays, a few genes were 
selected for further investigation. It would not have been feasible to look at all 
twenty genes due to the constraints of both time and funding for this study. The 
selected genes were used for protein studies; examining expression of the 
proteins at four stages of development. These studies were completed with a 
view to complete possible future functional studies.
The two genes selected for further investigation were axl and mcl-L Axl had 
previously been shown to be expressed in both bovine and rat lenses (Valverde et 
al. 2004) This study was completed to identify whether axl was also expressed in 
the mouse lens. The normal physiological role of axl in the lens is yet to be 
elucidated.
Mcl-1 demonstrated differential expression from both the PCR and array results. 
It is a member of the Bcl-2 family, members of which have been shown to be 
present in the lens previously. Overexpression of Bcl-2 has been shown to result 
in abnormal differentiation of fibre cells (Fromm and Overbeek 1997; Sanders 
and Parker 2003). There are two known isoforms of mcl-1, a short pro-apoptotic 
form and a longer anti-apoptotic form (Bae et al. 2000). The shorter isoform is 
formed as a result of alternative splicing of the mcl-1 gene. The presence of these 
two isoforms was examined to see if there was any change in expression of these 
two isoforms over the developmental stages examined.
Western blotting was completed to examine the expression of these two proteins 
in the lens during maturation. Four developmental stages were used: NB, P7, P I4 
and 4 weeks. Results are shown in Figure 3.10. Both axl and mcl-1 protein 
expression was confirmed in the mouse lens. Densitometry analysis was 
completed to identify differences in expression between the time points; results 
are shown in Figure 3.11. Statistical analysis of the western blotting results is 
given in Appendix 7. The only comparison that showed a statistically significant 
difference was between new bom and P7 for the long isoform of Mcl-1.
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Figure 3.10: Western blotting results. lOpg o f each protein sample was loaded onto the gel. 
Following the addition o f ECL reagents to the membrane, the membranes were exposed to the 
film for 10 minutes (actin exposure was 1 minute). The membranes were stripped and reprobed 
with an actin antibody to confirm equal loading o f protein in each well. Results presented 
demonstrate protein expression for both axl (A) and mcl-1 (B). Figures are representative o f the 
three sets o f results produced. Each western blot was completed using an individual protein 
sample for each o f the time points extracted from the lenses o f a litter o f pups (between 5 and 8 
pups).
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Figure 3.11: Graphical representation o f the western blotting results obtained. Results 
presented demonstrate the densitometry results obtained for the bands producedfrom the western 
blotting films. Protein expression for both axl (A) and mcl-1 (B) was observed. The results from 
the three sets o f western blotting experiments completed were combined to give the average 
optical density presented here. The results obtained from the blots o f the protein o f interest were 
normalised to the intensity measured for the actin loading control for each time point. Error 
bars represent the standard error o f  the mean. A statistically significant difference was observed 
in expression for mcl-1 L between NB and P7; statistical significance is demonstrated by the 
presence o f the asterisk.
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3.4. Discussion
In this study, the gene expression of 243 apoptosis-related genes in the mouse 
lens was compared between two time points, P7 and PI4, using a macroarray. 
Tissue at these developmental stages was relatively easy to obtain and an average 
litter provided enough RNA to hybridise to an array. By PI4, eye opening 
(Kuwabara and Imaizumi 1974), the initial flourish of denucleation and organelle 
degradation has been completed and so identification of the genes involved in 
these processes should be possible. Arrays had also been completed using cDNA 
synthesised from RNA extracted from newborn lenses, but these arrays were 
unsuccessful. This result was probably due to limited quantities of RNA 
extracted from the newborn lenses.
The cDNA used to hybridise the arrays in this study was labelled with P. For 
array detection 33P was used in preference to the more energetic emitter 32P. Due 
to the physical closeness of the cDNAs located on the arrays a strong 
hybridisation signal produced by a high energy emitter could interfere with, or 
mask, the detection of a target with a weaker signal. Simultaneous hybridisation 
can not be utilised using radiolabelled cDNA, so arrays for the two time points 
were completed in parallel.
3.4.1. Discussion of Array Results
The onset of organelle degradation precedes the postnatal stages examined in this 
study; secondary fibre cell denucleation begins at E l7.5, with the maturation of 
the lens complete by P14 (Kuwabara and Imaizumi 1974). However, as organelle 
degradation continues throughout life, some cells from the whole lens would be 
going through this process at each of the stages examined and so identification of 
the genes identified in these processes should be possible when compared to an 
earlier stage such as P7.
As discussed previously in Section 1.3.3, lens fibre cells have been shown to 
cease both transcription and translation at the time of organelle degradation 
(Faulkner-Jones et al. 2003; Ozaki et al. 1985; Shestopalov and Bassnett 1999). 
From the research discussed in Section 1.3.3, large quantities of RNA would not
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be expected to be extracted at the later stages due to its degradation in lens fibre 
cells. To overcome this potential problem, whole lenses were used to collect the 
samples in this study; as the lens continues to grow throughout the lifetime of the 
organism the epithelial cells will be constantly differentiating into fibre cells. 
During differentiation, the genes involved in the process of organelle degradation 
should still be expressed in the cells in the equatorial region and the outermost 
fibre cells of postnatal mouse lenses.
Over 100 (86 at P7 and 161 at P I4) of the genes immobilised on the array were 
shown to be expressed above background levels + 2SDs of background in at least 
one of the time points examined. Twenty genes showed significant differential 
expression, with higher expression at P I4. From the array results a larger number 
of genes were shown to be expressed above background at P14 when compared 
to P7. This was an unexpected result; by P14 the majority of lens maturation is 
complete. The only cells undergoing differentiation at this time point are those 
located at the equatorial region. Cells located in the epithelium near the ciliary 
body will still be proliferating and it is these cells along with those in the 
equatorial region that will still be actively transcribing RNA. The difference in 
gene expression observed could potentially be explained by the increase in size 
of the lens between P7 and P I4. Previous studies have observed that the OFZ 
increases in size by approximately 80pm/day encompassing more of the 
secondary fibre cells (Bassnett and Beebe 1992). The increase in size of the lens 
between these two time points would suggest an increase in proliferating 
epithelial cells and differentiating fibre cells; this could be a possible reason for 
the increase in number of genes expressed between these developmental stages.
In support of the suggestion that the apoptosis pathway has a role in lens 
differentiation, over one hundred apoptosis-related genes were shown to be 
present in the lens in this study. It is likely that even though these genes were 
identified at stages after the initial formation of the OFZ they could still be 
involved in its formation. However, the identification of these genes from the 
array results does not indicate where they are expressed (i.e. in which sub­
compartment in the lens). These genes may be expressed in the equatorial region 
where differentiation is beginning, or they could be located in the lens epithelium
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where they could be involved in epithelial remodelling or in the outer cortical 
lens fibre cells, which have yet to lose their nucleus.
Following the completion of the array results, 3 housekeeping genes were shown 
not to be expressed above background. Subsequently PCR reactions were 
completed which demonstrated expression of these genes in the lens, results of 
which demonstrate varying expression across the developmental time points. 
Normalisation of the array results was completed using the results obtained for 
the remaining housekeeping genes as standards. The variability of results for the 
three housekeeping genes tested by PCR could suggest that the expression of the 
remaining housekeeping genes used for the normalisation process could also vary 
during development. This correlates with the observation that the number of 
housekeeping genes surviving filtering differs between the two time points. This 
could then affect the normalisation process. However the 20 genes identified 
from normalisation with the housekeeping genes were also identified by global 
normalisation, adding weight to the suggestion that they are significantly 
differentially expressed.
3.4.2. Functions of the Genes Identified by the Arrays
Twenty genes were shown to have a significant change in gene expression 
between the two time points examined (shown in Table 3.1.); all with highest 
expression at PI4. A brief description of function of these genes is included here.
P53 is a well-characterised tumour-suppressor gene which has been shown to 
play a role in a number of cellular processes including responding to DNA 
damage (Kastan et al. 1991), apoptosis (Shaw et al. 1992) and cell cycle 
progression (Kuerbitz et al. 1992). Recently, p53 has been shown to be expressed 
in the lens epithelial cells of central and pre-germinative zones and in the lens 
fibre bow in the lens of adult mice (Pokroy et al. 2002). The role of p53 in lens 
cells has been examined through the use of transgenic mice generated to express 
wild-type human p53. These mice developed microphthalmia as a result of 
apoptosis induction in differentiating lens fibre cells (Nakamura et al. 1995). P53 
has also been observed to play a role in the differentiation of normoblasts; the 
advanced stage of erythropoiesis (Peller et al. 2003).
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Mouse double minute protein 2 (Mdm2) has been shown to have affects on the 
cell cycle, apoptosis and tumourogenesis through its interactions with other 
proteins including p53 and retinoblastoma 1 (reviewed in Momand et al. 2000). 
Mdm2, which has been shown to have intrinsic E3 ligase activity, is the main 
inhibitor of p53 maintaining low levels of p53 expression in non-stressed cells by 
increasing the degradation of p53 by the 26S proteasome (reviewed in Michael 
and Oren 2003).
Death-domain-associated protein (Daxx) was originally identified as a protein 
demonstrating specific binding to the death domain of the transmembrane death 
receptor FAS and was thought to be involved in the promotion of Fas-induced 
apoptosis (Yang et al. 1997b). However, homozygous deletion of Daxx was seen 
to results in embryonic lethality, with widespread apoptosis observed in Daxx- 
deficient embryos (Michaelson et al. 1999). This suggests that Daxx plays an 
important role in embryonic development. This protein has also been shown to 
play a role in regulating transcription. RNAi was used to prevent the expression 
of Daxx; cells showed increased apoptosis, suggesting an anti-apoptotic role for 
Daxx. Transcriptional activity was also observed to decrease (Michaelson and 
Leder 2003). Daxx is also known to be involved in the p53/mdm2 pathway. 
Downregulation of Daxx was seen to decrease mdm2 expression levels and it 
was noted that Daxx enhances the E3 activity of mdm2 towards p53 (Tang et al. 
2006).
The exact physiological function of the normal Huntingtin (hd) protein has yet to 
be elucidated. The mutant form of protein, containing a CAG expansion region in 
the first exon, has been shown to result in a progressive neurodegenerative 
disorder (reviewed in Reddy et al. 1999). Huntingtin has been shown to interact 
with a wide range of proteins, including caspase-3, and has been proposed to 
play a role in both membrane trafficking and apoptosis (Haijes and Wanker 
2003).
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Transforming growth factor p2 (tgfp2) has been shown to induce an epithelial- 
mesenchymal transition, characteristic of the changes observed in PCO 
(Wormstone et al 2002). A role for this family in lens differentiation has also 
been suggested with a previous study demonstrating that disruption of TGFp 
receptor signalling in lens fibre cells impaired fibre maturation (de Iongh et al 
2001).
Insulin-like growth factor 1 (IGF1) and insulin-like growth factor 1 receptor 
(IGFlr) have previously both been shown to be expressed in the lens. IGF-1 was 
shown to be expressed exclusively in the epithelial cells within the lens of chick 
embryos (Caldes et al 1991). The highest expression of IGF-1 r was observed in 
the mouse lens at the lens periphery where the germinative and transitional zones 
are located (Xie et al 2007). IGF-1 has been shown to be a potent differentiation 
factor in embryonic chick lenses inducing epithelial-fibre cell differentiation 
(Beebe et al 1987). In comparison, in rodent lenses IGF-1 was not shown to 
have the same effect on the cells, although it was shown to be capable of 
enhancing or maintaining the differentiation induced by FGF (Richardson et al 
1993). Overexpression of IGF-1 in the mouse lens resulted in an observed 
change in the morphology of the lens; a posterior expansion of the transitional 
zone. This suggests that IGF-1 may provide a spatial cue for this region of the 
lens (Shirke et al 2001).
DNA fragmentation factor (DFF) is a heterodimer composed of 40kDa and 
45kDa subunits (Liu et a l 1997). It was demonstrated that caspase-3 cleaves 
45kDa subunit (DFFA) at two sites to generate an active factor, resulting in 
DNA fragmentation without any further requirement for caspase-3 or other 
cytosolic proteases. DFFA has been shown to be cleaved in the chick lens during 
organelle degradation (Wride et a l 1999), although this could be a caspase- 
independent process as cleavage still occurred in the presence of general caspase 
inhibitor Boc-D-FMK.
Galectin-3 (gal-3) has been localised to the plasma membrane of ovine lens fibre 
cells where an interaction with MP20, an intrinsic membrane protein, was 
observed (Gonen et a l 2000). Expression patterns of gal-3 in the human, mouse
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and rat lenses have since been identified (Dahm et al. 2003). In human lenses, 
highest expression was observed during embryonic stages of development, 
although it continued to be expressed in adult lenses in both epithelial cells and 
early differentiating fibre cells (Dahm et al. 2003). Its expression was seen to 
decrease with maturation of the lens fibre cells; with no expression detected in 
mature lens fibres. The observations of the spatio-temporal expression of gal-3 
lead to the suggestion that this molecule could play a role in cell-cell interactions 
and the differentiation of fibre cells. Gal-3 is also thought to play an anti- 
apoptotic role; a high level of both functional and structural similarity between 
gal-3 and Bcl-2 has been observed and gal-3 has been shown to prevent 
apoptosis induced by staurosporine in a human cell line (Yang et al. 1996).
Axl, a receptor tyrosine kinase, has previously been shown to be expressed in 
both bovine and rat lens epithelium (Valverde et al. 2004). The presence of its 
ligand, Gas6, was observed in the aqueous humor. Experiments completed in this 
study demonstrated both mitogenic and anti-apoptotic roles of Gas6. It was 
proposed from this finding that the Gas6/Axl interaction could play a role in 
regulating the normal growth of lens epithelial cells.
Myeloid cell leukaemia-1 (Mcl-1) is a member of the Bcl-2 family of proteins 
predominantly localised in the mitochondrial membrane (Yang et al. 1995). Two 
isoforms of Mcl-1 have been identified; a short isoform, containing only a BH3 
domain, which is pro-apoptotic (Bae et al. 2000) and the originally identified 
long form, containing Bcl-2 homology domains 1, 2 and 3, shown to be anti- 
apoptotic (Kozopas et al. 1993). The long and short isoforms are capable of 
forming heterodimers and the balance between the two isoforms could determine 
the fate of the cells expressing both proteins. The long isoform was also shown to 
be capable of interacting with other proapoptotic Bcl-2 family members but not 
with anti-apoptotic members (Bae et al. 2000).
Milk fat globule epidermal growth factor 8 (Mfge8) was first identified in the 
membrane of milk fat globules (Stubbs et al. 1990). It has since been shown to 
be secreted by activated macrophages recognising apoptotic cells by binding to 
aminophospholipids such as phosphatidylserine (Hanayama et al. 2002).
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Macrophages have been shown to be present during mammalian lens 
development. Immunohistochemical studies have shown the presence of 
macrophages in the ectoderm, lens vesicle, lens cavity and surrounding 
mesoderm where they were observed to remove degenerating epithelial cells. 
Macrophage localisation was shown to correlate with areas of cell death 
(Nishutani and Sasaki 2006). However, during the process of lens cell 
differentiation flipping of phosphatidylserine from the inner to the outer leaflet of 
the membrane is not observed, so the presence of this gene in the lens may not 
have been predicted.
The family of integrins are heterodimeric membrane receptors which act as 
signalling molecules between the cytoplasm and the cell membrane (Wederall 
and De Longh 2006). The integrin family have previously been shown to have a 
role in organisation of the cytoskeleton and have demonstrated ability to generate 
intracellular signals inducing proliferation (Giancotti 1997). Western blotting 
was used to examine the expression of intergrins in the embryonic chick lens 
(Menko and Philip 1995). The results of this study did not show Integrin-aV 
expression.
Cyclin-dependent kinase 4 (cdk4) belongs to a family of serine/threonine protein 
kinases which are essential for the progression of the cell cycle (Sherr 1993). The 
kinase activity of this protein is regulated by a member of the cyclin family 
(cyclin D). Cdk4 has been shown to have role in the regulation of the Gl/S 
transition (G1 is the first gap phase, S is the DNA synthesis phase) (Sherr 1993). 
Both the mRNA and protein for cdk4 have previously been identified in both the 
epithelial and fibre cells of the rat lens during early development, E l6 to P8, 
alongside other members of the same family (Gao et al. 1999). Other members of 
the cyclin-dependent kinase family have been shown to be involved in the 
process of primary fibre cell denucleation in the embryonic chick lens (He et al. 
1998) so the presence of cdk4 in the rat lens during the stages of development 
described by Gao et al. could suggest a role for cdk4 in this process as well.
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Death associated protein 1 (Dapl) is a small proline rich protein shown to be 
located in the cytoplasm. Dapl belongs to a family of 5 novel genes, shown to 
mediate cell death induced by interferon-y (Levy-Strumpf and Kimchi 1998). 
Dapl is known to interact with the cytoplasmic death domain of TNF-R1 and 
overexpression of this protein has been shown to induce apoptosis (Liou and 
Liou 1999).
Five other genes were shown to be differentially expressed: P2rxl belongs to the 
family of P2x class of cell surface receptors. It functions as a ligand-gated ion 
channel activated by the binding of ATP. P2x family members have been noted 
to play a role in cellular signalling (Khakh and North 2006). Bcl-2 family 
member Bcl2ala (Al) is an anti-apoptotic protein shown to bind to bid and 
prevent apoptosis caused by cytochrome c release induced by TRAIL and CD95 
(Werner et al 2002). Two members of the sterol regulatory binding family, 
srebfl and srebf2, were also shown to be differentially regulated. These genes 
are transcription factors with a role in lipid biosynthesis (reviewed in Shimano
2001). The last of the genes shown to be differentially expressed was 
thrombospondin. Thrombospondin has previously been shown to be expressed in 
the eye where it was shown to have a role in modulating interactions between 
cells and the cellular environment (Hiscott et al. 2006). It is also known to play a 
role in the inflammatory response and angiogenesis (Adams and Lawler 2004).
3.4.3. Discussion of PCR confirmations
Semi-quantitative PCR results confirmed expression in the mouse lens of all 
differentially expressed genes identified from the arrays. The expression levels of 
the genes of interest at both P7 and P I4 demonstrated by the PCR results were 
compared to that obtained from the arrays. 52% of the genes tested (10/19) 
confirmed the differential expression observed from the array results; with higher 
expression at P14 observed. Gene expression for all genes was also observed in 
newborn and 4 week old lenses.
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The gene expression differences seen from the arrays were not observed from the 
PCR results, although a similar trend in expression was observed for the majority 
of the genes examined. Some genes e.g. IGF-1 and A l showed the opposite 
expression from the PCR results, demonstrating increased expression at P7.
The level of gene expression observed from the array results was seen to have no 
bearing on whether the expression would be confirmed by PCR (see Table 3.4). 
For example, from the array results integrin-aV was shown to have a 2.2 fold 
change in expression with original intensities of 6.5 at P7 and 14.6 at P14 but the 
PCR results for the gene demonstrated higher expression at P7.
Gene Name Ratio Observed from Array Results
Ratio Observed from 
PCR Results
P2rxl 8 .8 1 U n s u c c e s s f u l
Hd 7 . 3 4 1 .2 7
Dffa 3 . 8 4 0 .9 1
Mdm2 3 .5 1 2 . 0 8
Mfge8 3 .1 3 1 . 1 1
Igflr 2 .9 3 1 .0 6
Axl 2 . 9 0 . 3 6
Galectin-3 2 . 6 8 1 . 2 1
A l 2 . 6 6 0 . 1 9
Cdk4 2 . 5 8 1 . 0 0
Srebf2 2 . 5 7 1 . 2 2
TGFp2 2 . 4 3 1 .1 8
Dapl 2 . 2 3 0 . 9 9
Integrin-aV 2 . 2 3 0 .7 1
P53 2 . 2 1 1 .5 9
DAXX 2 . 1 8 1 .1 7
Thrombospondin 2 . 1 7 0 .3 0
IGF-1 2 . 1 2 0 .1 5
Srebfl 2 . 0 2 0 .8 4
Mcl-1 2 . 0 1 7 .0 7
Table 3.5: Ratio of gene expression observed from  the array and PCR results. The average 
expression was compared between P7 and PJ4 fo r  each o f the techniques and a ratio (P14/P7) 
was calculated. The ratios o f expression observed from the array results were not corroborated 
by the subsequent PCR reactions.
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Previously published lens microarray papers (Hawse et al. 2005; Ivanov et al. 
2005; Mansergh et al. 2004; Wride et al. 2003; Xiao et al. 2006) were examined 
to ascertain the PCR confirmation rate achieved for the genes demonstrating 
differential expression. Three of the studies looked at used semi-quantitative 
PCR to confirm the preferential expression of the genes identified in a particular 
cell type/strain (Hawse et al. 2005; Mansergh et al. 2004; Wride et al. 2003). The 
results of these studies varied between a 47% and 100% confirmation rate.
Two studies used quantitative PCR to confirm the difference in expression 
observed from the array results. The confirmation rate for this technique also 
varied; from 50% (Xiao et al. 2006) to 100% (Ivanov et al. 2005). Confirmation 
rate was seen to decrease with number of genes examined; Ivanov et al. 
confirmed the expression of 9 genes, Xiao et al. examined 80 and confirmed the 
expression of 40.
The results from the arrays and subsequent PCR confirmations show that the 
arrays used, although good at providing an overall profile of gene expression, 
may not be able to accurately demonstrate differential expression between time 
points. Quantitative PCR should be used to analyse the differences in gene 
expression more accurately.
The observation that these genes are expressed in the lens, does not necessarily 
suggest that they are involved in the processes of organelle degradation and/or 
denucleation. They could be involved in the general remodelling of the lens 
epithelium during development. However, the developmental time points for 
identification of apoptosis genes were selected because they represent periods 
during which the formation of the OFZ (involving apoptosis signalling) is 
progressing rapidly.
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3.4.4. Discussion of Western Blotting Results
Protein expression of both axl and mcl-1 was observed at all the developmental 
time points examined. Axl had previously been shown to be expressed in the 
epithelial cells of both rat and bovine lenses (Valverde et al. 2004). The results 
from this study demonstrated the expression of axl in the postnatal mouse lens. 
No statistically significant difference in expression of axl was observed between 
any of the stages examined.
Previously the expression of the ligand for axl, Gas6, was demonstrated in the 
aqueous humor (Valverde et a l 2004). The localisation of expression of axl and 
its ligand have lead to the suggestion that these proteins may play a role in the 
proliferating epithelial cells but not in fibre cells. Gas6 has been shown to have 
an anti-apoptotic role, protecting cells from TNFa induced apoptosis (Valverde 
et al. 2004). It has been hypothesised that the presence of these proteins could 
help regulate the normal development of the lens epithelium.
The western blotting results presented in this chapter demonstrated the 
expression of both the long and short forms of mcl-1 in the postnatal mouse lens. 
Looking at the results produced it has been observed that the short isoform of 
mcl-1 (the pro-apoptotic form), is expressed at higher levels than the long 
isoform. The long and short isoforms have been observed to form heterodimers 
and the balance between the two has been suggested to determine the fate of the 
cell (Bae et al. 2000). The presence of a higher quantity of the short isoform 
could suggest the activation of a pro-apoptotic pathway in the lens. A significant 
increase in the long isoform was observed between the newborn and P7 results.
Although densitometry is a useful tool for measuring the relative protein 
expressions, there are some negative factors that need to be considered. It is 
highly reliant on the gel being of the utmost quality. If there are any 
imperfections (such as samples running at slightly different speeds) then it is 
more difficult to obtain an accurate value for the molecular weight for each band. 
Problems encountered during the transfer process from gel to membrane can also 
impact the results obtained.
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The western blotting results produced from this study do not determine the 
localisation of these proteins; merely demonstrate their expression in the mouse 
lens. There is a large variation in results obtained from the western blotting 
experiments.
In summary the results included in this chapter show:
• Over 100 apoptosis-related genes (86 at P7 and 161 at P I4) were shown 
to be expressed above background + 2SDs in at least one of the stages.
• 20 genes were shown to be significantly differentially regulated between 
the two time points examined, all with highest expression at PI4.
• Semi-quantitative PCR was used to confirm differential expression for 
52% of the genes identified.
• Two genes were selected to undergo further investigation, axl and mcl-1, 
which could possibly lead to future functional studies. Protein expression 
of these two genes was confirmed at all developmental time points 
examined.
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Examination o f the Role o f Huntingtin in Mouse Lens Development
4.1. Introduction
Huntington’s disease is an autosomal dominant neurological disorder caused by 
triplet CAG repeat, encoding glutamine, in first exon of the huntingtin gene (hd) 
(reviewed in Reddy et al. 1999). This disease is characterised by involuntary 
movements, intellectual impairment and emotional disturbances. Huntington’s 
tends to be an age-related disease mainly affecting people in middle-age, 
although individuals with an increased number of triplet repeats present with an 
earlier onset of the disease (reviewed in Young 2003). The toxicity of huntingtin 
is directly correlated to the number of CAG repeats it contains; in an unaffected 
individual huntingtin will contain 9-34 CAG repeats whilst in those affected the 
gene will include more than 40 repeats (Snell et a l 1993).
The extended CAG repeat which leads to the toxic function of huntingtin, results 
in the inclusion of a long polyglutamine tract at the N-terminus of the protein 
(Sharp et al. 1995). This polyglutamine tract has been observed to increase the 
chance of protein aggregation (reviewed in Walker 2007). The huntingtin protein 
has been shown to interact with proteins that regulate transcription (Kegel et al.
2002), apoptosis (Zhang et al. 2006) and axonal transport (Velier et al. 1998). In 
addition to its interactions with other proteins, the mutant form of the protein is 
thought to have an effect on the function of the normal protein and this dominant 
negative effect has been proposed as a mechanism for Huntington’s pathogenesis 
(reviewed in Walker 2007).
A number of mouse models have been generated to elucidate the mechanism of 
Huntington’s disease. The mouse model used in this study was generated on a 
C57/B16 background. Gene targeting was utilised to introduce an extended 
(150bp) CAG repeat into exon 1 of huntingtin. A two-step gene targeting 
strategy was utilised; firstly exon 1 of the gene was replaced in embryonic stem 
cells (ES cells) with a selectable marker, hprt. The ES cells containing this 
modification were then identified and used in the second stage where the hprt 
marker was replaced with an extended repeat version of exon 1. The result of this
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ensures that the ES cells containing the modification only differ from the wild- 
type cells by the length of the CAG repeat (Lin et al. 2001). Expression of the 
mutant hd protein has been previously confirmed by western blotting in both the 
ES cells and in the brains of mutant mice (Lin et al. 2001). Mice with this knock- 
in mutation demonstrated late-onset behavioural and neuroanatomic 
abnormalities. No early developmental phenotype was noted and the mice were 
seen to develop normally with no severe neurological defects observed.
Results from Chapter 3 showed that huntingtin was differentially expressed 
between postnatal days 7 and 14 in the mouse lens, with highest expression at 
P I4. Semi-quantitative PCR results confirmed this differential expression and 
also demonstrated expression in both newborn and 4 week old mice. The aim of 
this study was to examine the morphology of the lens from eyes collected from 
mice with a mutant knock-in CAG repeat. The morphology was compared 
between wild type ('/'), heterozygotes (*/') and homozygotes (V~).
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4.2. Experimental Design
The methods used in this chapter have already been described in the general 
methods chapter (Chapter 2). This part of the study used eyes from the mouse 
line described previously in Section 4.1. Eyes were collected from P2 mice 
(provided by Dr. Lesley Jones’ lab based at the Heath Hospital). By P2, the OFZ 
in the centre of the lens has been established (Bassnett 2002). At this time point 
an alteration in the formation of the OFZ should be apparent, so the affect of this 
knock-in mutation could be identified. Tail tips were also collected from each 
pup to allow the genotype of each mouse to be established.
Following collection, excess tissue was removed from around the eyeball and 
small incisions were made in the back of the eye; this allowed for the fixative to 
enter the eye effectively. The eyeballs were then fixed in 4% PFA overnight 
before dehydrating and embedding in wax. Eyeballs were embedded with the 
optic nerve orientated towards the right of the embedding ring. Following 
sectioning (7pm sections) haematoxylin and eosin staining was utilised to 
examine the lenses and to note the morphological differences that were present, 
between the wild-type (WT), heterozygous (Hets) and homozygous (Horns) 
mice.
Images were taken of the haematoxylin and eosin staining using a Leica DMRA2 
microscope using the Lecia QWin V3 software (Leica Systems, UK). 
Photographs were taken of sections seen to include the optic nerve, these sections 
should be through the centre of the lens. Three eyes for each genotype, each from 
a different pup, were photographed with five sections from each eye collected for 
analysis.
Following the generation of images of the eyes from each of the genotypes, 
image analysis was performed using ImageProPlus (MediaCybemetics, UK). 
This allowed for measurements to be made of the overall size of the lens as well 
as measurements of the OFZ dimensions (see Figure 4.1 for details of the
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measurements made). The images were coded prior to analysis to avoid any bias 
of the results generated.
Figure 4.1: Diagram demonstrating the measurements taken fo r  each lens using the image 
analysis software. Measurements for aQ and b0 were not taken; instead these values were 
calculated using the results from the other measurements. Measurements for x were made in line 
with the iris.
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4.3. Results
Wax sections were stained with haematoxylin and eosin so the morphology of 
the lens could be examined. Results are shown in Figure 4.2. No obvious 
morphological changes were noted between the WT, hets and mutant lenses. 
Denucleation of the heterozygous and homozygous lenses appeared to be 
progressing as in the wild type. The OFZ was identified in all lenses examined 
by a change in the intensity of eosin staining in the centre of the lens and the 
disappearance of nuclei.
To examine the morphology of the lenses more closely measurements were taken 
using the image analysis software (Image-Pro Plus, UK). This allowed for more 
subtle changes in the lens morphology, e.g. alterations in the overall lens size or 
in the size of the OFZ, to be examined. Results are shown in Table 4.1.
Usable sections through the centre of the lens were not obtained for the 
heterozygote eyes, due to excessive tearing of the tissue during the sectioning 
process. The images gathered for this genotype were therefore not used for the 
image analysis as they could possibly skew the results obtained. An unpaired t- 
test was used to compare the average dimensions of the lenses from wild-type 
and homozygote lenses. No statistically significant differences were observed 
between Wt, Hets and mutants for any of the lens dimensions measured.
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Figure 4.2: Histological examination of lens 
morphology in Huntingtin mutant Vs WT, 
Vs Het mouse lenses. Lenses were stained 
with haematoxylin and eosin so the 
morphology o f the lenses could be examined. 
Lenses were compared between wild-type (-/- 
), heterozygotes (+/-) and homozygotes (+/+). 
Numbers on the left hand side o f the figure 
represent the magnification under which the 
picture was taken. Scale bars represent 
100pm. White arrows indicate the position o f  
the nuclei nearest the centre o f the lens i.e. at 
the border o f the OFZ. Measurements were 
made as detailed in Figure 4.1.
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Measurement Wild-type Homozygote p-value 1
1 2 3 1 2 3
X 8 0 3 . 7 0 7 6 6 . 9 4 7 0 5 . 9 5 7 6 8 .5 8 7 3 8 .3 1 7 2 4 .0 5 0 . 6 5 2
y 8 4 7 .7 1 7 5 8 .3 1 8 8 0 . 6 9 8 1 2 .4 7 7 9 2 .3 8 7 4 6 . 6 2 0 . 3 3 8
ai 1 8 9 .1 4 1 7 4 . 9 4 211.1 2 0 9 . 2 6 1 9 3 .5 5 2 1 4 . 1 7 0 .3 1 8
1 8 4 .9 9 1 9 3 . 3 7 2 0 3 . 5 2 2 2 2 . 7 0 2 0 0 . 6 7 2 2 6 .9 3 0 . 0 7 9
3o 4 2 9 . 5 6 3 9 8 . 6 3 2 9 1 . 3 3 3 3 6 .6 1 3 4 4 .0 9 2 8 2 .9 5 0 .3 2 3
b i 6 3 . 8 9 6 6 . 3 2 9 2 . 6 8 1 0 0 .4 0 6 6 .8 1 1 2 5 .3 5 0 .2 9 5
t>2 1 7 6 .3 6 1 1 9 . 1 7 1 3 8 .7 4 1 6 2 .8 7 1 4 2 .8 0 1 4 4 .1 2 0 . 7 8 8
b 0 6 0 7 . 4 7 5 7 2 . 8 2 6 4 9 . 2 8 5 4 9 .2 1 5 8 2 .7 7 4 7 7 . 1 5 0 . 1 2 7  |
Table 4.1; Results from image analysis o f haematoxylin and eosin staining o f Huntingin 
mutant Vs WT, Vs Het mouse lenses. The sections from 3 lenses from each genotype were 
photographedfor analysis. Four or five sections from the middle o f each lens (seen to include the 
optic nerve) were analysed (see Figure 4.1 fo r details o f the measurements made) and the 
average calculated. One measurement was made fo r each dimension for each o f the 5 sections 
from the 3 eyes from each genotype; the average measurement is presented here. The average 
measurements for each o f the distances were compared between the two genotypes using an 
unpaired t-test; the p-value is presented. All values given in the table (except the p-value) are 
given in microns.
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4.4. Discussion
The mouse model used in this study was generated to contain an extended CAG 
repeat (150bp) in the first exon of huntingtin. Lenses were collected from wild- 
type, heterozygous and homozygous mice. Following the examination of the 
structure of 3 lenses from each genotype no obvious morphological difference 
was observed. Denucleation was still seen to proceed along with formation of the 
OFZ in all the lenses examined. Further analysis was completed for the images 
produced from lenses from the wild-type and homozygous mice; no statistically 
significant differences were observed for any of the lens dimensions. This was 
not unexpected as Huntington’s is an age-related disease and there are no 
recorded developmental problems with the eyes of Huntington’s patients. Further 
work could look at the effect of the mutated gene in ageing mice, to see if any 
lens abnormalities arise later in life.
This model system demonstrated no developmental problems in the lens linked 
to the mutant form of hd. There is a possibility that the mutant protein is not 
expressed in the lens, this could explain the lack of an observed phenotype. 
Western blotting could be utilised to examine the specific expression of the 
mutant protein to confirm its presence or absence in the lens. The use of a 
knockout mouse could possibly provide a greater insight into the role hd plays in 
lens development. Deletion of the huntingtin protein has shown to be embryonic 
lethal (Duyao et al 1995), so a conditional knockout would have to be used to 
knock-out this gene in the lens selectively.
In summary the results of this chapter show:
• Lens morphology was not affected by the mutant form of the huntingtin 
protein.
• Denucleation was still seen to occur, suggesting that the mutant 
huntingtin gene does not affect this process during development.
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Apoptosis Gene Expression in the Embryonic Chick Lens: A Comparative Study
5.1. Introduction
In Chapter 3 the results for the mouse apoptosis arrays are presented. Genes 
shown to have high expression or demonstrating differential expression between 
the time points were identified. Following the identification of these genes, the 
expression of the genes shown to be differentially regulated was confirmed using 
RT-PCR. The aim of this part of the study was to examine the expression of 
genes identified from the mouse arrays in embryonic chick lenses. This would 
enable a cross-species comparison between the mouse and chick with a view to 
completing functional studies in the future.
Previous morphological studies suggest that the process of organelle degradation 
between mouse and chick is relatively similar although it is unknown whether the 
underlying biochemical mechanism is the same in both species (Bassnett 2002). 
Underlying differences in this process have been observed; chromatin 
marginalisation and subsequent collapse has been noted in the chick lens but not 
in the mouse.
In this study, six embryonic stages have been used to examine gene expression, 
ranging from embryonic day 6 (E6) to embryonic day 16 (E l6). From previous 
studies it has been observed that organelle degradation begins at approximately 
E12 and by E21 (hatching) the organelle free zone is as large as the diameter of 
the pupil of the eye (Bassnett and Beebe 1992). Previous studies have examined 
the disappearance of intracellular organelles in the embryonic chick lens; a brief 
description is given here.
Fragmented mitochondria were observed as early as E8 in the central fibre cells. 
By E10 the mitochondria were swollen and by E l2 the central region of the lens 
lacked mitochondria. Coincidently, the nuclei were found to decrease in size (at 
E8) and disappeared from the central fibre cells by E l2 (Bassnett and Beebe 
1992). Loss of nuclei and mitochondria was seen to occur simultaneously and 
abruptly (2-4hr). The endoplasmic reticulum was seen to disappear with the 
nucleus at the edge of the OFZ. The Golgi apparatus was seen to fragment in the 
cells at the lens equator (Bassnett 1995).
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The chick system is relatively cheap and easy to manipulate making it ideal for 
developmental studies. With the development of the in ovo electroporation 
technique very large complex constructs can be injected into a specific 
population of cells, allowing loss-of-function or gain-of-function studies to be 
completed (Chen et al. 2004; Nakamura et al. 2004). The use of this model 
system is further promoted with the recent availability of the chick genome. 
Genes shown to be expressed in the chick lens during this study could be 
knocked out using in ovo electroporation to investigate their function in the lens.
Also, the lens epithelial cell culture developed by Menko et al. demonstrated the 
formation of lentoid bodies following 3 days in culture (Menko et al. 1984). 
These lentoid bodies were seen to demonstrate characteristics of fibre cells. This 
culturing method has been demonstrated to be useful in determining the role of 
certain proteins in the lens. This method of cell culture has subsequently been 
used to look at the role of members of the apoptotic pathway in lens 
differentiation. Synthetic peptides were added to the lens epithelial cell cultures 
to knockdown the expression of caspases -1, -2, -4, -6 and -9; following the 
addition of these peptides to the cultures a decrease was observed in the number 
of degenerating nuclei (Wride et al. 1999). This system has also been used to 
examine the role of the TNF family in this process. The addition of TNFa to lens 
cell cultures induced nuclear degeneration, whereas when antibodies to TNFa, 
TNFR1 and TNFR2 were added to the cultures, blocking the function of these 
proteins, the number of degenerating nuclei was seen to decrease suggesting a 
role for this family of proteins in nuclear degradation in the lens (Wride and 
Sanders 1998).
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5.2. Experimental Design
The methods used in this chapter were previously described in the general 
methods chapter (Chapter 2). RNA was isolated from lenses of embryos at two 
day intervals between E6 and E l6. These time points were chosen as they 
encompassed stages of development both proceeding and following the onset of 
organelle degradation. These RNA samples were quantified and used to 
synthesise cDNA. This cDNA was subsequently used in semi-quantitative PCR 
reactions to examine the expression of the genes identified from the apoptosis 
arrays (results discussed in Chapter 3). Each PCR was completed three times, 
each time with a different cDNA sample collected from pooled lenses extracted 
from 20-24 embryos. PCR products were run out on a 2% agarose gel and the 
resulting intensities of the individual bands were quantified using Scion Image 
software (USA). The three sets of results were combined to give the average 
band intensity for each of the stages examined.
Primers were designed for the genes shown to have the highest expression from 
the array results as well as those shown to be differentially expressed. Eighteen 
of these genes had a known nucleotide sequence included in the NCBI database, 
Gene, and the FAST A sequence was used to design primers using the primer 
design programme Primer3 (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3 ww 
w.cgi). For the remaining 12 genes BLAST searches were completed; comparing 
the mouse accession number for the gene to the chick genome. Primer sequences 
are included in Appendix 4.
Following the completion of the BLAST search, four nucleotide sequences were 
identified with high homology to that of the mouse genes. Primers could not be 
designed for one of the highly expressed genes (mts-1) and 5 of the differentially 
expressed genes (al, axl, cdk4, DAXX and p2rxl); this was due to the limitations 
of the availability of the chick genome at the time this study was completed.
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5.5. Results
5.3.1. PCR Results
Before completing the PCR reactions, standard curves were generated to confirm 
that the results produced as a result of the PCR reaction are a result of the linear 
part of the reaction. A number of PCR reactions were completed using different 
cycle numbers to produce a standard curve. Standard curves for three genes; 
GAPDH (housekeeping gene used for normalisation), 14-3-3 eta (gene shown to 
have the highest expression from the array results) and mdm2 (gene shown to 
have the lowest expression from the array results) are shown in Figure 5.1.
Expression of the genes identified from the mouse arrays was examined using 
semi-quantitative RT-PCR (results shown in Figures 5.2. and 5.4). The average 
normalised band intensity was calculated and is presented graphically in Figures 
5.3 and 5.5. Normalised band intensities and fold differences observed from the 
PCR results are shown in Appendix 5.
80% (12/15) of the differentially expressed genes examined were shown to be 
expressed in the embryonic chick lens (see Figure 5.2). 90% (8/9) of the highly 
expressed genes examined were shown to be expressed in the embryonic chick 
lens (see Figure 5.3). Statistical analysis was completed to identify any 
significant differences in expression between the time points. Using a one-way 
ANOVA with Tukey’s post-hoc test no statistical significant differences were 
observed between any of the stages examined for any of the genes. An example 
of the statistical analysis is given in Appendix 6.
Galectin-3, IGF-1 and caspase-7 were not shown to be expressed at any of the 
time points examined. Whole embryo cDNA samples were used as a positive 
control to investigate whether these genes are truly not expressed in the lens or 
whether the primers are faulty. PCR reactions were completed under the same 
conditions as the original unsuccessful experimental PCRs. Following the 
completion of PCR reactions using the whole embryo samples, bands were
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observed for all three sets of primers suggesting that these genes are not 
expressed in the lens at the developmental stages examined.
The PCR reaction for TGFfi2 was unsuccessful; despite trying many different 
cycle numbers and annealing temperatures multiple bands were observed.
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Figure 5.1: Standard curves fo r semi-quantitative PCR o f chicken embryo lens. Standard 
curves were completed for three genes to check that the results obtained from the PCR reactions 
were a result o f the linear part o f  the reaction. Shown in this figure are the results for GAPDH, 
14-3-3 eta and mdm2. The gel used to produce the curve is shown underneath each graph. -RT: 
no RT control. From these results it was decided that the cycle number used for each o f these 
primer pairs would be as follows: GAPDH: 22 cycles, 14-3-3 eta: 25 cycles, mdm2: 30 cycles.
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F i g u r e  5 .2 :  Semi-quantitative PCR results for the chicken apoptosis genes shown to have 
differential expression between stages from the mouse array Results. GAPDH was used as a 
loading control, no RT controls were included in the PCR reaction. For the genes not shown to 
be expressed from the original experimental PCRs a positive control was used; i.e. a cDNA 
sample collected from a whole embryo. The results presented are representative o f the 3 PCR 
reactions completed for each gene.
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F i g u r e  5 .3 :  Graphical representation o f PCR results fo r the chicken apoptosis genes shown to 
have differential expression between stages from the mouse arrays. The results o f the three sets 
o f PCR results were combined to give the average band intensity presented here in the graph. 
Error bars displayed represent the standard error o f  the mean.
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F i g u r e  5 .4 :  Semi-quantitative PCR results fo r  the chicken apoptosis genes identified as having 
the highest expression from the mouse apoptosis arrays. GAPDH was used as a loading control, 
no RT controls were included in the PCR reaction. Caspase-7 was shown not to be expressed; a 
positive control (whole embryo cDNA) was used to confirm that this gene was not expressed in 
the lens. The results presented are representative o f  the 3 PCR reactions completed for each 
gene.
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PCR reactions were combined to give the average band intensity presented here in the graphs. 
Error bars displayed represent the standard error o f  the mean.
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5.4. Discussion
Previously, the majority of work carried out examining the process of lens 
differentiation has been completed using the mouse or rat lens. It has been 
suggested that this process is also similar in the chick lens (Bassnett 2002). The 
results presented in this study add weight to that argument, with expression of the 
majority of genes identified from the apoptosis arrays observed in the chick lens.
The time points examined in this chapter and those examined in Chapter 3 are 
directly comparable: organelle degradation begins at E l7.5 in mice with 
completion at eye opening (—P14), whereas in the chick, organelle degradation 
begins at E l2 and is complete by hatching E21. From this it can be assumed that 
E21 in the chick lens is equivalent to P I4 in the mouse lens, so E l4 would be 
approximately the same time point as NB mouse.
This system allowed the examination of the gene expression before the onset of 
organelle degradation at developmental time points preceding those examined in 
the mouse. Looking at the expression of the genes identified as differentially 
regulated, expression levels tend to increase after E6 (degradation of the 
mitochondria, nuclei and ER begins at E8). This increase in expression could be 
the signals required for the onset of organelle degradation.
IGF-1 has previously been shown to be expressed in embryonic chick lenses at 
embryonic days 8, 12, 15 and 19 (Caldes et al. 1991). Expression was found 
exclusively in the epithelial cells. From this study IGF-1 was not shown to be 
expressed between embryonic days 6-16. This result could possibly be explained 
by the relatively small number of epithelial cells contained within the lens 
compared to fibre cells. It could be that IGF-1 was expressed in the lens 
epithelium but at such low levels that the cycle numbers used in this study did 
not provide sufficient amplification for detection. Galectin-3 and caspase-7 were 
also shown to not be expressed from the PCR results presented here. There is no 
evidence in the published literature to suggest the presence of these genes in the 
embryonic chick lens.
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In conclusion, the results presented here provide evidence for the process of lens 
differentiation to be biochemically similar between the mouse and chick. 
Expression of the genes at the earlier time points examined from this study, could 
also suggest a role for these genes in the onset of organelle degradation. 
However, from these results there is no evidence that these genes are translated. 
Protein studies, i.e. western blotting and immunohistochemistry, should be 
completed to examine the expression of these proteins, in order to confirm a role 
for these genes in organelle degradation.
In summary, the results from this chapter show:
• 20 of the 23 genes identified from the mouse arrays were also shown to
be expressed in the embryonic chick lens, suggesting similarities in the 
biochemical process of lens differentiation in these two species.
• Galectin-3, IGF-1 and caspase-7 were not shown to be expressed in the 
chick lens at the time points examined.
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Discussion and Conclusions
6.1. Discussion of Results
During terminal differentiation of lens epithelial cells to fibre cells, all 
intracellular organelles are degraded. This ensures the formation of an optically 
clear tissue with no potentially light-scattering organelles. This process has been 
suggested to be an attenuated form of apoptosis (Bassnett 2002; Dahm 1999; 
Wride 2000). However, a number of recent studies have thrown doubt on this 
hypothesis.
Zandy et al. (2005) demonstrated that the executioner caspases are not required 
for organelle degradation. Knockout mice, generated with the inactivation of one 
or more of the executioner caspases, showed no difference in the size of the OFZ 
(Zandy et al. 2005). A number of studies have also been completed examining 
alternatives to the apoptosis pathway in this process of organelle degradation in 
the lens, including the ubiquitin pathway (Girao et al. 2005; Pereira et al. 2003; 
Shang et al. 1997), lipoxygenase (van Leyen et al. 1998) and autophagy (Matsui 
et al. 2006). Results of these previous studies have identified a functioning 
ubiquitin pathway in the lens and have shown that the components of the 
ubiquitin pathway are redistributed in the lens during differentiation (Girao et al. 
2005; Pereira et al. 2003; Shang et al. 1997). A recent study by Zandy and 
Bassnett also demonstrated that the increase in VEIDase activity in the lens at the 
onset of organelle degradation is not due to the activation of caspase-6 but is 
instead attributable to the proteasome (Zandy and Bassnett 2007).
However, in support of the hypothesis that the classical apoptosis pathway is 
utilised during lens development and differentiation, this study has shown that 
over a hundred apoptosis genes were shown to be expressed above background 
at the two time points examined (Chapter 3). Twenty genes were shown to be 
differentially regulated between P7 and P I4; these are developmental stages 
where a significant amount of organelle degradation occurs. Semi-quantitative 
PCR confirmed expression of all the genes identified from the arrays; 
corroborating the differential expression in approximately 50% of cases.
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The relatively low confirmation rate could be due to one of two things, either the 
nylon membrane arrays are not good at accurately demonstrating differential 
gene expression or semi-quantitative PCR is not accurate enough to confirm the 
array results. However, the results from this study do show that these arrays give 
a good overview of gene expression; no genes tested were shown to be expressed 
on the arrays but not in PCR reactions.
It cannot be determined from these results in which sub-compartments of the 
developing lens (e.g. epithelium, outer fibres, central fibres) the genes identified 
from the arrays are expressed. Also, from this study it is uncertain whether the 
genes identified from the array results would also be identified in any normal 
non-lens epithelial cell undergoing differentiation and remodelling.
Some of the genes identified from the arrays are known to interact with one 
another. Mdm2, p53 and Daxx have all been linked. Mdm2 inhibits the function 
of p53, and increases its susceptibility to degradation by the proteasome 
(reviewed in Michael and Oren 2003). Daxx has been noted to affect the 
expression of mdm2, and enhances the E3 ligase activity of mdm2 (Tang et al 
2006). A number of genes identified from the arrays play a role in cell cycle 
progression. This is not unexpected as during terminal differentiation, epithelial 
cells have to exit the cell cycle in order to allow them to differentiate.
Two of the genes, axl and mcl-1, shown to be differentially expressed, were also 
shown to be present at the protein level using western blotting (Chapter 3). Mcl- 
1 has two isoforms, the short pro-apoptotic form, and the longer anti-apoptotic 
form. From the western blotting results obtained from this study, higher 
expression of the short isoform of mcl-1 was observed when compared to the 
long isoform. This could suggest a role for the pro-apoptotic pathway in the 
differentiation of the lens.
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The process of denucleation during terminal differentiation has not only been 
observed in lens fibre cells but also in erythroblasts and keratinocytes. The 
terminal differentiation of mammalian erythrocytes has been shown to include 
the condensation of the nucleus and chromatin as observed in classical apoptosis 
as well as the destruction of the intracellular organelles. The DNA fragmentation 
pattern noted, however, was not as expected from an apoptosis process. Rather 
than the DNA laddering as seen in apoptosis, smears of DNA were observed 
when it was run on a gel, as seen in necrosis (Morioka et al. 1998). The role of 
caspases in this process has been examined (Carlile et al. 2004; Krauss et al. 
2005; Zermati et al. 2001). Results from these studies suggest an essential role 
for caspase in early erythropoiesis of mammalian erythrocytes, although they 
seem to play no role in the later stages, where enucleation occurs (Krauss et al.
2005).
Differentiation of keratinocytes was seen to include the fragmentation of DNA 
(Weil et al. 1999) and the loss of mitochondrial membrane potential (Allombert- 
Blaise et al. 2003). Fragmented DNA, as seen during classical apoptosis, and the 
activation of caspase-3 have both been demonstrated in differentiating 
keratinocytes (Polakowska et al. 1994; Weil et al. 1999). Following the addition 
of caspase inhibitors to cultured keratinocytes, nuclear loss was inhibited, 
although some aspects of keratinocyte differentiation were still seen to occur 
(e.g. flattening of the keratinocytes) (Weil et al. 1999). The terminal 
differentiation process of lens fibre cells, keratinocytes and erythrocytes have all 
been suggested to utilise members of the apoptotic pathway, in an attenuated 
form of apoptosis in order to complete denucleation. Although the pathways in 
these cell types have not been fully elucidated, the presence of these key 
apoptotic proteins suggests similar mechanisms are operating.
A transgenic mouse has been generated containing an extended CAG repeat in 
the first exon of huntingtin (Lin et al. 2001). This extended repeat has been 
shown to result in a toxic gain-of-function. In this study the morphology of 
lenses of wild-type, heterozygotes and homozygotes was examined. No obvious 
morphological changes were noted and there was seen to be no statistically 
significant difference observed for any of the lens dimensions between wild-type
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and homozygous lenses (Chapter 4). This was not unexpected as there is no 
recorded evidence of developmental eye problems in Huntington’s patients.
The normal physiological function of huntingtin remains to be elucidated. It has 
been shown to play an important role during development. The deletion of 
huntingtin in mice was shown to result in early embryonic lethality (Duyao et al. 
1995) and observations have also been made that mice expressing less than 50% 
of the normal level of wild-type hd demonstrate abnormalities of the central 
nervous system and were seen to die shortly after birth (White et a l 1997). A 
number of roles have been proposed for the wild-type protein due to the wide 
variety of proteins with which it interacts. An anti-apoptotic role has been 
suggested; wild-type huntingtin has been shown to protect cells from apoptosis 
induced by serum withdrawal and exposure to mitochondrial toxins (Rigamonti 
et al. 2000). Cells expressing the mutant form of this protein were shown to be 
more sensitive to these apoptotic stimuli. This anti-apoptotic role is thought to be 
attributable to the inhibition of caspase-3 by the huntingtin protein (Zhang et al.
2006). A role for huntingtin in transcriptional regulation has also been proposed; 
the wild-type protein has been shown to repress transcription (Kegel et al. 2002). 
It has been shown to interact with transcription factors including p53, TATA- 
binding protein and the C-terminal binding protein (CtBP) (reviewed in Haijes 
and Wanker 2003). Other roles have been suggested in both postsynaptic 
signalling and vesicle transport, transporting vesicles along the microtubules or 
cytoskeleton (reviewed in Haijes and Wanker, 2003).
With no blood supply and low level metabolism, the lens would be a good model 
system to examine the normal physiological function of huntingtin, but this 
would require a conditional knockout in which hd is selectively knocked out in 
the developing lens. Looking at the interacting partners of huntingtin, the 
presence of this gene in the lens suggests it could be involved in a number of 
processes; it could be expressed as an anti-apoptotic protein preventing complete 
apoptosis through its inhibition of caspase-3, although caspase-3 has been shown 
to not be essential for organelle degradation (Zandy et al. 2005). It could 
possibly be involved in the repression of transcription during differentiation of 
the lens epithelial cells or in membrane transport.
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The expression of the genes shown to be highly or differentially expressed from 
the mouse array results was tested in the embryonic chick lens. The majority of 
genes tested were shown to be expressed (Chapter 5). The time points examined 
in this study include a range of stages before and after the onset of organelle 
degradation. In chicks, organelle degradation begins at E l2, so an increase in 
expression immediately before this time point could suggest a role for this gene 
in triggering this process. These data presented here also suggests that the 
biochemical nature of the process of lens differentiation in both mouse and chick 
could be similar.
In conclusion the arrays used during this study give a good overall picture of 
apoptosis gene expression in the lens, though future studies still need to be 
completed to further elucidate the role of these genes/proteins in the process of 
lens development and differentiation. The observation that p53 and a number of 
its interacting partners are expressed in the lens could suggest an important role 
for this pathway in lens differentiation.
6.2. Future Work
The results presented in this study show apoptosis gene expression at the 
developmental time points examined although they do not demonstrate where 
these genes are expressed. Laser capture microdissection could be completed 
separating the lens epithelial cells from the lens fibre cells. Quantitative PCR 
could then be completed allowing the gene expression of epithelial cells to be 
compared to fibre cells. The localisation of these genes could lead to the 
generation of hypothesises about their role in the lens.
Also, from this study the gene expression has been examined but there is nothing 
to demonstrate that these genes are translated, so protein studies could be 
completed to study the changes in expression during development and also 
localise the protein to compartments within the lens.
The method of lens epithelial cell culture utilised by Menko et al. (1984) 
demonstrated the formation of lentoid bodies after 3 days in culture. These 
lentoid bodies demonstrated characteristics of lens fibre cells. Using this cell
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culture method antibodies or siRNA could be used to knockdown expression of 
genes and the affect on the lentoid bodies could be observed. This technique 
could be used to look at the role of the interaction between p53, mdm2 and Daxx. 
By suppressing the expression of one of these genes, the affect on the other genes 
could be examined.
An alternative method to examine the gene function could be in ovo
electroporation. This technique has been successfully completed introducing
RNAi into the cells of the lens vesicle to knockdown endogenous gene products 
(Chen et al. 2004). This technique could be utilised to complete loss-of-function 
studies, introducing RNAi to knockdown the expression of some of the genes 
identified in this study to examine their affect on lens development
Huntingtin has been suggested to play a role in membrane trafficking. To
examine whether huntingtin is involved in the trafficking process in the lens 
immunohistochemical studies could be completed to localise the huntingtin 
protein and components of the membrane trafficking system. Further studies 
could also be completed using a conditional knockout mouse. The Cre/LoxP 
system could be utilised under a crystallin promoter to dampen expression of 
huntingtin in the lens, to elucidate its function in the development of the lens.
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Appendix 1: Composition of Solutions
RNA gel composition
I Gel Volume Formaldehyde 10 x MOPS Double Autoclaved Water 1
100ml 18ml 10ml 72ml
150ml 27ml 15ml 108ml
200ml 36ml 20ml 144ml
250ml 45ml 25ml 180ml
1 300ml 54ml 30ml 216ml
Add sufficient agarose in water to give a final 1.5% agarose concentration (i.e. 
1.5g in 100ml). Add the formaldehyde and 10 x MOPS in fume hood after the 
agarose has boiled.
Running buffer for RNA denaturing gels
83 ml formaldehyde 
100ml 10 x MOPS 
817ml double distilled water 
10 x MOPS 
To make 1 litre:
Add 41.85g 4-morpholinepropanesulfonic acid (MOPS free acid) and 6.8g 
sodium acetate-3H20 and stir until completely dissolved. Add 20ml of 0.5M 
Na2EDTA solution and adjust pH to 7.0 with 10M NaOH. Adjust volume to 1 
litre with double autoclaved H2O. Store protected from light at 4°C.
Loading buffer for RNA denaturing gels
50% glycerol
lOmM EDTA
0.25% bromophenol blue
0.25% xylene cyanol FF
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Wash Solution I for Apoptosis Arrays
To make 500ml:
12.5ml 20 x SSPE to make a final concentration of 0.5 x SSPE 
50ml 10% SDS to make a final concentration of 1% SDS 
437.5ml double autoclaved water 
Wash Solution II for Apoptosis Arrays 
To make 500ml:
2.5ml 20 x SSPE to make a final concentration of 0.1 x SSPE 
50ml 10% SDS to make a final concentration of 1% SDS 
447.5ml double autoclaved water 
Stripping Solution for Apoptosis Arrays 
To make up 1 litre:
10ml 1M Tris-HCL pH 8 to give a final concentration of lOmM
ImM EDTA
100ml 10% SDS
0.5M Tris-HCl pH6.8
6g Tris base
60ml distilled water
Adjust to pH6.8 with HC1
Bring up to 100ml with distilled water
Store at 4°C
1.5M Tris-HCl pH8.8
27.23g Tris base
80ml distilled water
Adjust to pH 8.8 with HC1
Bring up to 150ml with distilled water
Store at 4°C
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10% APS
lg ammonium persulphate 
Dissolve in 10ml distilled water.
10 x TBS 
lOmM Tris 
150mM NaCl 
pH 7.6
Make up to 1 litre with water 
4% Paraformaldehyde (PFA)
Dissolve 4g paraformaldehyde powder in 100ml -  heat until dissolved -  store at 
4°C
1 xPBS
40g NaCl 
lgKCl
5.75gNa2HP04 
lg KH2P04 
5 litres distilled water
Stripping Solution for Western Blotting
15g glycine 
lg SDS 
10ml Tween20 
Set pH to 2.2
Make up to 1 litre with double autoclaved water.
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Appendix 2: List of Genes Included on the Array
Array
Coordinate Gene Family Gene Name
Accession
Number Gene Description |
A1 Genomic DNA GEN N/A
Genomic DNA j
PI Genomic DNA GEN N/A
Genomic DNA |
mpl0d09.rl Life Tech mouse embryo 8 | 
5dpc 10664019 Mus musculus cDNA I
82
Apoptosis-Related
ABP1 AA109909
clone IMAGE:568817 5' similar to
Factors gb:U 11863 AMILORIDE-SENSITIVE 
AMINE OXIDASE (HUMAN);, mRNA 
sequence
C2
Apoptosis-Related
Factors
ADAM 17 NM 009615
Mus musculus a disintegrin and 
metalloproteinase domain 17 (Adam 17),
mRNA
D2
Apoptosis-Related
API5 NM 007466
Mus musculus apoptosis inhibitor 5
Factors (Api5), mRNA
E2
Apoptosis-Related
ATM NM 007499
Mus musculus ataxia telangiectasia gene
Factors mutated in human beings (Atm), mRNA
F2 Apoptosis-Related CAD NM 007859 Mus musculus DNase inhibited by DNA
Factors fragmentation factor (Didff), mRNA
02
Apoptosis-Related
CAV2 AF141322
Mus musculus caveolin-2 mRNA, j
Factors complete cds I
H2
Apoptosis-Related
CD47 NM 010581
Mus musculus integrin-associated protein
Factors (Itgp), mRNA
12 Apoptosis-Related CHML ATT89156 Mus musculus rab escort protein-2 (Chml)
Factors gene, complete cds
Apoptosis-Related
Factors
Mus musculus cell death-inducing DNA
J2 CIDE-A NM 007702 fragmentation factor, alpha subunit-like
effector A (Cidea), mRNA
K2
Apoptosis-Related
Factors
CLDN3 NM 009902 Mus musculus claudin 3 (Cldn3), mRNA
12
Apoptosis-Related
Factors
Cln3 NM 009907
Mus musculus ceroid lipofuscinosis, 
neuronal 3, juvenile (Batten, Spielmeyer-
Vogt disease) (Cln3), mRNA
M2
Apoptosis-Related
Factors
Clu NM 013492
Mus musculus alpha-clustrin and beta- 
clustrin mRNA, complete cds
N2
Apoptosis-Related
Factors
Cox-l/Ptgsl NM 008969
Mus musculus prostaglandin-endoperoxide 
synthase 1 (Ptgsl), mRNA
02 Apoptosis-Related
Factors
Cox-2/Ptgs2 NM 011198
Mus musculus prostaglandin-endoperoxide 
synthase 2 (Ptgs2), mRNA 
ve53d06.yl Beddington mouse embryonic 
region Mus musculus cDNA clone
B3
Apoptosis-Related
Factors
CAS/CSE1 AI549625
IMAGE:821867 5' similar to 
SW:CAS HUMAN P55060 CELLULAR 
APOPTOSIS SUSCEPTIBILITY 
PROTEIN.;, mRNA sequence
C3
Apoptosis-Related
Factors
Ctsd NM 009983 Mus musculus cathepsin D (Ctsd), mRNA
D3
Apoptosis-Related Cytochrome p450
NM 008898
Mus musculus P450 (cytochrome)
Factors oxidoreductase oxidoreductase (Por), mRNA
E3
Apoptosis-Related
DAD-1 NM 010015
Mus musculus defender against cell death
Factors 1 (Dadl), mRNA
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F3
G3
H3
13 
J3 
K3 
L3 
M3 
N3
03 
B4 
C4 
D4 
E4 
F4 
G4 
H4
14
J4
K4
L4
M4
N4
04
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Apoptosis-Related
Factors
Gene Name
Dapl
DAXX
DEDD
DNAse 1 
DNAse2 
FemlB 
FLASH 
Galectin-3 
GAPDH 
GPX1 
GSN 
HD 
HnrpAl 
ICAD/DFFA 
Integrin-aV 
MFGE8 
PGES
MT-2
eNOS
iNOS
nNOS
ODC
P2RX1
uPARl
Accession
Number
AI196645
NM007829
NM011615
NM 010061
NM 010062
NM 010193
NM011997
XI6834 
NM 008084 
NM 008160 
NM 010354 
U24233 
NM 010447 
NM 010044 
NM 008402 
NM 008594 
AB041997
K02236
NM 008713 
NM 010927 
NM 008712 
NM 013614 
NM 008771 
NM 011113
Gene Description
ui53d07.yl Sugano mouse liver mlia Mus 
musculus cDNA clone IMAGE:1886125 5' 
similar to SW:DAP1 J1UMAN P51397 
DEATH-ASSOCIATED PROTEIN 1 ;, 
mRNA sequence 
Mus musculus Fas death domain- 
associated protein (Daxx), mRNA
Mus musculus tumor necrosis factor 
(ligand) superfamily, member 19 (Tnfsfl9- 
pending), mRNA
Mus musculus mRNA for 
deoxyribonuclease I, complete cds
Mus musculus deoxyribonuclease II 
(Dnase2), mRNA
Mus musculus feminization 1 b homolog 
(C. elegans) (Fernlb), mRNA
Mus musculus caspase 8 associated protein 
2 (Casp8ap2), mRNA
Mouse mRNA for Mac-2 antigen
Mus musculus glyceraldehyde-3-phosphate 
dehydrogenase (Gapd), mRNA
Mus musculus glutathione peroxidase 1 
(Gpxl), mRNA
Mus musculus gelsolin (Gsn), mRNA
Mus musculus huntingtin (Hd) mRNA, 
complete cds
Mus musculus heterogeneous nuclear 
ribonucleoprotein AI (Hnrpal), mRNA
Mus musculus DNA fragmentation factor, 
alpha subunit (Dffa), mRNA
Mus musculus integrin alpha V (Cd51) 
(Itgav), mRNA
Mus musculus milk fat globule-EGF factor 
8 protein (Mfge8), mRNA
Mus musculus PGES mRNA for 
prostaglandin E synthase, complete cds.
vf04g05.yl Knowles Solter mouse 
blastocyst B3 Mus musculus cDNA clone 
IMAGE:834776 5' similar to gb:K02236 
Mouse metallothionein II (MOUSE);, 
mRNA sequence 
Mus musculus nitric oxide synthase 3, 
endothelial cell (Nos3), mRNA
Mus musculus nitric oxide synthase 2, 
inducible, macrophage (Nos2), mRNA
Mus musculus nitric oxide synthase 1, 
neuronal (Nos I), mRNA
Mus musculus ornithine decarboxylase, 
structural (Ode), mRNA 
Mus musculus purinergic receptor P2X, 
ligand-gated ion channel, 1 (P2rxl), 
mRNA
Mus musculus urokinase plasminogen 
activator receptor (Plaur), mRNA
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B5
Apoptosis-Related
PDCD1 NM 008798
Mus musculus programmed cell death 1 j
Factors (Pdcdl), mRNA
C5
Apoptosis-Related
PDCD2 NM 008799
Mus musculus programmed cell death 2
Factors (Pdcd2), mRNA
D5
Apoptosis-Related
Factors
PIGA D26047 Mouse testis mRNA for Pig-a 
mj05g09.rl Soares mouse embryo
E5
Apoptosis-Related
PIN AF020185
NbME13.5 14.5 Mus musculus cDNA
Factors clone IMAGE:475264 5' similar to 
WP:T26A5.9 CE00788 mRNA sequence
F5
Apoptosis-Related
PLA2G1B NM 011107
Mus musculus phospholipase A2, group
Factors IB, pancreas (Pla2glb), mRNA
G5
Apoptosis-Related
Factors
ZAC1/PLAGL1 X95504 M.musculus mRNA for zinc finger protein
H5
Apoptosis-Related
Factors
PRKR NM 011163
Mus musculus eukaryotic translation I 
initiation factor 2 alpha kinase 2 (Ei£2ak2), I
mRNA
15
Apoptosis-Related
Factors
REQ NM 011262 Mus musculus requiem (Req), mRNA
J5
Apoptosis-Related
Factors
RP105/Ly78 NM 008533
Mus musculus lymphocyte antigen 78 
(Ly78), mRNA
K5
Apoptosis-Related
Factors
Mts-1 X16190 Mouse mtsl gene
L5
Apoptosis-Related
SAG-1 AF092877
Mus musculus zinc RING finger protein
Factors SAG mRNA, complete cds
M5
Apoptosis-Related
SARP-1 NM 009144
Mus musculus stromal cell derived factor 5
Factors (Sdf5), mRNA
Apoptosis-Related
Factors
Mus musculus secreted frizzled related
N5 SARP-2/sFRP-l U88566 protein sFRP-1 (Sffpl) mRNA, complete
cds
05
Apoptosis-Related
Factors
SFRP-5/SARP-3 AF117759
Mus musculus secreted ffizzled-related 
protein 5 (Sffp5) mRNA, complete cds
B6
Apoptosis-Related
SIAH1 NM 009172
Mus musculus seven in absentia IA
Factors (Siahla), mRNA
Apoptosis-Related
Factors
Mus musculus mRNA for sterol regulatory
C6 SREBF1 AB017337 element-binding protein-1 (SREBP-1), 
partial cds 
um32el2.yl Sugano mouse kidney mkia 
Mus musculus cDNA clone
D6
Apoptosis-Related
Factors
SREBF2 AW 106709
IMAGE:2236270 5’ similar to 
SW:SRE2 CRIGR Q60429 STEROL 
REGULATORY ELEMENT BINDING 
PROTEIN-2 ;, mRNA sequence
E6
Apoptosis-Related
Factors
TDAG8 NM 008152
Mus musculus G-protein coupled receptor 
25 (Gpcr25), mRNA
F6
Apoptosis-Related
TFAR15 AF159368
Mus musculus TF-1 cell apoptosis related
Factors protein-15 (Tfarl 5) mRNA, complete cds
G6
Apoptosis-Related
Factors
Thrombospondin NM 011580
Mouse thrombospondin 1 mRNA, 
complete cds
H6
Apoptosis-Related
TIAF1 AF 104984
Mus musculus TGF-b 1 -induced anti-
Factors apoptotic factor 1 mRNA, complete cds I
Apoptosis-Related
Factors
Mus musculus Tiall cytotoxic granule- I
16 TIAL1 NM 009383 associated RNA-binding protein-like 1 I 
(Tiall), mRNA
Apoptosis-Related
Factors
Mus musculus tumor-suppressing H
J6 TSSC3 NM 009434 subchromosomal transferable fragment 3 |
(Tssc3), mRNA 1
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K6
Apoptosis-Related
Factors
TXN NM 011660 Mus musculus thioredoxin (Txn), mRNA
L6
Caspases and 
Regulators
Caspase-1 NM 009807 Mus musculus caspase 1 (Caspl), mRNA
M6
Caspases and 
Regulators
Caspase-2 NM 007610 Mus musculus caspase 2 (Casp2), mRNA
N6
Caspases and 
Regulators
Caspase-3 NM 009810
Mus musculus caspase 3, apoptosis related 
cysteine protease (Casp3), mRNA
06
Caspases and 
Regulators
Caspase-6 NM 009811 Mus musculus caspase 6 (Casp6), mRNA
B7
Caspases and 
Regulators
Caspase-7 NM 007611 Mus musculus caspase 7 (Casp7), mRNA
C7
Caspases and 
Regulators
Caspase-8 AJ007749 Mus musculus mRNA for caspase-8
D7
Caspases and 
Regulators
Caspase-9 NM 015733
Mus musculus mRNA for caspase9, 
complete cds
E7
Caspases and 
Regulators
Caspase-11 NM 007609
Mus musculus caspase 11 (Caspl 1), 
mRNA
F7
Caspases and 
Regulators
Caspase-12 NM 009808
Mus musculus caspase 12 (Caspl2), 
mRNA
G7
Caspases and 
Regulators
Caspase-14 NM 009809
Mus musculus caspase 14 (Caspl4), 
mRNA
H7
Caspases and 
Regulators
FLIPL/Cash NM 009805
Mus musculus caspase homolog (Cash), 
mRNA
17
Caspases and 
Regulators
Granzyme B NM 013542
Mus musculus granzyme B (Gzmb), 
mRNA
J7
Caspases and 
Regulators
Granzyme A NM 010370
Mus musculus granzyme A (Gzma), 
mRNA
K7
Caspases and 
Regulators
cIAP-1 NM 007464
Mus musculus apoptosis inhibitor 1 
(Apil), mRNA
L7
Caspases and 
Regulators
cLAP-2 NM 007465
Mus musculus apoptosis inhibitor 2 
(Api2), mRNA
M7
Caspases and 
Regulators
NAIP NM 010872
Mus musculus neuronal apoptosis 
inhibitory protein 2 (Naip2), mRNA
N7
Caspases and 
Regulators
PARP NM 007415
Mus musculus ADP-ribosyltransferase 
(NAD+; poly (ADP-ribose) polymerase) 1 
(Adprtl), mRNA
07
Caspases and 
Regulators
PARP-2 NM 009632
Mus musculus ADP-ribosyltransferase 
(NAD+; poly (ADP-ribose) polymerase) 2 
(Adprt2), mRNA
B8
Caspases and 
Regulators
Sentrin/UBLl NM 009460
Mus musculus ubiquitin-like 1 (Ubll), 
mRNA
C8
Caspases and 
Regulators
Survivin NM 009689
Mus musculus apoptosis inhibitor 4 
(Api4), mRNA
D8
Caspases and 
Regulators
XIAP NM 009688
Mus musculus apoptosis inhibitor 3 
(Api3), mRNA
E8
Cell Cycle 
Regulators
53BP2 U58881
Mus musculus p53 binding protein 2 
homolog (p53BP2), partial cDNA
F8
Cell Cycle 
Regulators
APEX/Ref-1 NM 009687
Mus musculus apurinic/apyrimidinic 
endonuclease (Apex), mRNA
G8
Cell Cycle 
Regulators
Calcyclin NM 011313
Mus musculus calcium binding protein A6 
(calcyclin) (S100a6), mRNA
H8
Cell Cycle 
Regulators
CBP S66385
CREB-binding protein [mice, brain,
mRNA Partial, 7326 nt] |
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18 
J8 
K8 
L8 
M8 
N8
08
B9 
C9 
D9 
E9 
F9 
G9 
H9 
19
J9
K9 
L9 
M9 
N9
09
BIO 
CIO 
DIO
Gene Family
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Cell Cycle 
Regulators
Gene Name
CDC2
CDK2 NM 016756
CDK.4 NM 009870
CDK5 NM 007668
CDK6 AF 132483
Cyclin A NM 009828
Cyclin D1 M64403
Cyclin G1 NM 009831
DPI NM 009361
MDM2 NM 010786
c-myc NM 010849
p 15INK4b/CDKN2B NM 007670
pl9/NSG2 NM 008741
RBLl/pl07 U27177
RBL2/pl30 NM 011250
P300 AA881090
PAK1 NM 011035
PCNA NM 011045
pRB NM 009029
RBBP4/RbAp48 NM 009030
RBP1 AA474808
RBBP6/PACT/RBQ1 U28789
Spl NM 013672
TRP53/p53 NM 011640
Accession
Number
NM 007659
Gene Description
Mus musculus cell division cycle 2 
homolog A (S. pombe) (Cdc2a), mRNA 
Mus musculus mRNA for cyclin dependent 
kinase (CDK2L) - the 39 kDa variant of 
CDK2
Mus musculus cyclin-dependent kinase 4 
(Cdk4), mRNA
Mus musculus cyclin-dependent kinase 5 
(Cdk5), mRNA 
Mus musculus strain BALB/c cyclin- 
dependent kinase 6 (Cdk6) mRNA, 
complete cds
Mus musculus cyclin A2 (Ccna2), mRNA
Mus domesticus cyclin-like protein 
(induced by colony-stimulating factor 1) 
(CYL-1) mRNA, complete cds
Mus musculus cyclin G (Ceng), mRNA
Mus musculus transcription factor Dp 1 
(Tfdpl), mRNA
Mus musculus transformed mouse 3T3 cell 
double minute 2 (Mdm2), mRNA
Mus musculus myelocytomatosis oncogene 
(Myc), mRNA 
Mus musculus cyclin-dependent kinase 
inhibitor 2B (pl5, inhibits CDK4) 
(Cdkn2b), mRNA 
Mus musculus neuron specific gene family 
member 2 (Nsg2), mRNA
Mus musculus pi07 (pi07) mRNA, 
complete cds
Mus musculus retinoblastoma-like 2 
(Rbl2), mRNA 
vz06cl0.rl 
Soares_mammary_gland_NbMMG Mus 
musculus cDNA clone IMAGE: 1314930 5' 
similar to TR:Q09472 Q09472 El A- 
ASSOCIATED PROTEIN P300.;, mRNA 
sequence
Mus musculus p21 (CDKNlA)-activated 
kinase 1 (Pakl), mRNA
Mus musculus proliferating cell nuclear 
antigen (Pena), mRNA.
Mus musculus retinoblastoma 1 (Rbl), 
mRNA
Mus musculus retinoblastoma binding 
protein 4 (Rbbp4), mRNA 
ve62d06.rl Beddington mouse embryonic 
region Mus musculus cDNA clone 
IMAGE:822731 5' similar to gb:S66427 
RETINOBLASTOMA BINDING 
PROTEIN 1 (HUMAN);, mRNA sequence 
Mus musculus p53-associated cellular 
protein PACT mRNA, partial cds
Mus musculus transcription factor Spl 
mRNA, complete cds
Mus musculus transformation related 
protein 53 (Trp53), mRNA
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E10
Cytokines and 
Receptors
AR NM 013476
Mouse mRNA for Tftn androgen receptor 
(inactive)
F10
Cytokines and 
Receptors
ART/Agrp NM 007427
Mus musculus agouti related protein 
(Agrp), mRNA
G10
Cytokines and 
Receptors
Axl NM 009465
Mus musculus AXL receptor tyrosine 
kinase (Axl), mRNA
H10
Cytokines and 
Receptors
Dtk/Tyro3 U18933
Mus musculus receptor tyrosine kinase 
(Dtk) mRNA, complete cds
110
Cytokines and 
Receptors
EGF J00380 mouse epidermal growth factor (egf) mma
J10
Cytokines and 
Receptors
EGFR NM 007912
Mus musculus epidermal growth factor 
receptor (Egff), mRNA
K10
Cytokines and 
Receptors
erbB2 U71126 Mus musculus erbB2 mRNA, partial cds
L10
Cytokines and 
Receptors
erbB3 L47240
Mus musculus tyrosine kinase (erbB3) 
mRNA, partial cds
M10
Cytokines and 
Receptors
erbB4 AF059176
Mus musculus EGF-like growth factor 
receptor ErbB4 extracellular domain 
mRNA, partial cds
N10
Cytokines and 
Receptors
GAS1 NM 008086
Mus musculus growth arrest specific 1 
(Gasl), mRNA
010
Cytokines and 
Receptors
GAS2 NM 008087
Mus musculus growth arrest specific 2 
(Gas2), mRNA
Bll
Cytokines and 
Receptors
GM-CSF X02333
Murine mRNA for granulocyte- 
macrophage colony stimulating factor 
(GM-GSF)
Cll
Cytokines and 
Receptors
GM-CSF Ra NM 009970
Mus musculus colony stimulating factor 2 
receptor, alpha, low-affinity (granulocyte- 
macrophage) (Csf2ra), mRNA
Dll
Cytokines and 
Receptors
IFN-y R1 NM 010511
Mus musculus interferon gamma receptor 
(Ifngr), mRNA
Ell
Cytokines and 
Receptors
IFN-y R2 NM 008338
Mus musculus interferon gamma receptor 
2 (Ifngr2), mRNA
FI 1
Cytokines and 
Receptors
IGF-I NM 010512
Mus musculus insulin-like growth factor 1 
(IGF 1), mRNA
Gil
Cytokines and 
Receptors
IGF-II NM 010514
Mus musculus insulin-like growth factor 2 
(IGF2), mRNA
HI 1
Cytokines and 
Receptors
IGF R AF056187
Mus musculus insulin-like growth factor I 
receptor mRNA, complete cds
111
Cytokines and 
Receptors
IL-1 R AcP NM 008364
Mus musculus interleukin 1 receptor 
accessory protein (111rap), mRNA
Jll
Cytokines and 
Receptors
IL-lra M57525
Mouse interleukin 1 receptor antagonist 
(IL1RA) mRNA, complete cds
Kll
Cytokines and 
Receptors
IL-1 RI NM 008362
Mus musculus interleukin 1 receptor, type 
I(Illrl), mRNA
LI 1
Cytokines and 
Receptors
IL-1 RII NM 010555
Mus musculus interleukin 1 receptor, type 
II (It 1 r2), mRNA
Mil
Cytokines and 
Receptors
IL-la NM 010554
Mus musculus interleukin 1 alpha (111 a), 
mRNA
Nil
Cytokines and 
Receptors
1L-Ip NM 008361
Mus musculus interleukin 1 beta (11 lb), 
mRNA
o n Cytokines and 
Receptors
IL-2 NM 008366 Mouse mRNA for interleukin-2 (IL-2)
B12
Cytokines and 
Receptors
IL-2 Ra NM 008367
Mus musculus interleukin 2 receptor, alpha 
chain (I12ra), mRNA
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C12
Cytokines and 
Receptors
IL-2 RP NM 008368
Mus musculus interleukin 2 receptor, beta
chain (I12rb), mRNA j
D12
Cytokines and
IL-2 Ry NM 013563
Mouse interleukin 2 receptor gamma chain
Receptors mRNA, complete cds
E12
Cytokines and
IL-4 M25892
Mus musculus interleukin 4 (11-4) mRNA,
Receptors complete cds
FI2
Cytokines and
IL-4 Ra NM 010557
Mus musculus interleukin 4 receptor, alpha
Receptors (I14ra), mRNA
G12
Cytokines and
IL-10 NM 010548
Mus musculus interleukin 10 (1110),
Receptors mRNA
H12
Cytokines and
IL-10 Ra NM 008348
Mus musculus interleukin 10 receptor,
Receptors alpha (111Ora), mRNA
112
Cytokines and 
Receptors
IL-12 p35 M86672
Mus musculus interleukin 12 p35 subunit, | 
complete cds |
J12
Cytokines and
IL-12 p40 M86671
Mus musculus interleukin 12 p40 subunit,
Receptors complete cds
K12
Cytokines and
IL-12 Rpi NM 008353
Mus musculus interleukin 12 receptor, beta
Receptors 1 (1112rb 1), mRNA
L12
Cytokines and
IL-12RP2 NM 008354
Mus musculus interleukin 12 receptor, beta
Receptors 2 (I112rb2), mRNA I
M12
Cytokines and
IL-13 NM 008355
Mus musculus interleukin 13 (1113), I
Receptors mRNA j
Cytokines and 
Receptors
NR4=IL-13 receptor alpha chain [mice,
N12 IL-13 Ral S80963 embryonal stem cell, Genomic/mRNA, 
1680 nt]
012
Cytokines and
IL-15 NM 008357
Mus musculus interleukin 15 (1115),
Receptors mRNA
B13
Cytokines and
IL-15 Ra NM 008358
Mus musculus interleukin 15 receptor,
Receptors alpha chain (1115ra), mRNA 
Mus musculus domesticus C57 Black 6 x
C13
Cytokines and 
Receptors
Mannose 6-phosphate R U04710
CBA cation-independent mannose 6- 
phosphate/insulin-like growth factor II 
receptor precursor mRNA, complete cds
D13
Cytokines and 
Receptors
M-CSF NM 007778
Mus musculus colony stimulating factor 1 
(macrophage) (Csfl), mRNA
E13
Cytokines and 
Receptors
M-CSFR NM 007779
Mus musculus colony stimulating factor 1 
receptor (Csflr), mRNA
F13
Cytokines and 
Receptors
Prolactin NM 011164 Mus musculus prolactin (Prl), mRNA
G13
Cytokines and 
Receptors
TGF-P NM 011577
Mus musculus transforming growth factor, 
beta 1 (Tgfbl), mRNA
H13
Cytokines and
TGF-P2 NM 009367
Mus musculus transforming growth factor,
Receptors beta 2 (Tgfb2), mRNA
113
Cytokines and 
Receptors
TGF-p3 NM 009368
Mus musculus transforming growth factor, 
beta 3 (Tgfb3), mRNA I
J13
Cytokines and
TGF-P RI NM 007394
Mus musculus activin A receptor, type 1 |
Receptors (Acvrl), mRNA U
K.13
Cytokines and 
Receptors
TGF-p RII NM 009371
Mus musculus transforming growth factor, | 
beta receptor II (Tgfbr2), mRNA D
L13
Cytokines and
TGF-P RIII AF039601
Mus musculus betaglycan mRNA,
Receptors complete cds
M13
Cytokines and 
Receptors
TrkB NM 008745
Mus musculus neurotrophic tyrosine 
kinase, receptor, type 2 (Ntrk2), mRNA
Cytokines and 
Receptors
Mus musculus neurotrophin-3 receptor
N13 TrkC AF035400 non-catalytic isoform 2 (trkC) mRNA, 
complete cds
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013 
B14 
C14 
D14 
E14 
F14 
G14 
H14
114 
J14 
K14 
L14 
M14 
N14
014
B15
C15
D15
E15
F15
G15
H15
115
Mitochondrial
Associated
Mitochondrial
Associated
Mitochondrial
Associated
Mitochondrial
Associated
Mitochondrial
Associated
Mitochondrial
Associated
Mitochondrial
Associated
Mitochondrial
Associated
Mitochondrial
Associated
Mitochondrial
Associated
Mitochondrial
Associated
Mitochondrial
Associated
Mitochondrial
Associated
Mitochondrial
Associated
Signal
Transduction
Signal
Transduction
Signal
Transduction
Signal
Transduction
Signal
Transduction
Signal
Transduction
Signal
Transduction
Signal
Transduction
Signal
Transduction
Gene Name
A1
AIF/Pdcd8
Apafl NM 009684
Bad NM 007522
Bag-1 NM 009736
BAK NM 007523
Bax-a NM 007527
Bcl-2 NM 009741
Bcl-w NM 007537
Bcl-x NM 009743
BID NM 007544
Bim NM 009754
Cytochrome C NM 007808
Mcl-1 NM 008562
14-3-3 eta
AKT/PKB 
ALG4 
ASK1/MAP3K5 
Bel-10
CARDIAK
CRADD
TRAF3/CRAF1
DAP Kinase
Accession
Number
LI6462
NM 012019
NM 011738
NM 009652
AF055669
NM 008580
NM 009740
AA655189
NM 009950
NM 011632
AA620064
Gene Description
Mus musculus hemopoietic-specific early 
response protein (Al) mRNA, complete 
cds
Mus musculus programmed cell death 8 
(apoptosis inducing factor) (Pdcd8), 
mRNA
Mus musculus apoptotic protease 
activating factor 1 (Apafl), mRNA
Mus musculus Bcl-associated death 
promoter (Bad), mRNA
Mus musculus Bcl2-associated athanogene
1 (Bagl), mRNA
Mus musculus Bcl2 homologous 
antagonist/killer (Bak), mRNA
Mus musculus Bcl2-associated X protein 
(Bax), mRNA
Mus musculus B-cell leukemia/lymphoma
2 (Bcl2), mRNA
Mus musculus Bcl2-like 2 (Bcl212), 
mRNA
Mus musculus Bcl2-like (Bcl21), mRNA
Mus musculus BH3 interacting domain 
death agonist (Bid), mRNA
Mus musculus Bcl2 interacting mediator of 
cell death (Bim), mRNA
Mus musculus cytochrome c, somatic 
(Cycs), mRNA
Mus musculus myeloid cell leukaemia 
sequence 1 (Mcll), mRNA
Mus musculus tyrosine 3- 
monooxygenase/tryptophan 5- 
monooxygenase activation protein, eta 
polypeptide (Ywhah), mRNA
Mus musculus thymoma viral proto­
oncogene (Akt), mRNA
Mus musculus apoptosis-linked gene 4, F 
form (Alg-4) mRNA, partial cds
Mus musculus mitogen activated protein 
kinase kinase kinase 5 (Map3k5), mRNA
Mus musculus B-cell leukemia/lymphoma 
10 (Bel 10), mRNA 
vvl3al2.rl Stratagene mouse heart 
(#937316) Mus musculus cDNA clone 
IMAGE: 1211518 5' similar to 
TR:G 1236943 G1236943 RIP PROTEIN 
KINASE.;, mRNA sequence
Mus musculus CASP2 and RIPK1 domain 
containing adaptor with death domain 
(Cradd), mRNA
Mus musculus Tnf receptor-associated 
factor 3 (TraO), mRNA 
vl53dl0.rl Stratagene mouse skin 
(#937313) Mus musculus cDNA clone 
IMAGE:975955 5* similar to TR:G434847 
G434847 DAP-KINASE. ;, mRNA
sequence |
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vj56a01.yl Knowles Solter mouse
blastocyst B1 Mus musculus cDNA clone
J15
Signal
Transduction
DRAK2 AI585389
IMAGE:933000 5' similar to 
SW.DAPK HUMAN P53355 DEATH- 
ASSOCIATED PROTEIN KINASE 1 „ 
mRNA sequence
K15
Signal
Transduction
E2F1 NM 007891
Mus musculus E2F transcription factor 1 
(E2fl), mRNA
LI 5
Signal
Transduction
FADD NM 010175
Mus musculus Fas-associating protein with 
death domain (Fadd), mRNA
Signal
Transduction
Mus musculus neutral sphingomyelinase
M15 FAN NM 010945 (N-SMase) activation associated factor
(Nsmaf), mRNA
N15
Signal
GSK3B AF156099
Mus musculus glycogen synthase kinase 3 1
Transduction beta mRNA, complete cds 1
015
Signal
Transduction
IKK-a NM 007700
Mus musculus conserved helix-loop-helix 
ubiquitous kinase (Chuk), mRNA
B16
Signal
Transduction
IKK-p AF088910
Mus musculus IkB kinase-beta (Ikkb) 
mRNA, complete cds
mkl6fl0.yl Soares mouse p3NMF19.5
Signal
Transduction
Mus musculus cDNA clone
C16 MADD AI595199 IMAGE:493099 5' similar to TR:O08873
008873 RAB3 GDP/GTP EXCHANGE 
PROTEIN. ;, mRNA sequence
D16
Signal
Transduction
MEKK1 AF117340
Mus musculus MAP kinase kinase kinase 1 
(Mekkl) mRNA, complete cds
Signal
Transduction
Mus musculus myeloid differentiation
E16 MYD118 NM 008655 primary response gene 118 (Mydll8), 
mRNA
F16
Signal
Transduction
NF-kB DNA binding 
subunit
NM 008689
Mus musculus nuclear factor of kappa light 
chain gene enhancer in B-cells 1, pi05 
(Nfkbl), mRNA
G16
Signal
Transduction
NF-kB inducing kinase NM 016896
Mus musculus Nfkb inducing kinase (Nik- 
pending), mRNA
Signal
Transduction
Mus musculus avian reticuloendotheliosis
H16 NFicBp65 NM 009045 viral (v-rel) oncogene homolog A (Rela), 
mRNA
mh76el2.rl Soares mouse placenta 
4NbMP13.5 14.5 Mus musculus cDNA
116
Signal
Transduction
Par-4 AA023558
clone IMAGE:456910 5' similar to 
TR.G456282 G456282 CLONE PAR-4 
INDUCED BY EFFECTORS OF 
APOPTOSIS. ;, mRNA sequence
Signal
Transduction
Mus musculus phosphatidylinositol 3-
J16 PI-3 Kinase NM 011084 kinase, C2 domain containing, gamma
polypeptide (Pik3c2g), mRNA
K16
Signal
Transduction
PKC-a NM 011101
Mus musculus protein kinase C, alpha 
(Pkca), mRNA
mf46ell.yl Soares mouse embryo 
NbME13.5 14.5 Mus musculus cDNA
L16
Signal
Transduction
PP2A AI894369
clone IMAGE:408140 5' similar to 
gb:M64929 PROTEIN PHOSPHATASE 
PP2A, 55 KD REGULATORY SUBUNIT, 
ALPHA (HUMAN);, mRNA sequence I
M16
Signal
Transduction
PTEN NM 008960
Mus musculus phosphatase and tensin 1 
homolog (Pten), mRNA 1
Signal
Transduction
retinoic acid nuclear receptor isoform beta 1
N16 RAR02 S56660 2 [mice, embryonal carcinoma cell line, 1 
PCC7-MZ1, mRNA, 2971 nt] |
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Accession
Number Gene Description |
Signal
Transduction
Mus musculus receptor (TNFRSF)- j
016 RIP NM 009068 interacting serine-threonine kinase 1 1
(Ripkl), mRNA 1
B17
Signal
Transduction
RxR-p X66224
M.musculus mRNA for retinoid X j 
receptor-beta (mRXR-beta) I
Signal
Transduction
Mus musculus TRAF family member- |
C17 TANK NM 011529 associated Nf-kappa B activator (Tank), |
mRNA
mhl2f08.rl Soares mouse placenta I
Signal
Transduction
4NbMP13.5 14.5 Mus musculus cDNA j
D17 TRADD AAO13699 clone IMAGE:442311 5' similar to
PIR:A56911 A56911 TRADD protein - 
human mRNA sequence
E17
Signal
TRAF1 NM 009421
Mus musculus Tnf receptor-associated
Transduction factor 1 (Trafl), mRNA
F17
Signal
TRAF2 L35303
Mus musculus TNF receptor associated
Transduction factor 2 (TRAF2) mRNA, complete cds
G17
Signal
TRAF5 NM 011633
Mus musculus Tnf receptor-associated
Transduction factor 5 (Traf5), mRNA
H17
Signal
Transduction
TRAF6 NM 009424
Mus musculus Tnf receptor-associated 
factor 6 (Traf6), mRNA
117
Signal
TRANK NM 016764
Mus musculus peroxiredoxin 4 (Prdx4),
Transduction mRNA
J17
Signal
TRIP NM 011634
Mus musculus TRAF-interacting protein
Transduction (Traip), mRNA
K17
Telomerase
Related
TPl/Tepl NM 009351
Mus musculus telomerase associated 
protein 1 (Tepl), mRNA
L17
Telomerase
TERT/TP2 NM 009354
Mus musculus telomerase reverse
Related transcriptase (Tert), mRNA
M17
Telomerase
TR/TeRc U33831
Mus musculus telomerase RNA
Related component gene
N17
Telomerase
TRF1 NM 009352
Mus musculus telomeric repeat binding
Related factor 1 (Terfl), mRNA
”
Telomerase
TRF2 NM 009353
Mus musculus telomeric repeat binding
Related factor 2 (Ter£2), mRNA 
uo79f09.yl NCI_CGAP_Mam3 Mus 
musculus cDNA clone IMAGE:2648777 5'
B18 TNF Superfamily DR-6 A W211328 similar to TR:O75509 075509 TNFR- 
RELATED DEATH RECEPTOR-6. ;, 
mRNA sequence
C18 TNF Superfamily B-NGF NM 013609
Mouse nerve growth factor (NGF) 
precursor mRNA, complete cds
D18 TNF Superfamily NGFR AF105292
Mus musculus nerve growth factor 
receptor mRNA, complete cds
E18 TNF Superfamily TNF-0/TNFSF2 NM 013693
Mouse tumor necrosis factor (TNF) 
mRNA, complete cds
F18 TNF Superfamily TNF-p/TNFSFl NM 010735
Mus musculus lymphotoxin A (Lta), 1 
mRNA I  
Mus musculus tax-transcriptionally
G18 TNF Superfamily OX40L/TNFSF4 NM 009452 activated glycoprotein 1 ligand (Txgp 11), 
mRNA
H18 TNF Superfamily FasL/TNFSF6 NM 010177
Mus musculus Fas antigen ligand (Fasl), 
mRNA
Mus musculus tumor necrosis factor
118 TNF Superfamily TRAIL/TNFSF10 NM 009425 (ligand) superfamily, member 10 
(TnfsflO), mRNA
TRANCE/RANK 
L/TNFSF11
Mus musculus tumor necrosis factor
J18 TNF Superfamily NM 011613 (ligand) superfamily, member 11
(Tnfsfl 1), mRNA
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Accession
Number
K18 TNF Superfamily T WE AK/TNFSF12 
TALL-
AF030100
L18 TNF Superfamily 1/THANK/BAFF/TNFS
F13B
AF119383
M18 TNF Superfamily LIGHT/TNFSF14 AB029155
N18 TNF Superfamily TNF R1/TNFRSF1A NM 011609
018 TNF Superfamily TNF RII/TNFRSF1B NM 011610
B19 TNF Superfamily OX40/TNFRSF4 NM 011659
C19 TNF Superfamily CD40/TNFRSF5 NM 011611
D19 TNF Superfamily Fas/TNFRSF6 NM 007987
E19 TNF Superfamily
RANK/TRANCE/TNFR
SF11A
NM 009399
F19 TNF Superfamily OPG/TNFRSF1 IB NM 008764
A24 Genomic DNA GEN N/A
B24
Housekeeping
Genes
P2-Microglobulin NM 009735
C24
Housekeeping
Genes
P-Actin X03672
D24
Housekeeping
Genes
Cyclophilin A NM 008907
E24
Housekeeping
Genes
HPRT J00423
F24
Housekeeping
Genes
L19 NM 009078
G24
Housekeeping
Genes
Transferrin R X57349
H24
Housekeeping
Genes
a-Tubulin Ml 3446
124 Negative Control lxTE Buffer N/A
J24 Negative Control lxTE Buffer N/A
K24 Negative Control pUC19 M77789
L24 Negative Control E. coli b0658 gene AE000170
M24 Negative Control E. coli bl444 gene AE000241
N24 Negative Control E. coli b3535 gene AE000430
P24 Genomic DNA GEN N/A
Gene Description
Mus musculus TWEAK mRNA, partial 
cds
Mus musculus B-cell activating factor 
(Baff) mRNA, complete cds
Mus musculus mRNA for LIGHT protein, 
complete cds 
Mus musculus tumor necrosis factor 
receptor superfamily, member la 
(Tnffsfla), mRNA 
Mus musculus tumor necrosis factor 
receptor superfamily, member lb 
(Tnfrsflb), mRNA 
Mus musculus tax-transcriptionally 
activated glycoprotein 1 (Txgpl), mRNA 
Mus musculus tumor necrosis factor 
receptor superfamily, member 5 (Tnffsf5), 
mRNA
Mus musculus Fas antigen (Fas), mRNA 
Mus musculus tumor necrosis factor 
receptor superfamily, member 1 la 
(Tnfrsflla), mRNA 
Mus musculus osteoprotegerin (Opg), 
mRNA 
Genomic DNA
Mus musculus beta-2 microglobulin 
(B2m), mRNA
Mouse cytoskeletal mRNA for beta-actin
Mus musculus peptidylprolyl isomerase A 
(Ppia), mRNA 
Mouse hypoxanthine 
phosphoribosyltransferase (hprt) mRNA, 
complete cds 
Mus musculus ribosomal protein LI9 
(Rpll9), mRNA
M.musculus mRNA for transferrin receptor
Mouse alpha-tubulin isotype M-alpha-2 
mRNA, complete cds
lx TE Buffer
lx TE Buffer
pUC19 cloning vector.
E. coli b0658 gene (ybeX).
E. coli bl444 gene, putative enzyme; not 
classified.
E. coli b3535 gene (yhjR).
Genomic DNA
Table A2.1: Table of genes printed onto the apoptosis arrays. The table presents the 
information provided by Sigma. The table provides the gene name along with its array 
coordinates, gene family and a brief description o f  the gene.
163
Appendix 3: List of Genes Expressed Above 
Background at P7 and P14
Genes Expressed Above Background at P7
Gene ID Gene Family Mean Normalised Value
A B P 1 A p o p t o s i s - R e l a t e d  F a c to r s 2.20
C A S /C S E 1 A p o p t o s i s - R e l a t e d  F a c to r s 2 . 3 0
G S N A p o p t o s i s - R e l a t e d  F a c to r s 1 4 .8 6
A D A M  17 A p o p t o s i s - R e l a t e d  F a c to r s 3 . 0 4
C t s d A p o p t o s i s - R e l a t e d  F a c to r s 1 3 .5 5
H D A p o p t o s i s - R e l a t e d  F a c to r s 3 . 2 6
A P I 5 A p o p t o s i s - R e l a t e d  F a c to r s 2 . 9 7
C y t o c h r o m e  p 4 5 0  o x id o r e d u c t a s e A p o p t o s i s - R e l a t e d  F a c to r s 3 .3 8
H n r p A l A p o p t o s i s - R e l a t e d  F a c to r s 2 1 .7 1
S R E B F 2 A p o p t o s i s - R e l a t e d  F a c to r s 5 .0 3
A T M A p o p t o s i s - R e l a t e d  F a c to r s 2 .4 1
D A D - 1 A p o p t o s i s - R e l a t e d  F a c to r s 3 2 .6 3
I C A D /D F F A A p o p t o s i s - R e l a t e d  F a c to r s 4 . 3 0
P I N A p o p t o s i s - R e l a t e d  F a c to r s 5 0 . 6 4
C A D A p o p t o s i s - R e l a t e d  F a c to r s 2 . 7 0
D a p l A p o p t o s i s - R e l a t e d  F a c to r s 8.10
I n t e g r in - a V A p o p t o s i s - R e l a t e d  F a c to r s 7 . 1 0
M F G E 8 A p o p t o s i s - R e l a t e d  F a c to r s 2 .7 5
T h r o m b o s p o n d in A p o p t o s i s - R e l a t e d  F a c to r s 3 . 2 7
C D 4 7 A p o p t o s i s - R e l a t e d  F a c to r s 2 . 4 0
D E D D A p o p t o s i s - R e l a t e d  F a c to r s 4 . 0 2
C H M L A p o p t o s i s - R e l a t e d  F a c to r s 2 . 7 3
D N A s e  1 A p o p t o s i s - R e l a t e d  F a c to r s 2 . 3 5
R E Q A p o p t o s i s - R e l a t e d  F a c to r s 8 .8 9
T I A L 1 A p o p t o s i s - R e l a t e d  F a c to r s 1 5 .9 7
C I D E - A A p o p t o s i s - R e l a t e d  F a c to r s 2 .4 3
T S S C 3 A p o p t o s i s - R e l a t e d  F a c to r s 2.66
C L D N 3 A p o p t o s i s - R e l a t e d  F a c to r s 2 . 0 4
F e m l B A p o p t o s i s - R e l a t e d  F a c to r s 4 . 6 6
M ts -1 A p o p t o s i s - R e l a t e d  F a c to r s 2 3 . 7 4
T X N A p o p t o s i s - R e l a t e d  F a c to r s 1 4 .7 4
C ln 3 A p o p t o s i s - R e l a t e d  F a c to r s 2 .5 3
F L A S H A p o p t o s i s - R e l a t e d  F a c to r s 3 .4 1
n N O S A p o p t o s i s - R e l a t e d  F a c to r s 2 .4 1
S A G - 1 A p o p t o s i s - R e l a t e d  F a c to r s 4 . 2 6
C lu A p o p t o s i s - R e l a t e d  F a c to r s 7 5 . 3 6
G a le c t in - 3 A p o p t o s i s - R e l a t e d  F a c to r s 2 .7 1
O D C A p o p t o s i s - R e l a t e d  F a c to r s 1 7 .2 7
G A P D H A p o p t o s i s - R e l a t e d  F a c to r s 1 2 3 .3 0
S A R P - 2 / s F R P - l A p o p t o s i s - R e l a t e d  F a c to r s 3 9 . 3 4
C o x - 2 /P t g s 2 A p o p t o s i s - R e l a t e d  F a c to r s 2.12
G P X 1 A p o p t o s i s - R e l a t e d  F a c to r s 5 5 . 0 9
S F R P - 5 /S A R P - 3 A p o p t o s i s - R e l a t e d  F a c to r s 5 .0 2
C a s p a s e - 7 C a s p a s e s  a n d  R e g u la t o r s 1 8 .9 2
C a s p a s e - 2 C a s p a s e s  a n d  R e g u la t o r s 3 .2 3
P A R P C a s p a s e s  a n d  R e g u la t o r s 7 .2 5
C y c l in  G 1 C e l l  C y c l e  R e g u la t o r s 2 8 .6 1  I
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R B B P 6 / P A C T / R B Q 1 C e l l  C y c l e  R e g u la t o r s 7 . 5 0
D P I C e l l  C y c l e  R e g u la to r s 5 .0 8
M D M 2 C e l l  C y c l e  R e g u la to r s 5 . 1 5
A P E X / R e f - 1 C e l l  C y c l e  R e g u la to r s 1118
C a l c y c l i n C e l l  C y c l e  R e g u la to r s 3 .6 1
C B P C e l l  C y c l e  R e g u la to r s 1 3 .2 3
R B L 2 / p l 3 0 C e l l  C y c l e  R e g u la to r s 3 .49
C D K 2 C e l l  C y c l e  R e g u la t o r s 2.66
C D K 4 C e l l  C y c l e  R e g u la t o r s 3 . 0 4
p R B C e l l  C y c l e  R e g u la t o r s 3 . 6 0
R B B P 4 / R b A p 4 8 C e l l  C y c l e  R e g u la t o r s 6 . 1 4
C y c l i n  D 1 C e l l  C y c l e  R e g u la t o r s 3 .1 1
G M - C S F  R a C y t o k i n e s  a n d  R e c e p t o r s 1 3 .2 8
M a n n o s e  6 - p h o s p h a t e  R C y t o k i n e s  a n d  R e c e p t o r s 5 .0 2
M - C S F C y t o k i n e s  a n d  R e c e p t o r s 7 .2 8
I G F -I I C y t o k i n e s  a n d  R e c e p t o r s 4 . 2 9
T G F - p C y t o k i n e s  a n d  R e c e p t o r s 4 . 9 2
T G F - p 2 C y t o k i n e s  a n d  R e c e p t o r s 4 . 1 4
G A S 1 C y t o k i n e s  a n d  R e c e p t o r s 4 . 1 9
P - A c t in H o u s e k e e p i n g  G e n e s 1 0 0 .5 6
C y c l o p h i l i n  A H o u s e k e e p i n g  G e n e s 4 7 .1 1
L 1 9 H o u s e k e e p i n g  G e n e s 1 0 8 .6 3
a - T u b u l in H o u s e k e e p i n g  G e n e s 1 9 .5 8
B a g - 1 M i t o c h o n d r i a l  A s s o c i a t e d 1 1 .4 4
B c l - w M i t o c h o n d r i a l  A s s o c i a t e d 1 2 .4 0
C y t o c h r o m e  C M it o c h o n d r i a l  A s s o c i a t e d 9 .5 7
A K T /P K B S i g n a l  T r a n s d u c t io n 1 3 .2 3
A S K 1 /M A P 3 K 5 S i g n a l  T r a n s d u c t io n 6 . 3 7
M E K K 1 S i g n a l  T r a n s d u c t io n 8 .5 9
M Y D 1 1 8 S i g n a l  T r a n s d u c t io n 2 8 .6 1
D A P  K in a s e S i g n a l  T r a n s d u c t io n 4 . 1 8
E 2 F 1 S i g n a l  T r a n s d u c t io n 4 .2 5
P K C - a S i g n a l  T r a n s d u c t io n 7 .7 1
P T E N S i g n a l  T r a n s d u c t io n 8 .9 7
G S K 3 B S i g n a l  T r a n s d u c t io n 1 0 .2 4
1 4 - 3 - 3  e ta S i g n a l  T r a n s d u c t io n 4 7 . 4 5
T P l / T e p l T e l o m e r a s e  R e la t e d 1 3 .2 6
N G F R T N F  S u p e r f a m i ly 1 5 .3 3
Table A3.1: Genes surviving the filtering process at P7. Genes included in this table were 
shown to have an original spot intensity above the filtering value for at least half o f the 
representative spots.
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1 Gene ID Gene Family Mean Normalised Value 1
A B P 1 A p o p t o s i s - R e la t e d  F a c to r s 2 A 1
C A S /C S E 1 A p o p t o s i s - R e la t e d  F a c to r s 3/71
G S N A p o p t o s i s - R e la t e d  F a c to r s 1 5 .8 9
P D C D 1 A p o p t o s i s - R e l a t e d  F a c to r s 2 . 3 2
S I A H 1 A p o p t o s i s - R e l a t e d  F a c to r s 3 . 3 6
A D A M  1 7 A p o p t o s i s - R e la t e d  F a c to r s 3 .0 5
C ts d A p o p t o s i s - R e l a t e d  F a c to r s 1 5 .0 6
H D A p o p t o s i s - R e l a t e d  F a c to r s 2 1 . 9 6
P D C D 2 A p o p t o s i s - R e l a t e d  F a c to r s 3 .8 5
S R E B F 1 A p o p t o s i s - R e l a t e d  F a c to r s 5 .4 3
A P I 5 A p o p t o s i s - R e l a t e d  F a c to r s 3 .9 0
C y t o c h r o m e  p 4 5 0  o x id o r e d u c t a s e A p o p t o s i s - R e l a t e d  F a c to r s 4 . 6 2
H n r p A l A p o p t o s i s - R e l a t e d  F a c to r s 1 3 .3 5
P I G A A p o p t o s i s - R e l a t e d  F a c to r s 2 . 2 6
S R E B F 2 A p o p t o s i s - R e l a t e d  F a c to r s 11.86
A T M A p o p t o s i s - R e l a t e d  F a c to r s 2.20
D A D - 1 A p o p t o s i s - R e l a t e d  F a c to r s 2 7 . 4 9
I C A D /D F F A A p o p t o s i s - R e l a t e d  F a c to r s 1 5 .0 3
P I N A p o p t o s i s - R e l a t e d  F a c to r s 4 2 . 0 9
T D A G 8 A p o p t o s i s - R e l a t e d  F a c to r s 5 .0 2
C A D A p o p t o s i s - R e l a t e d  F a c to r s 2 . 4 6
D a p l A p o p t o s i s - R e l a t e d  F a c to r s 1 6 .8 5
I n t e g r in - a V A p o p t o s i s - R e l a t e d  F a c to r s 1 4 .6 1
P L A 2 G 1 B A p o p t o s i s - R e l a t e d  F a c to r s 3 . 1 9
T F A R 1 5 A p o p t o s i s - R e l a t e d  F a c to r s 4 . 0 0
C A V 2 A p o p t o s i s - R e l a t e d  F a c to r s 2 . 3 7
D A X X A p o p t o s i s - R e l a t e d  F a c to r s 4 . 3 2
M F G E 8 A p o p t o s i s - R e l a t e d  F a c to r s 7 . 8 9
T h r o m b o s p o n d in A p o p t o s i s - R e l a t e d  F a c to r s 6 . 0 4
C D 4 7 A p o p t o s i s - R e l a t e d  F a c to r s 3 . 5 8
D E D D A p o p t o s i s - R e l a t e d  F a c to r s 7 . 1 6
P R K R A p o p t o s i s - R e l a t e d  F a c to r s 2 . 7 6
C H M L A p o p t o s i s - R e l a t e d  F a c to r s 2 . 8 4
D N A s e  1 A p o p t o s i s - R e l a t e d  F a c to r s 4 . 1 7
R E Q A p o p t o s i s - R e l a t e d  F a c to r s 1 0 .5 1
T I A L 1 A p o p t o s i s - R e l a t e d  F a c to r s 1 3 .4 6
C I D E - A A p o p t o s i s - R e l a t e d  F a c to r s 2 .2 3
D N A s e 2 A p o p t o s i s - R e l a t e d  F a c t o r s 2 . 4 3
C L D N 3 A p o p t o s i s - R e l a t e d  F a c to r s 2 . 8 4
F e m l B A p o p t o s i s - R e l a t e d  F a c to r s 5 .9 1
M ts -1 A p o p t o s i s - R e l a t e d  F a c to r s 2 8 . 2 7
T X N A p o p t o s i s - R e l a t e d  F a c t o r s 12.88
C ln 3 A p o p t o s i s - R e l a t e d  F a c to r s 2 . 9 0
F L A S H A p o p t o s i s - R e l a t e d  F a c to r s 3 . 0 2
S A G - 1 A p o p t o s i s - R e l a t e d  F a c to r s 5 . 8 7
C lu A p o p t o s i s - R e l a t e d  F a c to r s 6 3 . 2 5
G a le c t in - 3 A p o p t o s i s - R e l a t e d  F a c to r s 6 . 6 7
O D C A p o p t o s i s - R e l a t e d  F a c to r s 1 8 .2 4
C o x - l / P t g s l A p o p t o s i s - R e l a t e d  F a c to r s 2 . 9 6
G A P D H A p o p t o s i s - R e l a t e d  F a c to r s 1 6 9 .8 7
P 2 R X 1 A p o p t o s i s - R e l a t e d  F a c to r s 1 8 .0 5
S A R P - 2 / s F R P - l A p o p t o s i s - R e l a t e d  F a c to r s 5 6 . 2 8
C o x - 2 /P t g s 2 A p o p t o s i s - R e l a t e d  F a c to r s 2 .6 3
G P X 1 A p o p t o s i s - R e l a t e d  F a c to r s 4 8 . 4 6
u P A R l A p o p t o s i s - R e l a t e d  F a c to r s 2 . 4 7
S F R P - 5 /S A R P - 3 A p o p t o s i s - R e l a t e d  F a c to r s 6 . 8 7
C a s p a s e - 7 C a s p a s e s  a n d  R e g u la t o r s 1 8 .7 9
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S e n t r i n / U B L l C a s p a s e s  a n d  R e g u la t o r s 3 . 5 7
C a s p a s e - 8 C a s p a s e s  a n d  R e g u la t o r s 2 . 7 0
S u r v iv i n C a s p a s e s  a n d  R e g u la t o r s 2 . 7 6
C a s p a s e - 9 C a s p a s e s  a n d  R e g u la to r s 3 . 6 6
X I A P C a s p a s e s  a n d  R e g u la t o r s 4 . 3 5
F L I P L /C a s h C a s p a s e s  a n d  R e g u la t o r s 3 .2 5
C a s p a s e - 2 C a s p a s e s  a n d  R e g u la to r s 3 . 9 4
C a s p a s e - 3 C a s p a s e s  a n d  R e g u la t o r s 4 . 8 7
P A R P C a s p a s e s  a n d  R e g u la t o r s 7 . 6 9
P A R P - 2 C a s p a s e s  a n d  R e g u la t o r s 3 . 6 2
C y c l in  G 1 C e C y c l e  R e g u la t o r s 5 1 . 2 8
R B B P 6 / P A C T / R B Q 1 C e C y c l e  R e g u la t o r s 6 . 5 0
D P I C e C y c l e  R e g u la t o r s 6 . 7 6
S p l C e C y c l e  R e g u la t o r s 4 T 2
M D M 2 C e C y c l e  R e g u la t o r s 1 6 .8 0
T R P 5 3 /p 5 3 C e C y c l e  R e g u la t o r s 7 . 0 1
5 3 B P 2 C e C y c l e  R e g u la t o r s 2 . 8 7
c - m y c C e C y c l e  R e g u la t o r s 3 .2 3
A P E X /R e f - 1 C e C y c l e  R e g u la t o r s 10.20
p  15  I N K 4 b /C D K N 2 B C e C y c l e  R e g u la t o r s 2 .6 3
C a lc y c l in C e C y c l e  R e g u la t o r s 6 . 5 4
P 1 9 / N S G 2 C e C y c l e  R e g u la t o r s 3 . 9 8
C B P C e C y c l e  R e g u la t o r s 1 2 .9 1
C D C 2 C e C y c l e  R e g u la t o r s 3 .8 1
C D K 2 C e C y c l e  R e g u la t o r s 3 . 1 8
p 3 0 0 C e C y c l e  R e g u la t o r s 4 .0 1
C D K 4 C e C y c l e  R e g u la t o r s 7 . 2 0
C D K 5 C e C y c l e  R e g u la t o r s 4 . 6 3
p R B C e C y c l e  R e g u la t o r s 3 . 6 2
R B B P 4 /R b A p 4 8 C e C y c l e  R e g u la t o r s 7 .7 5
I C y c l in  D 1 C e C y c l e  R e g u la t o r s 5 .6 1
R B P 1 C e C y c l e  R e g u la t o r s 3 .1 1
G M - C S F  R a C y t o k i n e s  a n d  R e c e p t o r s 1 5 .5 8
j M a n n o s e  6 - p h o s p h a t e  R C y t o k i n e s  a n d  R e c e p t o r s 5 . 3 6
I F N - y  R l C y t o k i n e s  a n d  R e c e p t o r s 3 . 4 7
M - C S F C y t o k i n e s  a n d  R e c e p t o r s 8 .3 3
A R C y t o k i n e s  a n d  R e c e p t o r s 3 .4 3
I F N - y  R 2 C y t o k i n e s  a n d  R e c e p t o r s 3 . 9 7
M - C S F  R C y t o k i n e s  a n d  R e c e p t o r s 4 . 0 9
A R T /A g r p C y t o k i n e s  a n d  R e c e p t o r s 3 . 0 0
I G F -I C y t o k i n e s  a n d  R e c e p t o r s 7 .6 5
I L -4  R a C y t o k i n e s  a n d  R e c e p t o r s 2 .9 1
P r o la c t in C y t o k i n e s  a n d  R e c e p t o r s 2 . 5 5
A x l C y t o k i n e s  a n d  R e c e p t o r s 8 .2 7
I G F -I I C y t o k i n e s  a n d  R e c e p t o r s 3 .5 5
T G F - |3 C y t o k i n e s  a n d  R e c e p t o r s 5 . 7 4
I G F  R C y t o k i n e s  a n d  R e c e p t o r s 6 . 8 4
I L - 1 0  R a C y t o k i n e s  a n d  R e c e p t o r s 3 . 1 7
T G F - p 2 C y t o k i n e s  a n d  R e c e p t o r s 9 . 3 2
T G F - p 3 C y t o k i n e s  a n d  R e c e p t o r s 4 .8 3
T G F - P  R I C y t o k i n e s  a n d  R e c e p t o r s 3 .0 8
G A S 1 C y t o k i n e s  a n d  R e c e p t o r s 5 .0 5
P 2 - M i c r o g lo b u l in H o u s e k e e p i n g  G e n e s 2 .9 1
P - A c t in H o u s e k e e p i n g  G e n e s 1 0 5 .5 4
C y c lo p h i l in  A H o u s e k e e p i n g  G e n e s 5 8 . 0 8
H P R T H o u s e k e e p i n g  G e n e s 5 .0 3
L 1 9 H o u s e k e e p i n g  G e n e s 8 2 .3 5
T r a n s f e r r in  R H o u s e k e e p i n g  G e n e s 3 . 6 9
a - T u b u l in H o u s e k e e p i n g  G e n e s 3 2 .6 1  1
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Appendix 3
Gene ID Gene Family Mean Normalised Value 1
B a g - 1 M it o c h o n d r ia l  A s s o c ia t e d 1 6 .0 8
B A K M it o c h o n d r ia l  A s s o c ia t e d 5 .2 4
B a x - a M it o c h o n d r ia l  A s s o c ia t e d 3 . 8 9
B c l - 2 M it o c h o n d r ia l  A s s o c ia t e d 4 . 9 8
B c l - w M it o c h o n d r ia l  A s s o c ia t e d 1 8 .9 4
B c l - x M it o c h o n d r ia l  A s s o c ia t e d 4 . 9 2
B I D M it o c h o n d r i a l  A s s o c ia t e d 3 .3 8
C y t o c h r o m e  C M it o c h o n d r i a l  A s s o c ia t e d 7 .1 3
M c l - 1 M it o c h o n d r i a l  A s s o c ia t e d 8 .0 4
A 1 M it o c h o n d r i a l  A s s o c ia t e d 6 .5 3
1 x T E  B u f f e r N e g a t i v e  C o n tr o l 2 . 8 7
E . c o l i  b l 4 4 4  g e n e N e g a t i v e  C o n tr o l T 9 2
E . c o l i  b 3 5 3 5  g e n e N e g a t i v e  C o n tr o l 2 . 2 8
A K T /P K B S ig n a l  T r a n s d u c t io n 9 .7 3
R x R - p S i g n a l  T r a n s d u c t io n 3 .7 5
T A N K S ig n a l  T r a n s d u c t io n 4 . 7 6
A S K 1 / M A P 3 K 5 S i g n a l  T r a n s d u c t io n 9 .3 3
M E K K 1 S i g n a l  T r a n s d u c t io n 9 . 9 2
B e l - 1 0 S i g n a l  T r a n s d u c t io n 4 .0 3
M Y D 1 1 8 S i g n a l  T r a n s d u c t io n 2 0 . 3 7
N F - k B  D N A  b in d in g  s u b u n it S i g n a l  T r a n s d u c t io n 4 . 2 2
T R A F 2 S i g n a l  T r a n s d u c t io n 3 .4 2
C R A D D S i g n a l  T r a n s d u c t io n 3 .2 1
T R A F 3 /C R A F 1 S i g n a l  T r a n s d u c t io n 4 . 0 6
N F - K B p 6 5 S i g n a l  T r a n s d u c t io n 6 . 7 2
T R A F 6 S i g n a l  T r a n s d u c t io n 6 . 6 0
D A P  K in a s e S i g n a l  T r a n s d u c t io n 5 . 0 9
T R A N K S i g n a l  T r a n s d u c t io n 4 . 5 2
P I -3  K in a s e S i g n a l  T r a n s d u c t io n 2.88
T R I P S i g n a l  T r a n s d u c t io n 2 . 4 5
E 2 F 1 S i g n a l  T r a n s d u c t io n 7 .2 5
P K C - a S i g n a l  T r a n s d u c t io n 9 . 2 0
F A D D S i g n a l  T r a n s d u c t io n 3 . 4 4
F A N S i g n a l  T r a n s d u c t io n 3 .9 8
P T E N S i g n a l  T r a n s d u c t io n 1 3 .3 0
G S K 3 B S i g n a l  T r a n s d u c t io n 7 . 9 9
R A R p 2 S i g n a l  T r a n s d u c t io n 4 . 7 2
1 4 - 3 - 3  e ta S i g n a l  T r a n s d u c t io n 2 8 . 9 5
I K K - a S i g n a l  T r a n s d u c t io n 4 . 3 7
T P l / T e p l T e l o m e r a s e  R e la t e d 7 .8 5
T R /T e R c T e l o m e r a s e  R e la t e d 5 . 8 0
N G F R T N F  S u p e r f a m i ly 1 2 .1 8
F a s L /T N F S F 6 T N F  S u p e r f a m i ly 3 .9 3
T A L L -
1/T H A N K /B  A F F / T N F S F 1 3  B T N F  S u p e r f a m i ly 4 . 6 0  |
Table A3.2: Genes surviving the filtering process at P14. Genes included in this table were
shown to have an original spot intensity above the filtering value for at least half o f  the 
representative spots.
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Appendix 4: Primer Sequences
Accession Number Gene Forward Primer Reverse Primer Annealing Temperature (°C) PCR Products
NM_001001303 Gapdh ACCACAGTCCATGCCATCAC TCCACCACCCTGTTGCTGT A 61 450
Genes shown to be differentially expressed between the two time points
NM_010414 Hd CTGCCACTCACCATTCTCACC CCTCATCCCATTCCTCCTCTC 62 213
NM_008771 P2rxl CTTGGCTATGTGGTGCGAGAG TTGAAGAGGTGACGACGGTTT 62 233
NM_010044 Dffa ACTTCCTCTGCCTTCCTTCCA GCCACATTCTTCCACTTCACC 62 160
NM_010786 Mdm2 GCACACACACACACACACACA AACATAGGCAACCACCAGGAA 61 240
NM_008594 Mfge8 CAACAACTCCCACAAGAAGAACA AGAAGGTCGTCAGCCACAGAA 61 220
NM_010513 IGFlr GCGGCGATGAAGAGAAGAAA TCAGGAAGGACAAGGAGACCA 62 216
NM_009465 Axl AAGAGCGATGTGTGGTCCTTC GGCAGAGCCTTCAGTGTGTTC 61 248
NM_010705 Galectin-3 ACAGTGAAACCCAACGCAAAC GCACAGACACACAACACACAAA 61 594
NM_009742 A1 ATTGCCCTGGATGTATGTGCT GGTTCTCTCTGGTCCGTAGTGTT 61 219
NM_009870 Cdk4 CGACGCAGAGTGAGAAGAGG TCAGGGAGGGAAGAAGACAGA 61 231
NM_009367 Tgf-p2 TT GGATGCT GCCTACTGCTTT GCTTCGGGATTTATGGTGTTG 61 212
NM_011640 p53 GCTGGAT AGGAAAGAGCACAGA GGTTGAGGGCAAGAAATGGA 61 239
NM_146057 Dapl CTGTGTCGCTAAGGAGGGATG TTACAACGGGAGAAACTGACGA 62 121
XM_127995. Srebf2 CAAGTCAGCAGCCAAGGAGAG TCACAAATCCCACAGAGTCCA 61 233
NM_008402 Itg-aV GGCTGCTGTGGAGATAAGAGG GCCTT GCT GAAT G AACTT GG A 61 162
NM_007829 DAXX AAAGAAGCAACTGGGCTCTGG GAGAAGCAGGGATGGAGAAGG 63 214
NM_008562 Mcl-1 atttctttcggtgcctttgtg AAACCCATCCCAGCCTCTTT 59 144
NM_010512 IGF-1 CTCTGCTTGCTCACCTTCACC CACTCATCCACAATGCCTGTCT 63 176
NM_011480 Srebfl TGGCTTGGTGATGCTATGTTG AGGGAACTGTGTGTGTTTCTGG 61 150
NM_011580 Thrombospondin CTGTGACCCTGGACTTGCTGT AGTATCCCTGAGCCCTTGTGG 64 203
Table A4.1: Mouse PCR Primers. This table shows the sequence o f the primers designed for the genes identified from the arrays along with the accession number o f  
the sequence for which the primers were designed, the annealing temperatures o f the primers and the expected product size.
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Accession Number Gene Forward Primer Reverse Primer Annealing Temperature (°C) PCR Product Size (bp)
Housekeeping genes not shown to be expressed above background
NM_009735 p2-Microglobulin CCTGGTCTTTCTGGTGCTTGT TATGTTCGGCTTCCCATTCTC
NM_013556 HPRT TTGGGCTTACCTCACTGCTTT CGCTC ATCTT AGGCTTTGT ATTTG
NM_016638 Transferrin R TCGGCAAGTAGATGGAGATAACA CACGCTTACAATAGCCCAGGTAG
Table A4.2: Mouse PCR primers designed for the housekeeping genes not shown to be expressed on the macroarrays. This table shows the sequence of the 
primers designed for the housekeeping genes identified from the arrays along with the accession number of the sequence for which the primers were designed, the 
annealing temperatures of the primers and the expected product size.
61
61
61
109
758
197
170
Accession Number Gene Forward Primer Reverse Primer Annealing Temperature (°C) PCR Product Size (bp)
NM_001001303 Gapdh GG AG AAACC AGCC AAGT ATG ATG AAAGGTGGAAGAATGGCTGTCA 61 138
Genes shown to be differentially expressed between the two time points
XM_420822 Hd CC AG AAGG AGGT GGT GGT GT AACAGGGCGAAGGGAAGAAG 62 250
- P2rxl Gene sequence not identified - - -
XM_417610 Dffa CTTGCCCAGAATCAAACCAAA CGTGTCAACCACATCCATCTC 61 195
XM_416084 Mdm2 AACTGGTGCCGTCCTAATCT T AAT GT ATGGT GGCTGGGTT G 59 148
XM_413867 Mfge8 GG AAG AT G AGGCTG AGT GGTG GCTGTG AT GGG AGGGTC AAA 62 208
NM_205032 IGFlr AAGTGCTCCGCTTTGTGATG GAGGCTTGTTCTCTTCGCTGT 61 204
- Axl Gene sequence not identified - - -
NM_214591 Galectin-3 CAGTTCCTCATTGTGCTTGG GGAC AGGGATTTGGTGTT AGG 59 165
- A1 Gene sequence not identified - - -
- Cdk4 Gene sequence not identified - - -
NM_001031045 Tgf-P2 CGGAAGGAGGAGGAAGAGGA GAGGGAAGAAGTGATGGCAGA 62 325
NM_205264 p53 CGCT ATG AG AT GCT G AAGG AG A CGTGGCT GAAGGG AAAT GG 62 237
NM_001031003 Dapl CACCAGCAGATTCAGGACAAA TGCGT AAGGT AGGAACACATAGAG 61 345
XM_416222 Srebf2 GTGCCTCTCCTTCAACCCTTT ATCATCCAGCCAAACCATCC 62 246
NM_205439 Itg-aV TTGATTGTTGGAGCCTTTGGT CTTTCCTTTGCCATCTGCTTT 60 189
- DAXX Gene sequence not identified - - -
XM_001233734 Mcl-1 GAGGGCTTTGTTGACTTCTTCC TCCACTTTGCCTTTCTCTCCT 61 178
NM_001004384 IGF-1 GATGCTCTTCAGTTCGTATGTGG GC AGATTT AGGTGGCTTT ATTGG 61 176
NM_204126 Srebfl GCAGAAGAGCAAGTCCCTCAA GTCGGCATCTCCATCACCTC 63 105
XM_421205 Thrombospondin GGGTGAAGCAAGAGAAACCAA CGCAAAGC AGGGATT AGAC A 60 250
Table A4.3: Chick PCR primers designed for genes shown to be differentially expressed from the macroarray results. This table shows the sequence of the 
primers designed for the genes identified from the arrays along with the accession number o f the sequence for which the primers were designed, the annealing 
temperatures of the primers and the expected product size. Genes for which a sequence could not be identified are highlighted in bold.
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Accession Number Gene Forward Primer Reverse Primer Annealing Temperature (°C) PCR Product Size (bp)
Genes shown to be highly expressed at both time points
NM_204900 Clusterin AAGCCCTGCCTCAAACACAC AGATGTCCTCCACTCCGTCCT 62 232
BX935086 Gpxl GC AAAGT GCTGCTGGT GGT TCGTTGGTGGCGTTCTCCT 62 160
BX931030 Pin ATCGTGGGAAGGAACTTTGG CAAGAAGGCTGAAGGAACTGG 61 178
NM_001007839 14-3-3 eta TTGCTGCTGGAGAGAAGAAGAA T G AC AGGG ATTGT G AAGT GG A 61 382
NM_204553 Sfrpl T GGG ACT G ACTGGTGTCTGG GGAGCAATGTGGGACTATGGA 62 219
NM_001007473 Dad-1 GGCTCGGTAGGTTCTGTGGT GG AAGG AGTT G AAGGG AAAGG 61 163
XM_414493 Cyclin G1 TACCTGGCTGTGAAGGCAAC GCTGGGTCTCAAGTCTCTCAA 60 250
BX932320 Mydl 18 ATTACCGCTCGTAGGGCTTCT AATCCGTCCTCCTCCATCAC 61 669
- Mts-1 No primer pair found - - -
XM_421764 Caspase-7 CCACCTTCTGCTTTCGCTTT TCGGTTGTTCTTCTTCTCCATTC 61 202
Table A4.4: Chick PCR primers designed for genes shown to be highly expressed on the macroarrays at both time points examined. This table shows the 
sequence of the primers designed for the genes identified from the arrays along with the accession number of the sequence for which the primers were designed, the 
annealing temperatures of the primers and the expected product size. Genes for which no primer pairs could be designed are highlighted in bold.
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Appendix 5: PCR Results
NB j P7 P14 4wk
Normalised
Value
Standard 
Error of 
Mean
Normalised
Value
Standard 
Error of 
Mean
Normalised
Value
Standard 
Error of 
Mean
Normalised
Value
Standard 
Error of 
Mean
Fold 1 
Difference 
(P14/P7)
Hd 117.38 56.10 44.29 5.68 56.18 8.18 69.15 17.13 1.27
Dffa* 107.37 40.33 48.91 15.05 44.30 5.49 34.50 11.21 0.91
Mdm2 27.94 13.49 53.03 10.83 110.39 68.08 151.41 100.92 2.08
Mfge8 91.58 56.57 55.43 22.66 61.48 19.55 45.37 10.05 1.11
IGFlr 120.07 78.36 44.40 15.46 47.12 9.68 116.58 38.67 1.06
Axl* 160.10 95.61 88.17 16.93 31.65 2.56 39.11 16.71 0.36
Galectin-3 37.18 9.98 35.11 21.79 42.38 14.86 127.67 90.91 1.21
Al* 102.55 36.81 55.54 20.96 10.58 1.90 19.09 16.22 0.19
Cdk4 177.40 67.30 100.87 51.76 100.72 37.98 78.88 38.91 1.00
Srebf2* 153.12 113.93 56.87 12.31 69.16 21.16 176.61 70.64 1.22
TGFp2 97.39 53.02 75.01 29.22 88.83 18.48 98.76 45.21 1.18
Dapl 58.87 28.60 56.92 15.63 56.21 16.59 48.52 17.48 0.99
Integrin-aV* 126.07 60.19 117.94 15.34 83.98 11.64 145.46 42.68 0.71
P53 36.04 19.14 16.76 9.57 26.61 6.74 32.88 15.97 1.59
DAXX* 54.40 27.75 29.71 21.13 34.75 22.40 62.17 50.04 1.17
Thrombospondin* 48.89 6.59 47.51 13.66 14.03 4.89 7.26 0.38 0.30
IGF-1* 85.37 20.23 108.07 34.72 15.84 3.59 10.55 4.55 0.15
Srebfl* 72.04 25.88 66.44 21.05 56.02 6.30 56.03 9.37 0.84
Mcl-1 43.92 20.13 4.88 1.50 34.51 11.54 108.41 46.93 7.07
Table AS.l: Densitometry Results fo r the differential gene expression observed by semi-quantitative PCR. Each PCR was completed three times each time using a different 
cDNA sample and the resulting bands from the PCR reactions were quantified using Scion Image. First, the results were normalised to that obtained for gapdh. Then the 
average band intensity and standard error of the mean were calculated from the three sets of results. These results are presented here. The fold difference was calculated. 
The asterisks mark the genes for which primers were designedfor the sequence identified as a result of a BLAST search.
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Appendix 6: Statistical Analysis of PCR Results
One way ANOVA was used with Tukey’s post-hoc test in SPSS (USA) to 
compare the normalised band intensities across time points in an attempt to 
identify significant changes in expression.
Mouse PCR Results
From the results, a statistically significant difference in expression was only 
noted in 2 genes, thrombospondin and IGF-1. Thrombospondin showed 
significantly differential expression between newborn and 4 weeks, and P7 and 4 
weeks. IGF-1 showed significantly different expression between P7 and P14 and 
P7 and 4 weeks.
Thrombospondin
ANOVA
Sum of 
Squares df Mean Square F Sig.
Between Groups 4302.712 3 1434.237 7.527 .010
Within Groups 1524.327 8 190.541
Total 5827.039 11
Table A6.1: ANOVA results obtained from  analysis o f  the mouse thrombospondin PCR 
results. Results are only significant i f  the sig. value is less than 0.05. A significant difference was 
observed (sig. value 0.010).
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Multiple Comparisons
Dependent Variable: Thrombospondin 
Tukey HSD
(I)
Timepoint (J) Timepoint
Mean
Difference
(I-J)
Std.
Error Sig.
95% Confidence Interval
Lower
Bound
Upper
Bound
2 1.37333 11.27064 .999 -34.7192 37.4659
1 3 34.85667 11.27064 .058 -1.2359 70.9492
4 41.62667(*) 11.27064 .025 5.5341 77.7192
2 1 -1.37333 11.27064 .999 -37.4659 34.7192
3 33.48333 11.27064 .069 -2.6092 69.5759
4 40.25333(*) 11.27064 .030 4.1608 76.3459
3 1 -34.85667 11.27064 .058 -70.9492 1.2359
2 -33.48333 11.27064 .069 -69.5759 2.6092
4 6.77000 11.27064 .929 -29.3225 42.8625
4
1 -41.62667(*) 11.27064 .025 -77.7192 -5.5341
2 -40.25333(*) 11.27064 .030 -76.3459 -4.1608
1 3 -6.77000 11.27064 .929 -42.8625 29.3225
* The mean difference is significant at the .05 level.
Table A6.2: Post-hoc test results obtained from  analysis o f  the mouse thrombospondin PCR 
results. Results are only significant if  the sig. value is less than 0.05. Timepoints 1: newborn, 2: 
P7, 3: PI4, 4: 4 weeks.
IGF-1
ANOVA
I Sum of 
| Squares df Mean Square F Sig.
Between Groups 21742.623 3 7247.541 5.863 .020
Within Groups 9889.449 8 1236.181
Total 31632.072 11
Table A6.3: ANOVA results obtained from  analysis o f  the mouse IGF-1 PCR results. Results 
are only significant if  the sig. value is less than 0.05. A significant difference was observed (sig. 
value 0.020).
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Multiple Comparisons
Dependent Variable: IGF1 
Tukey HSD
(I)
Timepoint
(J)
Timepoint
Mean Difference 
(I-J)
Std.
E rror Sig.
95% Confidence 
Interval
Lower
Bound
-114.6315
-22.4082
-17.1115
Upper
Bound
69.2315
161.4549
166.7515
1 2
3
4
-22.70000
69.52333
74.82000
28.70750
28.70750
28.70750
.857
.150
.116
2 1 22.70000 28.70750 .857 -69.2315 114.6315
3 92.22333(*) 28.70750 .049 .2918 184.1549
4 97.52000(*) 28.70750 .038 5.5885 189.4515
3 1 -69.52333 28.70750 .150 -161.4549 22.4082
2 -92.22333(*) 28.70750 .049 -184.1549 -.2918
4 5.29667 28.70750 .998 -86.6349 97.2282
4 1 -74.82000 28.70750 .116 -166.7515 17.1115
2 -97.52000(*) 28.70750 .038 -189.4515 -5.5885
3 -5.29667 28.70750 .998 -97.2282 86.6349 |
* The mean difference is significant at the .05 level.
Table A6.4: Post-hoc test results obtained from analysis of the mouse IGF-1 PCR results.
Results are only significant if  the sig. value is less than 0.05. Timepoints 1: newborn, 2: P7, 3: 
PI4, 4: 4 weeks.
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Chick PCR Results
No statistically significant differences in expression were observed. An example 
of the results obtained from the statistical analysis is shown below. Post-hoc test 
results are not included as there was no significant difference observed from the 
ANOVA results generated by the SPSS statistical package.
ANOVA
Sum o f Squares df MeanSquare F Sig.
Between Groups 13067.128 5 2613.426 .824 .556
Hd Within Groups 38061.011 12 3171.751
Total 51128.139 17
Between Groups 43720.497 5 8744.099 1.600 .234
P53 Within Groups 65572.521 12 5464.377
Total 109293.018 17
Between Groups 21217.084 5 4243.417 .747 .603
Mcl-1 Within Groups 68125.536 12 5677.128
Total 89342.621 17
Between Groups 17490.292 5 3498.058 2.100 .136
Mdm2 Within Groups 19991.936 12 1665.995
Total--------------------------- 37482.228 17
Table A6.5: Example o f the statistical results obtained from analysis o f the chick PCR results.
Results are only significant if  the sig. value is less than 0.05.
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Appendix 7: Statistical Analysis of Western Blotting 
Results
One way ANOVA was used with Tukey’s post-hoc test in SPSS (USA) to 
compare the normalised band intensities across timepoints in an attempt to 
identify significant changes in expression.
Axl
ANOVA
Sum of 
Squares df Mean Square F Sig.
Between Groups 3.776 3 1.259 2.380 .145
Within Groups 4.232 8 .529
Total 8.008 11
Table A7.1: ANOVA results obtained from analysis of the mouse axl western blotting results.
Results are only significant if the sig. value is less than 0.05.
No significant difference in expression was observed for Axl at any of the 
timepoints examined.
Mcl-1
Short Isoform: Mcl-ls
ANOVA
Sum of 
Squares df Mean Square F Sig.
Between Groups .013 3 .004 .768 .543
Within Groups .046 8 .006
Total .060 11
Table A7.2: ANOVA results obtained from analysis of the mouse mcl-1 s western blotting 
results. Results are only significant if  the sig. value is less than 0.05.
No significant difference in expression was observed for Mcl-1 s at any of the 
timepoints examined.
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Long Isoform: Mcl-1 l
ANOVA
Sum of 
Squares df Mean Square F Sig.
Between Groups .001 3 .000 5.148 .028
Within Groups .000 8 .000
Total .001 11
Table A7.3: ANOVA results obtained from analysis o f the mouse mcl-lL western blotting 
results. Results are only significant if  the sig. value is less than 0.05. Results showed a 
significant difference (sig. value 0.028).
Multiple Comparisons
Dependent Variable: Mcl-1 L 
Tukey HSD
(I)
Timepoint
(J)
Timepoint
Mean Difference 
(I-J)
Std.
E rro r Sig.
95% Confidence 
Interval
Lower
Bound
Upper
Bound
1.00 2.00 -.01881036(*) .00487130 .020 -.0344100 -.0032107
3.00 -.00633032 .00487130 .588 -.0219299 .0092693
4.00 -.00825779 .00487130 .385 -.0238574 .0073418
2.00 1.00 .01881036(*) .00487130 .020 .0032107 .0344100
3.00 .01248004 .00487130 .123 -.0031196 .0280797
4.00 .01055257 .00487130 .212 -.0050470 .0261522
3.00 1.00 .00633032 .00487130 .588 -.0092693 .0219299
2.00 -.01248004 .00487130 .123 -.0280797 .0031196
4.00 -.00192748 .00487130 .978 -.0175271 .0136721
4.00 1.00 .00825779 .00487130 .385 -.0073418 .0238574
2.00 -.01055257 .00487130 .212 -.0261522 .0050470
3.00 .00192748 [ .00487130 .978 -.0136721 .0175271
* The mean difference is significant at the .05 level.
Table A7.4: Post-hoc test results obtained from analysis of the mouse mcl-1 L PCR results.
Results are only significant if  the sig. value is less than 0.05. Timepoinst 1: newborn, 2: P7, 3: 
PI4, 4: 4 weeks.
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